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Abstract 
ABSTRACT 
Members of the Caliciviridae family are small, non-enveloped viruses with a single-
stranded positive sense RNA genome of about 7.5 kb in size. This family includes 
several significant pathogens of man and animals such as Norwalk virus which is the 
major causative agent of gastroenteritis in humans. Feline calicivirus (Fey) belongs to 
the Vesivirus genus and is an important pathogen of the upper respiratory-tract of cats. 
Fey is the best characterised member of the calicivirus family due to its efficient 
replication in cultured feline cells. Recent studies showed that cells infected with Fey 
undergo morphological and biochemical changes typical of apoptosis such as chromatin 
condensation, phosphatidylserine extemalization, activation of caspase-2, -3, -7 and 
cleavage of poly (ADP-ribose) polymerase. 
The aim of this project is to further characterize the molecular mechanism of Fey-
induced apoptosis and define the role of apoptosis in Fey replication. In this study we 
demonstrated that Fey induces translocation of the pro-apoptotic member of the Bc1-2 
family proteins Bax from the cytosol to the mitochondria. This occurs in parallel with a 
drop in the mitochondrial membrane potential and release of cytochrome c from the 
mitochondria to the cytosol. These mitochondrial events precede activation of caspase-3, 
-9 and extemalization of phosphatidylserine from the inner to the outer surface of the 
plasma membrane. In our attempt to investigate the events that lead to cytochrome c 
release and Bax translocation during FeY-induced apoptosis, we found that in addition 
to caspases, two other proteolytic systems, calpains and the proteasome, and possibly the 
double stranded RNA-activated protein kinase (PKR) are involved in Fey -induced 
apoptosis and may play an important role in the mitochondrial events. Finally, in the 
present study we demonstrated that apoptosis is not required for efficient viral 
replication. 
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1 INTRODUCTION 
1.1 CALICIVIRUS FAMILY 
The caliciviruses are a family of single-stranded RNA viruses which cause serious 
disease in both man and animals (reviewed in Clarke & Lambden, 1997; Thiel & Konig, 
1999; Clarke & Lambden, 2000). Caliciviruses were originally classified as members of 
the Picornaviridae family on the basis of their appearance under electron microscopy. 
However, it became clear that these viruses were different from the picomaviruses in 
their structure and replication strategy, thus, in 1978, they were reclassified as a new 
family: the Caliciviridae (Green et al., 2000). 
Characteristic features of this family of viruses include the organization of the viral 
genome in two or three open reading frames, with the sequences encoding the non-
structural proteins located at the 5' end and the presence of a single capsid protein 
encoded by a subgenomic mRNA (reviewed in Clarke & Lambden 1997; Green et al., 
2000). 
Based on phylogenetic analysis, the Caliciviridae family is divided into four major 
genera; Vesivirus, Lagovirus, Norovirus and Sapovirus (Table 1.1) (Green et al., 2000). 
Viruses within each genus share common features in the genome organization and 
reading frame usage. Selected examples of caliciviruses in each genus are described 
below. 
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FAMILY GENUS SPECIES 
Vesicular Exanthema of Swine virus 
(VESV) 
San Miguel Sea Lion virus (SMSV) 
Vesivirus Primate Calicivirus-l (Pan-I) 
Feline Calicivirus (FCV) 
Canine Calicivirus 
Walrus CalicivirusJWCV~ 
Rabbit Haemorrhagic Disease virus 
Lagovirus 
(RHDV) 
European Brown Hare Syndrome virus 
(EBHSV) 
GENOGROUP I: 
Norwalk virus (NV) 
Southampton virus (SHV) 
CALICIVIRIDAE GENOGROUP II: 
Norovirus Leeds virus Lordsdale virus (LDV) 
Camberwell virus 
GENOGROUP III: 
Bovine Enteric Calicivirus Jena (BEC-
Jena) 
GENOGROUP 1: 
Sapporo virus (SV) 
Manchester virus 
Sapovirus GENOROUP II: London/92 virus 
GENOGROUP III: 
Porcine Enteric Calicivirus-Cowden (Po-
Cowden) 
Table 1.1: The Caliciv;ridae family. Table categorizing the members of the Caliciviridae by family, 
genus and representative species. Adapted from Clarke & Lambden, J 997; 2000; Green et al., 2000; 
Lopman et ai, 2002. 
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1.2 VESIVIRUS 
1.2.1 Vesicular Exanthema of Swine virus. 
This genus includes the virus considered to be the prototype species of caliciviruses, 
Vesicular Exanthema of Swine virus (VESV). This virus was the first documented 
calicivirus associated with a disease (Clarke & Lambden, 1997). 
The last outbreak of VESV occurred in 1956 in the US and was traced to the feeding of 
meat from sea mammals resulting in a pig-to-pig infection (Thiel & Konig, 1999). 
VESV causes a contagious disease in pigs with symptoms that are indistinguishable from 
those of foot and mouth disease, such as formation of vesicular lesions predominantly on 
the snout, oral mucosa and feet (reviewed in Carter et al., 1991). The virus can be found 
in all tissues of the infected pigs and depending on the virus type, host and environmental 
factors, the infection carries a high risk of piglet mortality. 
1.2.2 San Miguel Sea Lion virus. 
A closely related virus was isolated from lesions on the flippers of sea lions on San 
Miguel island, California. This virus, termed San Miguel Sea Lion virus (SMSV) was 
also found in fish that were preyed on by sea lions, raising the possibility that SMSV 
could be transmitted through food (Carter et al., 1991). 
SMSV is serologically distinct from VESV, but these viruses are clearly related as they 
show a high nucleotide sequence homology, similar host range and clinical symptoms. 
Interestingly, SMSV can also produce symptoms of vesicular exanthema when 
inoculated into pigs. Consequently, it is possible that VESV is a virus of marine origin 
that spread to pigs through contaminated feed of marine source (Clarke & Lambden, 
1997). 
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1.2.3 Feline Ca/icivirus. 
Feline Calicivirus (FCV) is another member of the Vesivirus genus, first isolated in 1957 
in New Zealand when a cytopathic virus was recovered from cats dying from 
panleukopenia (Carter et ai., 1991). FCV is the second largest cause (after Feline 
Herpesvirus) of feline upper respiratory tract infection. Infection is associated with 
vesiculation/ulceration of the oral cavity, conjunctivitis, trachitis, rhinitis, fever, anorexia 
and lethargy (reviewed in Carter & Cubbitt, 1998). The degree of illness exhibited by 
infected animals ranges from mild disease to severe respiratory disease and pneumonia, 
usually associated with virulent strains. Mortality may reach 33%, especially among 
kittens which are more susceptible to the virus. However, the virus is able to establish a 
persistent infection in some animals which become long life carriers. The tonsils are 
likely to be the major, but not the only, site for viral persistence (Carter et ai., 1991). The 
virus is transmitted by inhalation of infected droplets or by ingestion and virus particles 
can be isolated from the upper respiratory tract and other sites such as spleen, lymph 
nodes, kidney and blood (Studdert et ai., 1970). For a long time, FCV was the only 
member of the caliciviruses that could be grown in tissue culture. Therefore, it is 
probably the best characterized member of the Caliciviridae family and it has been used 
for years as a model for the non-cultivable human caliciviruses (Clarke & Lambden, 
1997; 2000; Green et ai., 2000). 
1.3 LAGOVIRUS 
1.3.1 Rabbit Haemorrhagic Disease virus. 
The type species of Lagovirus, Rabbit Haemorrhagic Disease virus (RHDV), was first 
isolated in China in 1984 during an outbreak in rabbits. Outbreaks of a disease showing 
similar clinical signs have been reported in Korea, Europe, Australia and New Zealand 
(Meyers et al., 2000). The virus isolated from infected livers was initially classified as a 
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picornavirus or parvovirus until detailed analysis of the capsid structure and genome 
composition indicated that RHDV was a member of the calicivirus family (Ohlinger et 
al., 1990). The course of rabbit hemorrhagic disease is dramatic; the virus causes a 
pronounced enlargement of the liver and a necrotizing hepatitis that kills the rabbits often 
within a few days (Thiel & Konig, 1999). 
A system for in vitro infection of isolated rabbit primary hepatocytes had been 
established (Konig el al., 1998); however the hepatocyte system is difficult to use in 
routine analysis and expression of viral sequences in prokaryotic or insect systems, as 
well as transient expression in mammalian cells, have been used to study RHDV viral 
replication and polyprotein processing (Alonso et al., 1996; Wirblich et al., 1996; 
Meyers et al., 2000). The genome of RHDV was the first full-length sequence reported 
for the caliciviruses (Meyers et al., 1991) and was shown to be closely related to 
European Brown Hare Syndrome virus (EBHSV) a virus first described in Sweden in 
1980 and then recognized in several European countries including the UK (Carter et al., 
1991; Wirblich et al., 1994). The pathology of EBHSV infection is very similar to the 
one described above for RHDV. 
1.4 NOROVIRUS 
The remaining two genera, Norovirus and Sapovirus, include human caliciviruses 
(HuCVs) associated with acute non-bacterial gastroenteritis in humans worldwide 
(reviewed in Clarke & Lambden, 2000). HuCVs have been grown in primary human 
embryo cells in culture and also in a dolphin cell line (Carter et aI., 1991). However, 
these methods have not been widely applied as the human embryo cells are not widely 
available and the dolphin cells rapidly loose their ability to support viral replication. In 
addition, in common with other enteric viruses, virus growth depends on a proteolytic 
supplement such as trypsin which damages the cells. These factors, combined with the 
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fact that these viruses have a fragile, single stranded RNA genome, have represented a 
tremendous obstacle to characterize the viral replication strategy and genome 
organization. 
The main experimental approaches for defining the structure of the viral genome include 
a combination of site-directed mutagenesis and in vitro translation studies, as well as 
expression of the viral genome in prokaryotic, insect and mammalian systems (Liu et al., 
1999; Seah et al., 1999; Hardy et al., 2002; Belliot et al., 2003; Blakeney et ai., 2003). 
Recently, a tissue culture and animal system has been established for a new member of 
the Norovirus genus, the Murine Norovirus-l (MNV -I). This virus is able to infect the 
intestinal tract of mice following oral inoculation and grows in macrophage and dendritic 
cells, providing the first tissue culture model for a norovirus (Wobus et al., 2004). 
Noroviruses are the most common cause of viral diarrhoea outbreaks worldwide in adults 
(Lopman et aI, 2002). The viruses are contracted via the oral route and replication is 
thought to occur in the small intestine. In the absence of other factors, infections are 
typically mild and the duration of illness is relatively short. The disease is characterized 
by nausea, vomiting, non-bloody diarrhoea, abdominal cramps and headache (Lopman et 
ai, 2002). Norwalk virus (NV) was first described in 1972 during an epidemic of 
gastroenteritis in a school in Norwalk, Ohio (Clarke & Lambden, 1997). It is now 
believed that 95% of non-bacterial gastroenteritis outbreaks are caused by NV (Green et 
al.,2000). 
Based on genetic divergence in the polymerase and capsid region, noroviruses are 
divided into three distinct genogroups (GGs). GGI and II contain human infecting 
viruses, such as GGI Norwalk virus and GGII Lordsdale virus. The GGIII includes 
animal viruses such as Bovine Enteric virus (BEV -Jena) (Green et al., 2000; Lopman et 
al., 2002). Examination of negatively stained NV by electron microscopy showed that 
this virus lacks the cup shape characteristic of caliciviruses and has an amorphous 
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appearance with a fuzzy outer edge (Clarke & Lambden, 2000). For this reason, NV 
became the prototype strain for a group of morphologically similar viruses associated 
with epidemic gastroenteritis, commonly called Small Round Structured viruses or 
Norwalk like viruses (Green et al., 2000). 
1.5 SAPOVIRUS 
Human enteric caliciviruses with the characteristic cup shape morphology were 
segregated from the Norwalk like viruses and classified as a separate genus: Sapovirus 
(Green et al., 2000). These viruses are also known as classical HuCVs. 
As for the noroviruses, sapoviruses are divided into three GGs; again the first two GGs 
contain human viruses (GG! Manchester virus and GGIl Londonl92 virus) while the third 
contains animal viruses such as Porcine Enteric Calicivirus-Cowden strain (Po-Cowden) 
(Lopman et al., 2002). 
The prototype of this genus, Sapporovirus (SV), was detected in an outbreak of 
gastroenteritis in young children and infants in 1982 in Sapporo, Japan (Clarke & 
Lambden, 2000). SV was one of the first HuCV with classical morphology to be 
characterized as antigenically distinct from NV, although the first published sequence for 
classical HuCV was that of the Plymouth strain in 1994 (Lambden et al., 1994). The 
availability of this and other full length genomic sequences provided the final evidence 
that these viruses are genetically distinct from the Norwalk like viruses (Clarke & 
Lambden, 2000). 
The route of infection and the clinical symptoms are similar to those of noroviruses 
(Lopman et al., 2002). Classical HuCVs or Sapporo like viruses are rarely reported and 
are usually associated with paediatric gastroenteritis (Clarke & Lambden, 2000). 
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1.6 CALICIVIRUS MORPHOLOGY 
The caliciviruses take their name from the characteristic cup-shaped depressions that can 
be seen on the surface of some, but not all, of these viruses (Figure. 1.1). The virions are 
not enveloped and are composed of a single major structural protein of about 62 kDa. 
The virus particles are 40.5 nm in diameter and exhibit a T=3 icosahedral symmetry 
(reviewed in Carter et ai., 1991; Clarke & Lambden, 1997; Green et ai., 2000). 
Under electron microscopy, negatively stained virions show 32 large cup shape surface 
hollows surrounded by 90 distinctive arch-like capsomeres (Prasad et al.. 1994b). Each 
capsomere is a dimer of the capsid protein, thus the capsid is made up of 180 capsid 
protein units in total. The cup-like hollows display a very characteristic pattern when 
viewed along the two-, three- and five-fold axes of symmetry (Figure 1.2) (Prasad et al., 
1994a). Along the two-fold symmetry axis, four dark hollows are seen arranged as a 
cross. Along the three-fold axis, a central dark hollow is surrounded by six others 
forming a "star of David", a pattern which is unique to the caliciviruses. Finally, the view 
along the five-fold axis shows a central hollow with ten spike-like projections around the 
periphery of the particle forming a "ten point sphere". 
X-ray crystallography studies revealed that the capsid proteins have two domains (Prasad 
et ai., 1999). The shell domain (S), which corresponds to the N-terminal region of the 
capsid protein, forms the inner part of the capsid. The protruding domain (P), 
corresponding to the C-terminal region of the capsid protein, forms the arch like structure 
that emanates from the shell. The P domain is further divided into two subdomains, a 
central stem domain termed PI and a distal globular head domain, called P2, which 
appears to be bilobed. A comparison of the capsid protein from various caliciviruses 
reveals that the S domain is well conserved, the PI subdomain is only moderately 
conserved and the P2 subdomain is highly variable (Chen et ai., 2004). According to 
these observations, the P domain displays two types of structural variation. One of them 
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involves the relative orientation of the P domain with respect to the S domain, and the 
other involves the shape and the size of the P2 sub domain (Chen et aI., 2004). It has been 
suggested that this hypervariable P2 subdomain is involved in cell binding, antigenicity 
and host specificity (Chen et al., 2004). 
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Figure 1.1: Calicivirus morphology. egative contrast electron micrographs of 
Pan-l (A) and NY (B). ote the absence of the characteristic cup-shape hollows in 
NY virions. Bars represent 50 nrn. Image reconstruction of Pan-I (C) and NY like 
particles (D) from cryo-electron microscopy. Adapted from Green e/ al. , 2000. 
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2 3 5 
Figure 1.2: Three dimensional structures of calicivirus virions. (Upper) 
Negative contrast electron micrographs of calicivirus particles showing the 
characteristic cup-shape hollows on the surface of the virions. (Lower) Diagram 
representing the cup-shape hollow patterns along the two- (cross), three (star of 
David) and five-fold axes (ten points sphere). Adapted from Carter el al., 1991 . 
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1.7 THE CALICIVIRUS GENOME 
The caliciviruses have a single-stranded RNA genome of positive polarity, about 7-8 kb 
in length (reviewed in Clarke & Lambden, 1997; Carter et al., 1992a). The genome is 
polyadenylated at the 3'end and lacks a methylated cap at the 5' end. Instead, the viral 
RNA is covalently linked to a 15 kDa viral protein called virion protein genome-linked 
(VPg) (Herbert et al., 1997). The non-structural polyprotein coding sequences are located 
at the 5' end of the genome while the structural polypeptide coding sequences are located 
at the 3' end (Figure 1.3) (Clarke & Lambden, 2000; Green et ai., 2000). 
Amongst the calicivirus family, the arrangement of the open reading frames (ORFs) 
determines two different genome organizations. In the first one, typical of vesiviruses 
and noroviruses, the sequences encoding the non-structural polyprotein and the capsid 
protein are in different ORFs. In lagoviruses and sapoviruses these ORFs are fused 
together, producing a giant polyprotein precursor (Clarke & Lambden, 1997). These two 
different genome organizations are represented in the genomes of FCV (Vesivirus) and 
RHDV (Lagovirus) (Figure 1.3). 
1.7.1 FCV genome. 
The FCV genome contains three ORFs (Tohya et al., 1991; Carter et aI., 1992a; Carter, 
1994). The first ORF (ORF1) begins at nucleotide 20 and encodes the non-structural 
proteins (Neill, 1990), the second ORF (ORF2) encodes the precursor of the viral capsid 
protein (Neill et al., 1991; Carter et ai., 1992b) and the 3' terminal ORF (ORF3) a small, 
highly basic protein (Herbert et al., 1996). The nucleotide sequence at the junction 
between ORFI-ORF2 and ORF2-0RF3 is absolutely conserved. The termination codon 
for ORF 1 is followed by two bases and the first base of the initiation codon for ORF2 
which is, therefore, frameshifted -1 relative to ORFI (GTT TGA GC d.TG TGC). 
ORF3 is frameshifted -I relative to ORF2 but in this case the termination codon of 
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ORF2 overlaps the initiation codon of ORF3 by four nucleotides (AAG TTd. TG AAT). 
1.7.2 RHDVgenome. 
The RHDV genome contains two ORFs. ORFI is located at the 5' end ofthe genome and 
begins at nucleotide 10. In contrast with FCV, ORFI contains the non-structural protein 
sequence fused and in frame with the capsid protein sequence forming a contiguous 
coding region that occupies 94% of the viral genome (Meyers et al., 1991). This ORF 
encodes the non-structural and the capsid proteins as a large polyprotein precursor of 
2344 amino acids (257 kDa) (Meyers et al., 1991). 
ORF2 corresponds in size and location to the sma1l3'terminal ORF3 of FCV. This ORF 
has a 17 nucleotide overlap with ORFI and is frameshifted -1 relative to it (Meyers et al., 
1991). ORF2 encodes for a protein of 177 amino acids that shares 29% amino acid 
sequence identity with the FCV ORF3 protein. Interestingly, computer analysis of the 
Manchester virus (Sapovirus genus) genome sequence predicts a third ORF overlapping 
with the capsid sequence but in a different frame (Liu et al., 1995). This ORF is 483 
nucleotides in length and encodes a small basic protein of 161 amino acids (17.5 kOa). 
The same ORF has been found in another UK virus, Plymouth virus (Liu et al., 1995). 
The start codon for this ORF is in a strong favoured context for translation initiation, 
suggesting that a biologically active protein product may be expressed during viral 
replication. 
A common feature between these different genome organizations is the presence of a 
repeated sequence of 24-25 nucleotides located at the 5' end and at the start of the capsid 
sequence (Lambden et al., 1994). These short repeated sequences may have a role in 
replication and transcription or in providing signals for packaging of the viral RNA into 
the virus capsid. However, these characteristic repeated sequences are not found in 
members of the Sapovirus genus (Clarke & Lambden, 1997). 
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Recently, it has been proposed that the ORF3 nucleotide sequence contains an important 
cis-acting RNA signal for the replication of the viral genome (Sosnovtsev et al., 2005). 
Two types of mutation were introduced into an infectious FeV clone to evaluate the 
functional importance of ORF3 and its encoded protein, VP2. One was a point mutation 
that generated a premature stop codon at the beginning of the ORF3 sequence and the 
other was a deletion of the entire ORF3, with the exception of the first six codons and the 
poly-A tail. The effects of these mutations were very different. The point mutation was 
tolerated by the viral replication machinery, but infectious virus could not be recovered, 
suggesting that VP2 is essential for productive replication. The deletion mutation was 
lethal for the virus, demonstrating that the ORF3 nucleotide sequence contains structural 
elements involved in replication of the viral RNA (Sosnovtsev et al., 2005). 
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Figure 1.3: The caliciviru genome organization. The calicivirus genome is a single-stranded RNA 
of positive polarity, polyadenylated at the 3' end and covalently linked to a viral protein (VPg) at the 5' 
end. Members of the Caliciviridae family present two different arrangements of the ORFs. The FeV 
genome (representative of Vesivim and orovirll genus) is organized into three ORFs. ORF I encodes 
non-structural proteins. ORF2 encodes the capsid protein (VP I) and ORF3 a minor component of the 
virion (VP2). The RHDV genome (repre entative of Lagovirus and Sapo virus genus) displays two 
ORFs. The first encodes the non- tructural proteins and the cap id protein while ORF2 encodes VP2. 
The caliciviruse produce an abundant subgenomic RNA which is 3' coterminal with the genomic R A 
and is al 0 covalently linked to VPg at the 5' end. The R A encodes the capsid protein and VP2. 
Regions with amino acid sequence homology to the picomaviral TPase, proteinase (Pro) and 
polymera e (Pol) are repre ented. The black arrows denote the location of the first AUG codon in each 
ORF. Adapted from Clarke & Lambden, 1997. 
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1.8 SVBGENOMIC RNA 
After infection of cells, FCV produces an abundant 2.4 kb single-strand RNA of positive 
sense which has been demonstrated to be 3' co-terminal with the genomic RNA (Figure 
1.3) (Neill & Mengeling, 1988; Carter, 1990; Herbert et al., 1996). This subgenomic 
RNA is also polyadenylated at the 3' end and covalently linked to the VPg protein at the 
5' end (Herbert et al., 1996; 1997). The sub genomic RNA functions as a bicistronic 
mRNA encoding both ORF2 and ORF3 (Neill et aI., 1991; Herbert et al., 1996). 
Detection of the minus strand copies of the subgenomic RNA in infected cells suggests 
that it can replicate like the genomic RNA (Carter, 1990). 
The subgenomic RNA is also produced by SMSV and VESV (Clarke and Lambden, 
1997), RHDV (Meyer et al., 1991), EBHSV (Wirblich et al., 1994) and MNV I (Wobus 
et al., 2004). In addition, analyses of stool samples from human volunteers infected with 
NV have shown the presence of a 2.3 kb RNA, suggesting that NV may also encode a 
subgenomic RNA (Jiang et al., 1993). Studies on the subgenomic RNA of FCV and 
RHDV mapped the 5'end of this RNA to nucleotide 5297 and 5296 on the viral genome 
respetively (Meyer et al., 1991; Neill et 01., 1991). The subgenomic RNA contains the 
short repeated sequences at the 5' end identical to that at the start of the capsid sequence 
and very similar to that at the 5' end of the viral genome (Meyer et al., 1991; Neill et al., 
1991). 
Two major models have been proposed for subgenomic RNA synthesis in positive-strand 
RNA viruses (reviewed in Miller & Koev, 2000). The first is the internal initiation model 
in which the polymerase synthesizes the positive subgenomic RNA strand from an 
internal promoter recognized on the negative RNA strand. In the premature termination 
model, the polymerase dissociates from the genomic template at an internal terminator 
leading to the synthesis and accumulation of a truncated negative strand which will be 
the template for the positive subgenomic RNA strand. Recent studies of subgenomic 
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RNA synthesis in vitro using a recombinant RHDV polymerase supports the internal 
initiation model (Morales et al., 2004). 
It has been demonstrated that both genomic and sub genomic RNA are packed separately 
into viral particles (Meyers et al., 1991; Neill, 2002). The encapsidation of the 
subgenomic RNA leads to the production of low density viral particles also called 
defective particles with unknown function. Interestingly, FCV strains with low virulence 
produce more defective particles than virulent strains (Neill, 2002). It is possible that 
these defective particles may interfere with infection, competing with the binding and 
uptake of the complete infectious viral particles, but the precise mechanism and the 
reason for the interference are not known. 
1.9 NON- STRUCTURAL PROTEINS 
The first ORF of the calicivirus genome contains regions that have amino acid sequence 
homology with the 2C-like NTPase, 3C-like cysteine protease and 3D-like RNA 
dependent RNA polymerase regions of the picornaviruses (Figure 1.3) (Neill, 1990). 
Previous studies regarding the synthesis of viral proteins in feline kidney cells infected 
with FCV, demonstrated the presence of several non-structural proteins ranging in size 
from approximately 13 kDa to 96 kDa (Carter, 1989). The maturation of such proteins 
involves a co-translational autocatalytic processing of a long polyprotein precursor of 
about 1763 amino acids. This process is catalyzed by the viral 3C-like cysteine 
proteinase which can cleave the polyprotein precursor in cis and in trans, leading to the 
release of the mature viral proteins. Mutagenesis studies confirmed that cysteine in 
position 1193, located within the putative active site, was essential for the activity of the 
FCV proteinase (Sosnovtsev et al., 1999). 
In vitro expression of FCV ORFI and direct N-terminal sequence analysis allowed the 
identification of five cleavage sites recognized by the viral proteinase, that define the 
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borders of six non-structural proteins: the proposed FCV ORF I polyprotein gene order is 
NH2 - p5.6 - p32 - p39 (NTPase) - p30 - Vpg - 3C like cysteine proteinase (Pro) - RNA 
dependent RNA polymerase (Pol) - COOH (Figure 1.4) (Sosnovtsev et al., 2002). All of 
these proteins were recognized by specific antisera either in an in vitro system or in 
infected cells and mutagenesis studies on an infectious FCV c-DNA clone demonstrated 
that all these cleavages are essential for the virus growth. Similar cleavage patterns of the 
polyprotein precursor have been found in NV (Jiang et al., 1993), Southampton virus 
(SHV) (Liu et al., 1996), MD145-12 norovirus (Belliot et al., 2003), RHDV (Meyers et 
al., 2000) and human Sapovirus Mcl 0 (Oka et al., 2005). 
In members of the Lagovirus and Sapovirus genera, since the non-structural proteins are 
fused with the capsid protein, an additional cleavage performed by the viral proteinase is 
required to release the mature RNA polymerase from the capsid protein (Figure 1.4). 
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Figure 1.4: Caliciviru polyprotein proces ing. Calicivirus ORF 1 encodes a large po lyprotein 
precursor that is proce ed by co-translational autocatalytic cleavages catalyzed by the vira l proteinase. 
This proce leads to the maturation of several non- tructural proteins and, in the case of RHDV, of the 
cap id protein. The diagram repre ent the mature viral proteins released from the po lyprotein 
precur or and the major cleavage ite (black arrows) recognized by the viral proteinase of Vesivirus, 
Lagoviru and orol'irus. Recently, polyprotein processing of the apovirus Me 10 has been described 
and hown to be very similar to RHD (Oka el al., 2005). An additiona l cleavage site has been 
ugge ted in the -terminal protein of MD 145-12 (not hown) ( eah el aI., 2003). Amino ac ids 
flanking the cleavage ite are indicated u ing one letter code (A: alanine; D: aspartic acid; E: glutamic 
acid; : glycine; : asparagine; Q: glutamine; : erine; T: threonine). Adapted from Meyers el aI., 
2000; 0 novt ev et aI., 2002; Belliot el al., 2003. 
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1.9.1 N-terminal proteins. 
The N-tenninal region of the calicivirus genome is highly divergent between members of 
this family. In Vesivirus, Lagovirus and Sapovirus genera, two proteins, p5.2 and p32 for 
FCV, pI6 and p23 for RHDV, are derived from this region (Meyers et al., 2000; 
Sosnovtsev et al., 2002; Oka et al., 2005). In contrast, in Norovirus genus a single 
protein, called the N-tenninal protein, is produced from this region (Liu et al., 1996; 
Hardy et al., 2002; Belliot et al., 2003), although a further proteolytic processing of this 
N-tenninal protein has recently been suggested (Seah et al., 2003). The norovirus N-
tenninal protein shows no significant amino acid sequence similarity to any viral or 
cellular proteins (Ettayebi & Hardy, 2003). However, this protein contains two conserved 
regions, an "H-Box" with histidine residue and an asparagine and cysteine dipeptide 
motif, which has been found in a group of cellular proteins involved in the control of 
mammalian cell proliferation, such as H-revI07, and in some picornavirus 2A proteins 
(Hughes & Stanway, 2000; Fernandez-Vega et al., 2004). In addition, the C-tenninus of 
the N-tenninal protein presents a hydrophobic region (HR) conserved in all caliciviruses 
and similar to the HR ofthe picornavirus 28 protein (Fernandez-Vega et al., 2004). 
Expression of NV N-terminal protein in feline and human cells results in disassembly of 
the Golgi apparatus into discrete aggregates (Fernandez-Vega et al., 2004). In addition, it 
has been shown that the NV N-tenninal protein disrupts protein trafficking to the cell 
surface and forms a stable complex with vesicle associated membrane protein (V AMP)-
associated protein (V AP-A) (Ettayebi & Hardy, 2003). V AP-A is a SNARE (sensitive 
factor attachment protein receptor) binding protein involved in regulated vesicle 
transport. However, it is not clear if the interaction between the NV N-terminal protein 
and V AP-A is directly responsible for the disruption in protein trafficking. 
The FCV N-terminal protein (p32) does not share the same structure as the norovirus N-
terminal protein, although it contains a C-terminal HR region. However, expression of 
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p32 in cells does not lead to disassembly of the Golgi apparatus (F emandez-Vega et al., 
2004). 
1.9.2 2C like NTPase. 
Downstream of the N-tenninal proteins, sequence analysis has revealed a region in the 
calicivirus genome that contains a NTP-binding domain (Clarke & Lambden, 1997). 
Evidence for NTP hydrolysis activity has been proven only for the RHDV and SHY 2C 
like NTPase protein (Pfister & Wimmer, 200 I). Comparison of the amino acid sequence 
of FeV NTPase with those of RHDV and SHY shows similarities of 47 and 35 % 
respectively (Sosnovtsev et al., 2002). In FCV infected cells, this protein is associated 
with a membranous replication complex, suggesting a possible role in replication of the 
viral genome (Green el al., 2002). 
1.9.3 VPg. 
The genomic and sUbgenomic RNA of caliciviruses are covalently linked at the 5' end to 
a viral protein called VPg, a common feature in many positive strand RNA viruses such 
as picomaviruses, potyviruses, luteoviruses and comoviruses (reviewed in Wimmer el 
al., 1982). This protein is present in FCV -infected cells as a mature product of about 12.6 
kDa, as well as a viral genome linked fonn of about 15.5 kDa. The latter is also present 
in the virions (Sosnovtsev & Green, 2000). 
The sequence encoding for the calicivirus VPg is located immediately upstream of the 
3C-like cysteine proteinase sequence (Clarke & Lambden, 2000). Comparison of the 
amino acid sequence of VPg between different members of the calicivirus family has 
revealed a common structure, with the presence of two hydrophilic amino acid clusters at 
the N-tenninus, the KGK(NIT)K and (DIE)EY(D/E)E motifs (Sosnovtseva et al., 1999). 
In particular, the latter region contains a tyrosine that is conserved among all the 
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calicivirus members. In picornaviruses, the viral VPg is linked to the viral genome by a 
bond between the 0 4 tyrosine and 5' -P atom of the terminal uridylic acid residue. The 
uridylylation of picornavirus VPg is mediated by the viral RNA polymerase in a poly(A)-
dependent reaction and functions as a primer for RNA synthesis during replication. In a 
similar way, RHOV VPg is uridylylated in vitro at tyrosine residue in position 21 by the 
recombinant RHOV polymerase, suggesting a possible role of VPg in RNA replication 
(Machin et al., 200 I). Consistent with this hypothesis, FCV VPg utilizes an analogous 
tyrosine (y24) to form a covalent bond with the viral RNA (Mitra et ai., 2004). In 
addition to its possible role in RNA replication, a role for VPg in the translation of the 
viral mRNA has recently been proposed. 
The calicivirus mRNA lacks the m7G cap structure at the 5'end and there is no evidence 
that caliciviruses use an internal ribosome entry mechanism to direct translation of the 
viral mRNA (Clarke & Lambden, 2000). In addition, it has been demonstrated that 
during FCV infection, cleavage of eukaryotic initiation factors-4GI and II (eIF-4GI and 
II) (Willcocks et al., 2004) and of the poly(A)-binding protein (PABP) (Kuyumcu-
Martinez et ai., 2004) leads to inhibition of host cell protein synthesis, thus a cap-
alternative and/or cap-independent mechanism must exist to direct translation of the 
calicivirus mRNA. 
There are several pieces of evidence for the role of VPg in initiation of protein synthesis 
on calicivirus mRNA. It has been shown that removal of VPg from the viral RNA by 
protease digestion results in loss of infectivity and significantly reduces translation of 
FCV RNA in vitro (Herbert et ai., 1997). Furthermore, it has recently been demonstrated 
that recombinant NV VPg binds to purified eukaryotic initiation factor 3 (eIF-3) in vitro 
and to native elF3 in mammalian cell lysates (Daughenbaugh et ai., 2003). Further 
analysis of the role of VPg in translation of the viral mRNA demonstrated a direct 
interaction between the FCV and Lordsdale virus (LOV) VPg with the cap binding 
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protein, eukaryotic initiation factor-4E (eIF-4E) (Goodfellow et al., 2005). The VPg-eIF-
4E interaction is required for the viral translation since the eIF-4E inhibitor 4E-BP1 (4E-
binding protein I) significantly inhibited VPg dependent translation in vitro (Goodfellow 
et al., 2005). In addition, VPg-dependent translation was insensitive to cap analogue, 
suggesting that VPg binds eIF-4E at a different site to that of the cap. Taken together, 
these observations suggest that VPg may function as a cap substitute to recruit 
components of the translation machinery and initiate protein synthesis. 
1.9.4 3C-like cysteine proteinase. 
The existence of the 3C-like cysteine proteinase (3CPro) was first predicted by nucleotide 
sequence analysis of FCV (Neill, 1990). Subsequent functional analyses of the RHOV 
proteinase confirmed the proteinase activity (Boniotti et al., 1994). 
The calicivirus 3CPro belongs to the family of viral proteinases that resemble the cellular 
chymotrypsin-like serine proteases (Boniotti et al., 1994). The nucleophilic serine 
residue of the cellular enzymes is replaced by a cysteine residue in the viral proteinases. 
The 3CPro is responsible for the maturation of the calicivirus protein, processing the 
polyprotein precursor in cis and in trans and it has been extensively characterized in 
RHOV (Boniotti et al., 1994). Sequence and mutational analysis have identified three 
amino acids, histidine I 135 (H II3\ aspartic acid1152 (01152) and cysteine 1212 (C 1212), as 
constituents of the catalytic triad of the RHDV protease, where the C1212 represents the 
nucleophilic residue (Boniotti et al., 1994). RHOV 3CPro cleaves preferentially after a 
glutamic acid (E) residue in the PI position although cleavage was also observed after 
glutamine (Q) and 0 residues (Wirblich el al., 1995). This requirement was attributed to 
the presence of a conserved H1227 in the putative substrate binding pocket (Boniotti el al., 
1994). Substitution of H1227 with either leucine (L) or glycine (G) abolished the activity 
of the enzyme confirming that this residue is important in substrate binding and 
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recognition (Boniotti et al., 1994). RHDV 3Cpro prefers amino acids with small side 
chains in the PI' position and large and hydrophobic amino acids in the P2 position 
(Wirblich et al., 1995). Consistent with these results, studies on the substrate specificity 
of NV and MD145-12 3CPro, two members of the Norovirus genus, have shown same 
amino acid preference in the PI' and P2 positions (Hardy et al., 2002; Belliot et al., 
2003; Blakeney et af., 2003). In addition, the NV 3Cpro tolerates only large hydrophobic 
residues in the P4 position (Hardy et al., 2002). 
Analysis of the cleavage sites in different caliciviruses has shown that FCV 3Cpro, like 
RHDV 3Cpro, cleaves preferentially after E residues (Sosnovtsev et af., 1999) while the 
SHY and NV 3CPro seem to process more efficiently at cleavage sites with a Q residue in 
the P I position (Liu et af., 1996; Hardy et al., 2002). However, it has been shown that 
substitution of E with Q in NV polyprotein cleavage sites does not alter the processing of 
these cleavage sites, suggesting that the secondary structure of the substrate is important 
for efficient cleavage processing (Hardy et af., 2002; Blakeney et af., 2003). 
1.9.5 RNA dependent RNA Polymerase. 
The virally encoded RNA-dependent RNA polymerase (RdRP) is an essential enzyme 
responsible for the replication of the calicivirus genome. 
The RHDV RdRP has been expressed in Escherichia coli and has been shown to 
efficiently synthesize RNA from RNA primer template duplex (Vazquez et af., 1998). It 
has been demonstrated that in FCV, the active form of the RdRP is the 78 kDa 
proteinase-polymerase precursor (Pro-Pol) (Wei et aJ., 200Ia). The 78 kDa Pro-Pol has 
both proteinase and polymerase function (Sosnovtseva et al., 1999). Comparison 
between RHDV RdRP and FCV Pro-Pol has shown that the polymerase activity of the 
first enzyme is 105 to 106 lower then the second (Wei et al., 200Ia), suggesting that even 
in RHDV the active form of RdRP is probably the Pro-Pol precursor. Consistent with this 
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observation, it has been shown that the Pro-Pol accumulates to significant levels in Fey 
infected cells (Sosnovtseva et al., 1999) and in primary cultured hepatocytes infected 
with RHDY (Konig et al., 1998). In addition, the cleavage between the RDHY Pro-Pol 
precursor is inefficient and does not occur readily (Wirblich et af., 1995; Joubert et af., 
2000). 
Two internal cleavage sites were also described for the Fey 78 kDa Pro-Pol that are 
utilized less efficiently by the viral proteinase (Sosnovtsev et aJ., 1999). The predicted 
cleavage products from either cleavage site can not be readily detected in Fey -infected 
cells. Inactivation of these two putative cleavage sites by mutagenesis had no significant 
effect on viral replication. In addition, the internal cleavage sites are predicted to 
inactivate the catalytic and the RNA binding activities of the polymerase (Sosnovtsev et 
aI., 1999, Wei et af., 200Ia). The function of these internal cleavage sites is therefore not 
clear. It is possible that these cleavage sites are only exposed in misfolded Pro-Pol 
precursors and they may represent a quality control mechanism to eliminate the 
misfolded Pro-Pol which could interfere with viral replication. A suggested hypothesis is 
that the processing within the polymerase domain prevents the spatial restriction of the 
proteinase and/or modulates the substrate specificity of the proteinase (Sosnovtsev et af., 
1999). 
Recently, two active forms of the NY polymerase have been described: the Pro-Pol 
precursor and the fully processed polymerase, with comparable polymerase activities 
(Belliot et af., 2005). Like Fey, the NY Pro-Pol functions as an active proteinase and 
polymerase. It is unclear if these two active forms of the norovirus polymerases have 
different roles during viral replication. 
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1.10 POLYPROTEIN PROCESSING 
Analysis of the polyprotein processing among different members of the calicivirus family 
has revealed two distinct strategies to release the mature viral proteins. 
During the processing of the FeV polyprotein, an N-terminal p77/p71 and a C-terminal 
pl20 precursors were detected (Sosnovtsev et al., 2002). The first two are further 
processed to yield the p5.6, p32 and p39 NTPase mature viral proteins. The p120 
precursor, corresponding to p30-VPg-Pro-Pol, can be processed either into p30 and p88 
(VPg-Pro-Pol) or into p43 (p30-VPg) and p78 (Pro-Pol) proteins (Figure 1.5) 
(Sosnovtseva et al., 1999; Sosnovtsev et al., 2002). These precursors are further 
processed to release the mature viral proteins. Time course experiments in feline kidney 
cells infected with FCV have shown that only p43 and p78 precursors can be readily 
detected (Sosnovtsev el al., 2002; Green el al., 2002). Similar patterns of polyprotein 
processing have been found in RHDV (Meyers el al., 2000). 
One striking difference between noroviruses and FCV and RHDV is the absence of an N-
terminal precursor analogous to the FCV p77/p71 (Belliot et af., 2003). In norovirus 
MD 145-12, the polyprotein is processed into a mature N-terminal protein, mature 2C like 
NTPase and a 113 kDa precursor (pll3) corresponding to p20-VPg-Pro-Pol (Figure 1.6) 
(Belliot et al., 2003). The latter is further processed to yield the mature viral proteins as 
well as the Pro-Pol and p20-VPg (analogous to p43 in FCV) precursors. Similar cleavage 
patterns have been found in other noroviruses (Jiang et al., 1993; Liu et al., 1996, 1999; 
Seah el al., 1999). 
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Figur 1.5: Fey polyprotcin proccs ing. The diagram show the tran ient and stable viral precur or 
a well a mature viral protein generated during the proce sing of the FeV polyprotein precur or. 
Adapted from Sosnovtsev el al., 2000. 
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Figure 1.6: MD142-12 polyprotein processing. The diagram shows the transient and stable viral 
precur or a well a mature viral proteins generated during the processing of the MD142-12 
polyprotein precursor. Adapted from Belliot el af., 2003 . 
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The highly ordered polyprotein processing observed in caliciviruses suggests a regulated 
protein-processing cascade, producing precursors and mature proteins with different 
functions. This mechanism is typical in positive strand RNA virus such as 
picornaviruses. There are several possible ways to achieve an ordered mechanism of 
polyprotein processing. One of these is a kinetic control of processing at individual sites. 
This does not seem to be the case as in FCV -infected feline cells or in RHDV -infected 
primary hepatocytes, the accumulation of the mature viral protein and stable precursors 
occurred at about equal rates (Sosnovtsev et al., 2002; Meyers et al., 2000). 
Another way to regulate polyprotein processing is a hierarchical order of cleavages such 
as processing at site B can only occur when site A is already been cleaved. It has been 
shown that mutation of a cleavage site in the polyprotein precursor of RHDV and 
MD145-l2 affects cleavage at other sites (Meyers et al., 2000; Belliot et al., 2003). In 
RHDV, prevention of processing between p37 and p41 (corresponding to the FCV p39 
and p43 respectively), completely blocks the processing ofp4l, leading to the production 
of a fusion protein corresponding to p37-p4l which has never been found during 
expression of the wild-type RHDV proteins (Meyers et al., 2000). In addition, in NV 
MD 145-12 suppression of the cleavage site between the NTPase and p20 results in the 
utilization of a nearby alternative cleavage site by the proteinase in cis (Belliot et al., 
2003). These observations demonstrate that the conformation of the polyprotein and of 
the intermediate precursors is very important in the recognition and accessibility of the 
cleavage sites. 
The last possibility is different substrate specificity between the mature proteinase and its 
precursors. It has been demonstrated that the NV MD145-12 mature proteinase can 
cleave efficiently in trans the polyprotein precursor at all cleavage sites while its 
precursor, Pro-Pol, is unable to cleave the p115 precursor (Belliot et al., 2003). This 
different substrate specificity can generate a hierarchical order of cleavage reaction that 
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controls polyprotein processing. 
It should be noted that although the expression of calicivirus ORFI in prokaryotic or in 
vitro systems represent powerful tools to study the viral replication strategy especially for 
the non-cultivable HuCVs, they are artificial systems and may not reflect the situation 
inside the infected cells. For example, expression of SHY and MD145-l2 ORFI in a 
coupled transcription and translation system lead to the formation of the pX-VPg-Pro-Pol 
precursor (where X is pllS for MD14S-12 or pl13 for SHY) that is not efficiently 
processed to release the mature proteins (Liu et al., 1996; Belliot et al., 2003). When 
these ORFls were expressed in mammalian cells, this precursor was processed with high 
efficiency, as large amount of the mature viral proteins were detected (Seah et al., 1999). 
Thus, in addition to the mechanisms described above, it is possible that cellular factors 
can regulate polyprotein processing and the release of the mature viral proteins. 
Despite some differences observed among caliciviruses in their processing strategies to 
release the mature non-structural proteins, the Pro-Pol and pX-VPg (where X is p43 in 
FCV, p41 in RHDV or p38 in MD14S-12) precursors seem to accumulate efficiently in 
all the caliciviruses analyzed, suggesting an important function of these precursors during 
calicivirus replication (Liu et al., 1996; Sosnovtsev et al., 2002; Meyers et al., 2000; 
Belliot et al., 2003). The Pro-Pol is the bifunctional proteinase-polymerase precursor 
discussed in section 1.9.S. The function ofpX-VPg is not known. In FCV-infected cells, 
this protein is associated with a membranous replication complex and it may serve as an 
anchor for the VPg protein to this membrane complex (Sosnovtsev et al., 2002). 
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1.11 STRUCTURAL PROTEINS 
In caliciviruses, the subgenomic RNA functions as a bicistronic mRNA that encodes the 
structural proteins. In the Vesivirus and Norovirus genome organization, ORF2 is not in 
frame with ORFI, precluding an efficient production of the capsid protein (reviewed in 
Clarke & Lambden, 1997). The synthesis of a subgenomic RNA provides an efficient 
mechanism to produce high copies of the capsid protein (Herbert et al., 1996). In the 
RHDV genome organization, typical of Lagovirus and Sapovirus genera, the capsid 
protein sequence is fused and in frame with the sequence encoding the non-structural 
protein, thus the capsid protein can be released by a proteolytic cleavage from the 
polyprotein precursor (Wirblich et al., 1995). However, the capsid protein is also 
translated from the subgenomic RNA (Boniotti et al., 1994). These mechanisms generate 
two types of the capsid protein with different N-termini. Microsequence analysis of the 
capsid protein present in the mature virions suggests that the major capsid protein species 
is derived from the subgenomic RNA (Parra et ai., 1993). 
The small ORF located at the 3' end of the calicivirus genome encodes a minor structural 
protein called virion protein 2 (VP2) (Clarke & Lambden, 1997). This ORF is 
frameshifted relative to the preceding ORF and the expression of VP2 is very low. In 
FCV -infected cells, this protein is expressed at approximately 10% of the amount of 
mature capsid (Hertbert et al., 1996). It has been demonstrated that VP2 is translated 
from the subgenomic RNA (Herbert et al., 1996) by a termination-dependent reinitiation 
mechanism that accounts for the low efficiency ofVP2 production (Meyers, 2003). 
1.11.1 Capsid protein. 
Caliciviruses possess a single capsid protein, called virion protein 1 (VP 1), encoded by 
ORF2 of the calicivirus genome (Clarke & Lambden, 1997). In FCV, the capsid protein 
is initially translated as a 73 kDa precursor protein (Carter, 1989; Sosnovtsev et al., 
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1998) which is rapidly cleaved to yield the mature 62 kDa capsid protein by the removal 
of the first 125 amino acids from the N-terminus (leader of the capsid, LD). The rate of 
this processing is relatively high, and the precursor accumulates in infected cells only 
under conditions that inhibit this cleavage process, such as the addition of proteinase 
inhibitors to the growth medium or propagation of the virus at elevated temperature 
(Carter, 1989). The protein responsible for this cleavage is the FCY ORF I-encoded 
proteinase (Sosnovtsev et al., 1998). The LD released from the processing of the capsid 
protein precursor can be detected in FCY-infected cells but not in the mature virions 
(Tohya et al., 1999). 
A further cleavage of the FCY capsid protein has been detected late in FCY infection, 
producing a fragment of about 40 kDa (Carter et al., 1989); this process can be inhibited 
by the pan-caspase inhibitor z-Y AD-fink, suggesting a role of caspases in this process 
(AI-Molawi et al., 2003). Indeed, it has been shown that caspase-2 and -6 are able to 
cleave recombinant FCY capsid protein to a 40 kDa product in vitro (AI-Molawi et ai., 
2003). The role of this fragment during replication or pathogenesis is unknown. 
Analysis of the stool samples from volunteers infected with NY have led to the 
identification of a 59 kDa and a 32 kDa capsid protein (Greenberg et ai., 1991). The 
expression of NY ORF2 in a baculovirus expression system resulted in the production of 
a 58 kDa capsid protein that was able to self assemble into virus-like-particles (YLPs), 
morphologically and antigenic ally indistinguishable from purified virions (Jiang et ai., 
1992). In addition, a 32 kDa minor protein was also found in the infected cells. N-
terminal sequence analysis showed that the 32 kDa protein is produced by trypsin 
cleavage of the 58 kDa capsid protein at lysine in position 227 (Hardy et ai., 1995). In 
the same study, it was demonstrated that the 32 kDa protein found in the stools of NV-
infected volunteers was in fact the 32 kDa cleavage product. 
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Expression of different animal as well as human calicivirus capsid proteins In a 
baculovirus expression system results in the formation of VLPs (Clarke & Lambden, 
1997). In particular, expression of the capsid protein from non-cultivatable human 
calicivirus represents an important source of antigen that can be used for clinical, 
epidemiological and immunological studies of calicivirus infections (Clarke & Lambden, 
1997) 
1.11.2 Virion Protein 2. 
All caliciviruses possess a 3' -terminal ORF encoding a minor component of the mature 
virions, VP2, of unknown function (Clarke & Lambden, 2000). VP2 is present in the 
mature virions as well as in recombinant VLPs of RHDV and NV, although this protein 
is not essential for the formation of empty VLPs (Wirblich et al., 1996; Glass et al., 
2000). It was proposed that due to its basic positive charge characteristics, VP2 might 
interact with nucleic acids and the internal acidic domains of the calicivirus virions, 
providing a structural basis for encapsidation of the genomic RNA (Herbert et al., 1996). 
It has been shown that the sequence between amino acid 108 and 152 of NV VP2 is 
responsible for protein-protein interaction between VP2 and VP1 proteins (Glass et al., 
2003). Deletion of the corresponding region in FCV VP2 dramatically affects the 
production of infectious virus (Sosnovstev et al., 2005). In the same study, the authors 
have shown that the C- and N-termini are also important, as point mutations in this 
region prevent the release of mature virions. 
It should be noted that mutations in VP2 proteins do not affect viral replication but 
infectious virus cannot be recovered. Trans-complementation with an expression plasmid 
encoding functional VP2 restores the production of infectious viral particles that can 
infect new cell monolayers, resulting in virus replication without the release of infectious 
viral progeny (Sosnovstev et al., 2005). 
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1.12 CALICIVIRUS REPLICATION 
The replication cycle of caliciviruses has not been characterized as well as many other 
positive-strand RNA viruses as most of the caliciviruses cannot be propagated in tissue 
culture cells. FCY was for a long time the only cultivable calicivirus, thus the life cycle 
of Fey is better characterized than other caliciviruses. Virus entry into cells is receptor-
mediated (Kreuz et al., 1994) but the identity of this receptor is not known for all the 
caliciviruses. It has been shown that both native and recombinant RHDV particles can 
recognize A and H type 2 blood group oligo saccharides and attach to the epithelial cells 
of the upper respiratory and digestive tract (Ruvoen-Clouet et af., 2000). Similar results 
have been obtained for recombinant NY particles which can recognize the H type 1 and 
types 3-4 as a ligand on gastroduodenal epithelial cells (Marioneau et al., 2002). 
Recently, it has been demonstrated that the feline JAM-I (junctional adhesion molecule-
I) is a functional receptor for FCY (Makino et af., 2006). In particular, expression of 
feline JAM-I in FeV non-permissive cells renders them susceptible to Fey infection. 
These data provide useful information on the identity of the calicivirus receptor as other 
caliciviruses may use the same receptor to bind and infect the host cells. 
The penetration and the uncoating processes during FCY infection seem to be mediated 
by an endocytic pathway followed by a pH-dependent step as lysosomotropic agents, 
such as chloroquine which prevents acidification of intracellular vesicles, blocks the viral 
replication (Kreutz & Seal, 1995). 
In Fey -infected cells, the genomic and subgenomic RNA are detectable at 2 hours post 
infection, reach a steady state level at 4 hours and are still present 8 hours post infection 
(Neill et al., 1991). Within 5 hours post infection, all the mature viral proteins as well as 
the stable precursors can be detected in infected cells (Sosnovstev et af., 2002; Green et 
af., 2002). The infected cells show evidence of rounding at 6 hours post infection and 
extensive internal membrane rearrangement with accumulation of vesicles (Green et af., 
34 
Introduction 
2002). Similar ultra structures have been found in primary hepatocytes and macrophages 
infected with RHDV and NV MD145-12 respectively (Konig et al., 1998; Wobus et al., 
2004). The FCV replication complex is associated with intracellular membranes and with 
several non-structural proteins such as Pro-Pol, p30-VPg, p30, p32 and the p39 NTPase 
suggesting that all these proteins playa role in RNA replication (Green et al., 2002). The 
structural proteins are also associated with the replication complex indicating that the 
membranes of the replication complex might form a scaffold for packaging of the viral 
RNA. At late stage of infection, FCV replication causes apoptosis of the host cells (AI-
Molawi et al., 2003; Sosnovtsev et al., 2003). Infected cells present characteristic 
hallmarks of apoptosis such as condensed nuclei, phosphatidylserine extemalization and 
activation of caspase-2, -3, -6, -7, -8 and -9. FCV-induced apoptosis seems to require 
viral replication as UV -inactivated virions which retain the ability to bind to CRFK cells 
fail to induce apoptosis (Sosnovtsev et al., 2003). Similar to FCV infection, condensed 
nuclei were observed in primary cultured hepatocytes infected with RHDV (Konig et al., 
1998). Apoptosis has also been detected in vivo in rabbits experimentally infected with 
RHDV (Alonso et al., 1998). Infected rabbits present extensive hepatocyte apoptosis 
which results in liver tissue damage and probably in lethal hepatitis associated with 
RHDV infection. Collectively, these results suggest that apoptosis of the host cells may 
represent a common outcome of calicivirus infection and also an important step in 
calicivirus-associated pathogenesis in vivo. 
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1.13 APOPTOSIS 
1.13.1 From Necrobiosis to Apoptos;s. 
The first morphological observation of physiological cell death was made in 1842 by 
Vogt during the description of the amphibian metamorphosis (Vaux, 2002). In a lecture 
given in 1858, the German pathologist Rudolf Virchow distinguished necrosis from a 
process of "spontaneous wearing out of living parts", which he termed necrobiosis 
(Gerschenson & Geske, 2001). Fleming, in 1885, used the term "chromatolysis" to 
describe the condensation of chromatin in "half moons" during the degeneration of the 
epithelial lining cells of regressive ovarian follicles (Granville e/ al., 1998). Some other 
observations occurred during the XIXth and in the early XXth centuries but it was in 1951 
that the embryologist Gluckmann clearly described the phases of cell death during 
vertebrate development (Granville et al., 1998). The term "programmed cell death" was 
first used in 1961 by Lockshin and Williams who showed that this process occurs during 
insect development and it is energy and gene transcription dependent (Vaux, 2002). 
In 1965, Kerr introduced the criteria to distinguish between necrosis and programmed 
cell death (reviewed in Kerr, 2002). He noted that cell death similar to that described by 
Gluckmann, occurred in individual hepatocytes after the induction of hepatic ischemia 
and he also demonstrated that this form of cell death was different to that of necrotic 
cells. Although this process was at first described by Kerr as "shrinkage necrosis", it was 
only in 1972 that Kerr, Wyllie and Curie proposed the term apoptosis, a Greek word 
describing the process of leaves falling from a tree or petals from a flower, to depict this 
specific type of cell death (Kerr e/ al., 1 972). Since then, enormous progress has been 
made in the field and what was only a morphological description, has now become a 
central concept in biology. 
Apoptosis is a term used to describe the most typical and frequent phenotype of 
programmed cell death. It is a genetically controlled, energy-dependent process of cell 
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death conserved through evolution in all metazoans (Raff, 1992; Ameisen, 2002; Vaux, 
2002). It is now clear that apoptosis is an essential component of animal development 
participating in morphogenesis, sexual differentiation, deleting superfluous structures and 
in the epigenetic self organization of the immune and nervous systems (reviewed in 
Jacobson et al., 1997; Vaux & Korsmeyer, 1999; Krammer, 2000; Yuan & Yankner, 
2000). 
Apoptosis also occurs in adult tissue to control cell numbers and to remove non-
functional, damaged cells (Raff, 1992). It represents a quality control procedure and a 
defence mechanism to eliminate potentially harmful cells (auto-reactive lymphocytes), 
infected cells and the emergence of genetic heterogeneity and the progression towards 
cancer (Raff, 1992; Vaux & Korsmeyer, 1999). 
Deregulation of the apoptotic process is responsible for many diseases in humans. It is 
remarkable that the first component of the apoptotic system was recognized in a human 
disease. The human bel-2 (B-celllymphomas) gene was found to be over-expressed in 
follicular lymphoma, one of the most common cancer of blood cells in humans, as a 
result of a t( 14: 18) chromosome translocation (Vaux et al., 1988). It was shown that bel-
2 did not act, like other oncogenes (c-myc or abl), to promote cell proliferation, instead it 
prevented cell death after growth factor withdrawal: this was the first experimental 
evidence that inhibition of apoptosis could lead to cancer in humans (Vaux et al., 1988). 
On the other hand, excessive apoptosis is related to neurodegenerative disorders such as 
Alzheimer's and Parkinson's (Yuan & Yanker, 2000), and many other diseases like 
acquired immuno-deficiency syndrome (AIDS) and stroke. 
1.13.2 Genetic control of apoptosis. 
The first evidence for a genetic programme of apoptosis came from studies in the 
nematode Caenorhabditis elegans (Horvitz et al., 1982). During the development of the 
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Caenorhabditis elegans hermaphrodite, 131 of 1090 somatic cells generated undergo cell 
death which morphologically resembles apoptosis (reviewed in Horvitz, 1999). Using 
classical genetic approaches, several single cell mutations were identified that affect the 
apoptotic pathway. These mutations have defined three groups of genes involved in 
apoptosis (reviewed in Metzstein et al., 1998; Horvitz, 1999). 
The first group of genes includes the ces-l (cell death specification) and ces-2 that affect 
cell death of the sister cells of the two neurosecretory motor neurons, causing these cells, 
which normally die, to survive. 
The second group of genes affect most, if not all, the 131 cells undergoing apoptosis and 
includes egl-l (egg-laying defective), ced (cell death abnormal)-3, ced-4 and ced-9. 
The last group of genes includes nuc-1 (nuclease-I), which is involved in the degradation 
of DNA, and ced-l, ced-2, ced-5, ced-6, ced-7, ced-10, and ced-12 which function in the 
phagocytosis process of the apoptotic cells. 
The second group of genes is defined as the core of the apoptotic process and they have 
been most extensively studied. The ced-3 and ced-4 mutants were first described by 
Robert H. Horvitz and his collaborators (Ellis et ai, 1986); they showed that loss of 
function in ced-3 and ced-4 caused the survival of all 131 cells which normally die, 
demonstrating that ced-3 and ced-4 are involved in programme cell death. The ced-4 
gene was the first ced gene to be cloned (Yuan & Horvitz, 1992); this gene encodes a 
protein homologous to the mammalian Apaf-l (apoptotic protease activating factor-I), a 
key component of the apoptosome. The function of the CED-4 protein is to interact with 
CED-3 and facilitate its activation (Chinnaiyan et al., 1997). 
The ced-3 gene encodes a protein that shares sequence homology with the mammalian 
ICE (interleukin-If3-converting enzyme), a cysteine protease involved in the maturation 
of the interleukin-I f3 cytokine (Yuan et al., 1993). The CED-3 protein is involved in the 
execution ofapoptosis in Caenorhabditis elegans. 
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The ced-9 gene is a negative regulator of apoptosis as loss of function by mutation causes 
apoptosis in cells that normally live, resulting in the death of the embryo (Hengartner et 
al., 1992). The CED-9 protein is homologous to the mammalian Bcl-2 protein 
(Hengartner & Horvitz, 1994). 
The egl-l gene encodes a protein of 91 amino acids that contains a BH3 (Bcl-2 
homology region) like-domain; loss of function by mutation of this gene causes the 
survival of all 131 cells. The EGL-l protein binds to and directly inhibits CED-9, 
inducing cell death (Conradt & Horvitz, 1998). 
Based on genetic and biochemical data, a linear model for the activation of apoptosis has 
been proposed in Caenorhabditis elegans (reviewed in Metzstein et al., 1998; Horvitz, 
1999): in normal, living cells, CED-9 binds and sequesters CED-4 in the mitochondria, 
preventing the activation of CED-3. In cells that are programmed to die, EGL-l binds 
CED-9 causing the release of CED-4 which in tum binds and facilitates the activation of 
CED-3. This simple and linear model of apoptosis in Caenorhabditis elegans had a 
profound effect in the field: the identification of the core apoptotic pathway in the 
nematode and its homologues in mammals and in other invertebrates, has led to the 
concept that apoptosis is a process of very ancient origin which predates the separation of 
the nematodes and vertebrates, and which has been conserved through evolution in all 
metazoans. 
1.13.3 Morphological and biochemical hallmarks o/apoptos;s. 
Initially, analysis of apoptosis was based mainly on well defined morphologic features 
which are essentially those described by Kerr (Kerr et al., 1972). Dying cells present 
shrinkage of the cytoplasm and a condensed nucleus in which the chromatin appears 
pyknotic and compacted into dense masses (reviewed in Saraste & Pulkki, 2000; Geske 
& Gerschenson, 2001). As apoptosis continues, the nucleus becomes fragmented. In the 
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final stage of apoptosis, the cell detaches from the surrounding tissue and breaks up into 
several membrane-bound vesicles containing intact organelles and nuclear fragments. 
In vivo these apoptotic bodies are engulfed by neighbouring cells and macrophages. If 
these apoptotic bodies are not phagocytosed, as in an in vitro system, they will undergo a 
necrosis-like degradation called secondary necrosis. In vivo, apoptosis occurs in 
individual cells and is not associated with an inflammatory response as the intracellular 
contents are not released in tissues. 
Activation of endonucleases during apoptosis was the first marker that did not rely on 
morphology. The activation of caspase activated deoxyribonucleases (CAD), the murine 
homologous of the human DNA fragmentation factor subunit 40 (DFF -40), cleaves the 
DNA into intemucleosornal fragments of high molecular weight that produce the 
classical DNA ladder in agarose gel electrophoresis specifically associated with 
apoptosis (Liu et al., 1997). 
Another biochemical characteristic of apoptotic cells is the exposure of phosphatidyl 
serine from the inner to the outer surface of the plasma membrane that serves as a 
recognition signal for the engulfment of dying cells by macrophages and neighbouring 
cells (Fadok et al., 1992). 
Probably the best known apoptotic feature, also responsible for almost all of the 
biochemical and morphological changes in apoptosis, is the activation of a proteolytic 
system involving a specific family of proteases: the cysteinyl aspartate specific 
proteinases (caspases). 
1.14 CASPASES 
Caspases are a class of cysteinyl proteases that specifically cleave on the C-tenninal side 
of an aspartic acid residue in the scissile bond (Alnenni et ai, 1996). Despite all the 
infonnation and the amount of experimental evidence on the central role of caspases in 
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the execution of apoptosis, it is very surprising that the first caspase to be identified, 
named ICE or caspase-l, was not involved in apoptosis but in the proteolytic maturation 
of the pro-interleukin 1 P to its biological active form (Cerretti et al., 1992). The first clue 
for a possible role of ICE or related family members in apoptosis came from the 
discovery that CED-3, a pro-apoptotic protein in Caenorhabditis elegans, is a homologue 
of the mammalian ICE protein (Yuan et aI, 1993). 
Since then, at least 14 mammalian caspases have been identified, of which 8 are involved 
in apoptosis, with their homologues in nematode, insect and hydra (Cohen, 1997; 
Earnshaw et al., 1999; Chang & Yang, 2000; Shi, 2002; Fuentes-Prior & Salvesen, 
2004). Several observations indicate the role of caspases in apoptosis. Natural or 
synthetic inhibitors that abrogate caspase activity can effectively prevent or delay the 
apoptotic phenotype. Gene deletion studies have shown that caspases (in particular 
caspase-3, -8 and -9) are required for apoptosis during mammalian development 
(reviewed in Vaux & Korsmeyer, 1999). Caspase-8 -/- mouse embryos die at day 11 with 
abnormal formation of the heart (Varfolomeev et al., 1998). Similarly, caspase-3 or 
caspase-9 knockout mice die early in development and show profound defects in 
apoptosis in the nervous system resulting in brain overgrowth (Kuida et al., 1996; 1998). 
Finally, specific caspase cleavage sites have been found in the majority of the proteins 
proteolytically processed during apoptosis. 
1.15 STRUCTUTRE OF MAMMALIAN CASPASES 
1.15.1 Zymogen organization. 
All caspases share common features that characterised this family of proteases (reviewed 
in Cohen, 1997; Earnshaw et al., 1999, Fuentes-Prior & Salvesen, 2004). Caspases are 
synthesised as an inactive single chain pro-enzyme. Each zymogen (procaspase) contains 
an N-terminal prodomain, a large subunit and a C-terminal small subunit. The large 
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subunit contains the active site cysteine within a conserved QACXG (where X is R, Q or 
G) pentapeptide (Wolf & Green, 1999). An aspartic acid cleavage site separates the 
prodomain from the large subunit and the large from the small subunit although in some 
caspases, an interdomain linker containing two aspartate cleavage sites separates the 
large and the small subunits (Cohen, 1997). The presence of these caspase cleavage sites 
in the structure of the procaspases is consistent with the ability of caspases to auto-
activate or to be activated by other caspases (Nicholson, 1999). 
Based on phylogenetic analyses, caspases have been classified into three major 
subfamilies: the ICE, CED-3 and ICH-I (Ice and ced-3 homologue) subfamilies (Cohen, 
1997; Donepudi & Grutter, 2002). The ICE subfamily consists mostly of inflammatory 
caspases (exceptions are the murine caspase-12 and human caspase-4 involved in 
apoptosis and human caspase-14 of which no specific role has been found). The CED-3 
and ICH-I subfamilies contain caspases involved in apoptosis (Figure 1.7). 
The individual caspases have two major structural differences that are correlated with 
their biological functions: the substrate specificity and the length as well as the amino 
acids sequence of the N-tenninal prodomain (Nicholson, 1999; Wolf & Green, 1999; 
Donepudi & Grutter, 2002; Shi, 2002). Caspases recognize at least four contiguous 
amino acids, named P4, P3, P2, PI, and cleave after the C-terminal PI residue. The 
optimal tetrapeptide substrate specificity has been defined using a synthetic 
combinatorial peptide library (Nicholson et af., 1999). All mammalian caspases have an 
absolute requirement for an aspartic acid residue in the PI position, while the amino acid 
residues in the P2-P3-P4 positions are not conserved and determine the substrate 
specificities of the different caspases (Shi, 2002; Fuentes-Prior & Salvesen, 2004). 
Despite these simple requirements, caspases are extremely stringent, indicating that the 
three-dimensional context is very important for the recognition and the proteolysis of the 
substrate (Nicholson, 1999). 
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The N-terminal prodomain is the other major structural difference between the individual 
caspases (Wolf & Green, 1999; Donepudi & Griitter, 2002). Caspase-3, -6 and -7 are 
characterized by a short N-terminal prodomain of about 20-30 residues while caspase-8, -
10 and caspases of the ICH-l and the ICE subfamily have an extended prodomain (>90 
amino acids) (Figure 1.7). Based on these structural differences and their biological role, 
caspases can be divided in two groups: the inflammatory caspases (caspase-l,-5,-11,-13) 
and the apoptotic caspases (caspase-2, -3, -4, -6, -7, -8, -9, -10, -12). In addition, 
according to the order and the mechanisms of activation, the apoptotic caspases can be 
further classified into initiator (caspase-2, -4, -8, -9, -10, -12) and effector caspases 
(caspase-3, -6, -7; Figure 1.7) (Earnshaw et al., 1999; Nicholson 1999; Chang & Yang, 
2000). 
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Figure 1.7: Mammalian caspa e . The diagram hows the clas ification and the biological function 
of mammal ian caspa es. All mammalian ca pa e are of human origin except for murine caspa e-II , 
-12 and bovine ca pa e-l3. Ca pase-14 has been found mainly in the epidermis and it may be 
involved in keratinocyte differentiation. Ea h ca pa e pos es an -temlinal prodomain, a large and a 
mall ubunit. Apoptotic effector caspa es ha e a hort prodomain while inflammatory and apoptotic 
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recognized, the CARD and DED domain . The e domains mediate the interaction between caspases 
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1.15.1 Initiator and effector caspases. 
The initiator caspases are the first to be activated in a particular death pathway (Shi, 
2002). They present long N-tenninal prodomains important for their activation. Among 
these prodomains, two different types of elements are known: the death effector domain 
(DED) and caspase recruitment domain (CARD) (Wolf & Green, 1999). Although they 
are unrelated, CARDs and DEDs have similar structures composed of six closely packed 
antiparallel amphipathic a-helices (Fuentes-Prior & Salvesen, 2004). These elements 
mediate the interaction between the long prodomains of initiator caspases and specific 
adapter molecules which drive their activation (Green, 1998; Stennicke & Salvesen, 
2000). A major difference between these elements is the nature of their interaction: the 
OED-OED and CARD-CARD associations are mediated by charge-charge and 
hydrophobic interactions respectively (Kaufmann & Hengartner, 200 I). Two copies of 
OED elements are found in caspase-8 and -10, associated with death receptor initiated 
cell death (extrinsic pathway). Caspase-9, associated with mitochondrial initiated cell 
death (intrinsic pathway), caspase-2, -4, -12 as well as the inflammatory caspases contain 
one copy ofCARO elements (Cohen, 1997; Earnshaw et al.. 1999). 
The other important feature of initiator caspases is the substrate specificity which allows 
them to recognise their targets: the effector caspases (Nicholson, 1999). Caspase-2 
represents an exception among the initiator caspases: instead of the classical tetrapeptide, 
caspase-2 recognises a pentapeptide sequence (P5-P~P3-P2-Pl) in its target substrates 
with a requirement of a leucine residue in the P5 position. In addition, the substrate 
specificity is similar to those of the effector caspases, thus caspase-2 may represent an 
initiator caspase that induces apoptosis through the direct cleavage of the death substrates 
without the activation of effector caspases. 
The effector caspases are usually activated by the initiator caspases and they are 
responsible for the majority of the proteolytic events that lead to the apoptotic phenotype 
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(Green, 2000). They are characterized by the presence of a short N-terminal prodomain 
which lacks the homotypic recruitment elements. The function of this domain is not 
clear. It could be involved in subcellular localization and/or in the activation step of the 
effector caspases (Chang & Yang, 2000; Fuentes-Prior & Salvesen, 2004). 
1.15.3 Structure of active caspases. 
To achieve the active form, the caspases undergo a complex structural rearrangement 
including proteolytic cleavage between the large and the small subunit and the large and 
the N-terminal prodomain (Shi, 2002). Although these cleavages are not necessary for 
the activation of initiator caspases (Boatright & Salvesen, 2003), all the active caspases 
display the same arrangement, the only exception is caspase-9 which does not require the 
removal of the N-terminal prodomain (Renatus et ai., 2001). 
The active caspase is a homodimer of two catalytic domains (monomers) composed of 
the large and small subunits derived from a single caspase molecule (review in Fuentes-
Prior & Salvesen, 2004). The monomers are arranged in a head to tail configuration and 
homodimerization is mediated by hydrophobic interaction between the small subunits. 
The catalytic sites are composed of the amino acid residues from the large and the small 
subunit, thus each homodimer contains two active sites at the opposite ends of the 
molecule (Chang & Yang, 2000). There is no evidence for a co-operativity or allosteric 
modulation between these sites and they can function independently (Wolf & Green, 
1999). 
The binding pockets for the P4-P3-P2-Pl recognition sequence are named S4-S3-S2-S1, 
respectively (Shi, 2002). The Sl and S3 subsites are almost the same in all caspases 
explaining the requirement for an aspartate in PI and the preference for a Glu in P3. In 
contrast, the S2 and S4 subsites display considerable variation among caspases 
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confirming that the P2 and P4 residues determine the substrate specificity of the different 
caspases (Cohen, 1997, Shi, 2002). 
1.16 MECHANISM OF CASPASE ACTIVATION 
The activation of caspases can be divided into two mechanisms known as homo-
activation and hetero-activation (Stennicke & Salvesen, 2000). The first mechanism is 
involved in the activation of the initiator caspases and reflects the important property of 
these caspases to activate themselves. In contrast, the hetero-activation mechanism 
occurs during the activation of the effector caspases as these caspases are activated by the 
initiator caspases or other proteases. 
1.16.1 The induced proximity modeL 
The common quaternary structure of the mature caspases has led to the concept that both 
initiator and effector caspases are activated by a proteolytic cleavage within the 
interdomain linker between the small and the large subunit (Green, 1998; Budihardjo et 
al., 1999). In the case of the homo-activation mechanism, it was thought that this 
cleavage occurs when the initiator caspases are brought into close proximity of each 
other increasing the local enzyme concentration; in such condition, initiator caspases can 
process themselves due to their intrinsic zymogen activity. This mechanism is known as 
the induced proximity model (Salvesen & Dixit, 1999) (Figure 1.8). 
1.16.2 The proximity induced d;mer;zanon modeL 
Recent biochemical and structural evidences have revealed that the activation 
mechanisms of initiator and effector caspases are completely distinct. These studies have 
shown two fundamental differences between initiator and effector caspases: first, under 
physiological conditions initiator caspases exist as inactive monomers while the effector 
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caspases are already present as inactive dimers; second, the cleavage of the interdomain 
linker is essential for the effector caspases to acquire the active catalytic conformation 
but is not necessary for the initiator caspases (Stennicke et ai, 1999; Renatus et ai, 2001; 
Boatright et aI, 2003; Donepudi et ai, 2003). 
Based on these observations, it has been proposed that dimerization, and not the 
cleavage, of initiator caspases is the driving force of their activation (review in Boatright 
& Salvesen, 2003; Fuentes-Prior & Salvesen, 2004). This hypothesis, termed proximity 
induced dimerization (Boatright et aI, 2003), represents an updated version of the 
original induced proximity model: the inactive monomeric zymogens of initiator 
caspases require dimerization to assume the active conformation (Figure 1.8). 
The proximity induced dimerization model is supported by several experimental studies. 
In vitro, recombinant caspase-8 and -9 exist in equilibrium between a major inactive 
monomeric and minor active dimeric fraction (Renatus et aI, 2001; Boatright et aI, 2003). 
In addition, caspase-8 and -9 with specific mutations at the dimer interface act as 
dominant-negative mutants and fail to induce apoptosis in many transfected cell lines 
(Boatright et ai, 2003; Chang et al., 2003). 
A further confirmation of the proximity induced dimerization model comes from the 
observation that c-FLIPL (Fas-associated death-domain-like IL-IJ3-converting enzyme 
[FLICE]-like inhibitory protein long) forms active dimers with procaspase-8 (Micheau et 
al., 2002). c-FLIPL is an inactive homologue of caspase-8 (see below). The association 
between c-FLIPL and procaspase-8 leads to the formation of a heterodimer in which only 
one partner, the caspase-8, possesses the enzymatic activity (Micheau et al., 2002). 
1.16.3 The induced conformational modeL 
Although the proximity induced dimerization hypothesis represents an advance over the 
previous induced proximity model, alternative models may still be possible (Shi, 2004b). 
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Caspase-9 is nonnally activated upon the binding to Apaf-l into a large complex called 
apoptosome (section 1.18.1). The proximity induced dimerization model argues that 
Apaf-I would facilitate the dimerization of caspase-9 inducing its activation in the 
apoptosome (Renatus et 01., 2001). It has been shown that processed as well as dimeric 
fonns of caspase-9 posses an enzymatic activity that represents only a fraction of the 
activity associated with the caspase-9 in the apoptosome (Chao et 01., 2005). Thus it has 
been proposed that Apaf-l would act as an allosteric regulator enhancing the activity of 
caspase-9 in the apoptosome, a mechanism tenned induced confonnational model 
(Figure 1.8). 
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Based on the proximity induced dimerization model, it seems that the cleavage observed 
during the activation of initiator caspases functions only to stabilize the dimer and it is 
neither necessary nor sufficient to activate these caspases (Boatright et aI., 2003; 
Boatright & Salvesen, 2003). One important consequence of this hypothesis is that the 
assumption that caspase cleavage is an indicator of their activation may be valid only for 
the execution caspases. In this context, cleavage of initiator caspases by granzyme B or 
by the effector caspases as a feedback activation loop cannot be used as an interpretation 
of their activation (Boatright et al., 2003; Boatright & Salvesen, 2003). 
Two recent papers have shown that the cleavage of caspase-8 can lead to its activation in 
the absence of dimerization. Using a cell free system approach, the authors have shown 
that in the absence of any dimerization stimulus, direct cleavage of caspase-8 by either 
granzyme B or effector caspases (such as caspase-6), produces active caspase-8 which 
can function as an active monomer (Murphy et al., 2004; Sohn et al., 2005). Thus, in 
some contexts, cleavage of initiator caspases can be still interpreted as an indicator of 
their activation. 
Based on these experimental observations, we suppose that the activation of initiator 
caspases depends on two factors: the physiological context and the type of caspases. 
Under certain conditions, oligomerization (which can be hetero or homo-dimerization for 
caspase-8) can drive the activation of initiator caspases; however, at least for caspase-8, 
an interchain proteolytic cleavage performed by certain proteases, like granzyme B or 
caspase-6 (Murphy et aI., 2004; Sohn et al., 2005). is sufficient to induce its activation. 
How does the oligomerization event occur in vivo? As the activation of initiator caspases 
inevitably triggers a cascade of downstream caspase activation, this process is highly 
regulated and requires multiprotein activating complexes in which initiator caspases 
oligomerize through interactions between their N-terminal prodomain and specific 
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adapter proteins. The activation complex involved depends on the pathway triggered by a 
specific apoptotic stimulus. There are two well defined apoptotic pathways: the death 
receptor (extrinsic) and the mitochondrial (intrinsic) pathway. 
THE DEATH RECEPTOR PATHWAY 
The extrinsic (or death receptor) pathway is responsible for elimination of unwanted cells 
during development, immune system education and immunosurveillance. This pathway 
is triggered by the engagement of cell surface death receptors with their specific ligands 
(reviewed in Peter & Krammer, 2003; Lavrik et al., 2005). The death receptors (DRs) are 
a family of transmembrane proteins that belong to the tumor necrosis factor (TNF)/nerve 
grow factor (NGF) receptor superfamily. Mammalian death receptors include: Fas/APO-
I/CD-95, TNF-RI, DR-3/Apo-3IWSL-IITRAMP, DR-4/TRAIL-RI, DR-S/TRAIL-
R2ITRICK-2IKlLLER and DR-6 (Ashkenazi & Dixit, 1998; Lavrik et al., 2005). These 
receptors share conserved cysteine rich domains (CRO) at their extracellular domains, 
which define their ligand specificity (Bodmer et al., 2002). The cytoplasmatic domains 
contain a homotypic recruitment element of 60-70 amino acids, termed death domain 
(DO), necessary for signal transduction (Ashkenazi & Dixit, 1998). 
The activation ligands, also called death ligands, are structurally related homotrimeric 
molecules that belong to the TNF gene superfamily: Fas ligand (Fas-L) binds to Fas 
receptor, TNF-a. to TNF-Rl, Apo-3 ligand (Apo-3L) to Apo-3 and Apo-2 ligand (Apo-
2L or TRAIL) binds to DR-4 and DR-5 (Ashkenazi & Dixit, 1998). 
1.17.1 Fas-mediated death receptor pathway. 
The Fas apoptotic pathway has been extensively studied and has become the model for 
the mammalian extrinsic pathway (Figure 1.9) (Peter & Krammer, 2003; Lavrik et al., 
2005). Fas is constitutively present in various tissues but its ligand is expressed mainly in 
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activated T lymphocytes and natural killer cells. Fas-induced apoptosis plays an 
important role in lymphoid tissue homeostasis and removal of virally-infected and tumor 
cells. Unstimulated Fas exists as a pre-associated homotrimer in the plasma membrane. It 
has been shown that this association depends on the first CRD called the preligand 
binding assembly domain (PLAD) (Peter & Krammer, 2003). Mutations in this domain 
disrupt the signal from Fas, demonstrating the physiological importance of this pre-
association (Siegel et al., 2000). 
Upon ligation to Fas-L, Fas receptor fonns microaggregates at the cell surface leading to 
recruitment of the adapter protein F ADD (Fas associated death domain) (Algeciras-
Schimnich et 01., 2002). This protein contains a DD at its C-tenninus and binds to the 
cytoplasmatic tail of Fas via DO homotypic interactions. F ADD also contains a OED in 
its N-tenninal region. The DED of F ADD interacts with the DED in the prodomain of 
caspase-8 leading to the recruitment of procaspase-8 (Peter & Krammer, 2003). Fas, 
F ADD and pro-caspase-8 do not associate under non-apoptotic conditions and the reason 
for this phenomenon is still not known. It is possible that under nonnal condition, F ADD 
is in an auto-inhibitory confonnation through an interaction between its DD and DED 
domains. The aggregation of Fas by its ligand may induce a high-affinity binding site for 
the DD of F ADD, thus displacing the DD from the DED and making them available for 
the binding with procaspase-8 DEDs. 
The complex fonned by Fas, FADD and pro-caspase-8 (and possibly other proteins) is 
known as the death-inducing-signaling complex (DISC) (Ashkenazi & Dixit, 1998; Peter 
& Krammer, 2003). 
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1.17.2 Mechanism of caspase-B activation. 
The activation of procaspase-8 proceeds in a specific order and requires dimerization as 
well as cleavage processing (Chang et al., 2003). Within the DISC, procaspase-8 
dimcrizes to acquire its catalytically active conformation as predicted by the proximity 
induced dimerization model (Boatright et al., 2003; Boatright & Salvesen, 2003, Chang 
et al., 2003). It has been shown that these newly formed procaspase-8 dimers are able to 
cleave neighbouring dimers in a specific order: first, cleavage in the interchain domain 
separates the large and the small subunit and a second cleavage removes the N-terminal 
prodomain. The mature caspase-8 is then released to the cytosol where it can activate the 
effector caspases. This model, known as the interdimer processing mechanism (Chang et 
al., 2003), represents an elegant explanation for a paradoxical mismatch between the 
number of binding sites in the Fas/FADD complex and the procaspase-8 dimer (Fuentes-
Prior & Salvesen, 2004). After activation. the trimeric state of the death receptor 
theoretically supports the binding of three procaspase-8 molecules. Two of these 
procaspase-8 molecules dimerize within the same complex while the third procaspase-8 
dimerizes with the unpaired procaspase-8 of an adjacent DISC complex (Chang et al., 
2003). This model is supported by the observation that clustering of death receptor 
complexes is an important step in CD95 induced apoptosis (Algeciras-Schirnnich et al .• 
2002). In this context, it has been proposed that high levels of death receptor clustering 
induce a massive release of mature caspase-8 and inevitably apoptosis. In contrast, low 
levels of death receptor clustering cause only a transient activation of the procaspase-8 
dimer which could initiate a proliferative signal, a pathway that seems to be important in 
T cells (reviewed in Algeciras-Schimnich el al., 2002; Peter & Krammer, 2003). 
Interestingly, it has been shown that the procaspase-8 dimer and the mature caspase-8 
have different substrate specificities (Chang el al., 2003). The procaspase-8 dimers can 
cleave another dimer precursor but they are unable to cleave the effector caspases, while 
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mature caspase-8 is exactly the opposite: this different substrate specificity may be an 
explanation of the dual role of caspase-8 in apoptosis and proliferation (Chang et al., 
2003). 
The signaling pathway mediated by DR-4 and DR-5 is similar to that of Fas and it is 
activated by their ligand TRAIL (tumour necrosis factor-related apoptosis-inducing 
ligand) (Peter & Krammer, 2003; Lavrik et al., 2005). DR-4, DR-5 and TRAIL are 
expressed in many tumor and normal tissues although it has been shown that TRAIL 
induces apoptosis specifically in tumor tissues (Chang & Yang, 2000). For this reason, 
TRAIL has been extensively studied as an anticancer reagent. The different responses to 
TRAIL may be due in part to the presence of decoy receptors in normal but not in tumour 
cells (Budihardjo et al., 1999; Chang & Yang, 2000). 
1./7.3 TNF-RI-mediated death receptor pathway. 
The TNF-RI (tumour necrosis factor receptor-I) mediates the pleiotropic effects of the 
inflammatory cytokine TNF-a. The TNF-RI is expressed ubiquitously while its ligand is 
only express by activated macrophages and T cell in response to infection (Chang & 
Yang, 2000). TNF -a can induce either apoptosis or the expression of pro-inflammatory, 
immunomodulatory and anti-apoptotic genes through the activation of NF-KB (nuclear 
factor KB) and AP-I (reviewed in Budihardjo el al., 1999; Barnhart & Peter, 2003; 
Chang & Yang, 2000). Recently, an elegant model to explain the mechanism governing 
the decision to induce one of these pathways has been proposed (Figure 1.10) (Micheau 
& Tschopp, 2003). This model involves the formation of two sequential complexes. The 
first complex (complex I) is generated in the plasma membrane by the binding ofTNF-a 
to the TNF-RI. This event induces the association between the adapter molecule 
TRADD (tumour necrosis factor receptor-associated death domain), and TNF-Rl via DO 
interaction; in tum, TRADD recruits TRAF-2 (tumour necrosis factor receptor-associated 
56 
Introduction 
factor type-2) and RIP-I (receptor interacting protein I) leading to the activation ofNF-
KB. In contrast with the Fas or TRAIL signaling pathway, FADD and caspase-8 are not 
recruited to the activated receptor, thus this complex does not induce apoptosis (Harper et 
al., 2003; Micheau & Tschopp, 2003). 
The pro-apoptotic signal depends on the formation of a second complex (complex II) in 
the cytoplasm. After internalization of complex I, TRADD, RIP-I and TRAF-2 soon 
dissociate from TNF-RI and the DDs of TRADD, previously engaged in the interaction 
with the DDs of TNFR-I, become available to bind the DDs of FADD leading to the 
formation of complex II (Micheau & Tschopp, 2003). The ability of the newly formed 
complex II to induce apoptosis depends on the signal previously triggered by complex I: 
if the activation of NF -tCB is productive then the expression of anti-apoptotic genes, such 
as c-FLIPl , inhibits complex II; in contrast, if the activation of NF-teB is not productive, 
the complex II recruits caspase-8 and induces apoptosis (Micheau & Tschopp, 2003). 
The signal pathway through Apo-3/DR-3 is similar to TNF-RI, however the expression 
pattern of Apo-3 and its ligand Apo-3L1DR-3L differs from those of TNF-RI and TNF-
a: Apo-3 is expressed mainly in the immune tissues while its ligand is present 
constitutively in many tissue (Chang & Yang, 2000). 
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1.17.4 Regulation of the death receptor pathway. 
The extrinsic as well as the intrinsic pathway are subjected to strict regulation to prevent 
occasional activation of initiator caspases. In the intrinsic pathway, one of these 
mechanisms acts through the expression of decoy receptors on the cell surface. Decoy 
receptors for TRAIL (DcR-l and R-2) and Fas-L (DcR-3) have been described (Golstein, 
1997; Pitti et 01., 1998). These receptors are unable to transmit the death signal because 
they lack the cytoplasmatic domain (OcR-I) or have truncated death domains (OcR-2). 
Thus, decoy receptors may inhibit apoptosis by sequestering the death ligands away from 
the death receptors or by complexing the death receptors upon binding to the trimeric 
ligand (Ashkenazi & Dixit, 1998; Budihardjo et 01., 1999). Recently, it has been 
demonstrated that OcR-2 forms a ligand-independent heterotrimeric complex with 
TRAIL-R2 through the interaction between their PLAO domains thus inhibiting TRAIL-
R2-mediated apoptosis (Clancy el a/., 2005). It is still unknown if the other decoy 
receptors function in a similar manner. DcR-l and DcR-2 have been found to be 
expressed more in normal than tumour tissues, explaining the increased sensitivity of 
tumor cells to TRAIL. In contrast, DcR-3 is over-expressed in lung and colon cancer and 
it may represent a mechanism for tumor evasion (Budihardjo ef a/., 1999). 
Another regulation mechanism of the intrinsic pathway prevents procaspase-8 
recruitment and/or inhibits its activation within the DISC. Probably the best studied 
inhibitor of the intrinsic pathway is FLIP (Fas-associated death domain-like IL-lf3-
converting enzyme [FLICE]-like inhibitory protein). This protein was first discovered as 
a viral protein (v-FLIP) expressed by y-herpesviruses and was capable of blocking Fas-
mediated apoptosis. Two mammalian homologues were then identified, c-FLIP-short (c-
FLIPs) and -long (c-FLIPd, which are two alternatively spliced form of FLIP 
(Budihardjo el al., 1999; Peter & Krammer, 2003; Peter, 2004). 
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c-FLIPs and v-FLIP have two tandem DEDs homologous to those of caspase-8. These 
two proteins seem to have only anti-apoptotic functions competing with caspase-8 and -
10 for OED domains ofFADD (Peter & Krammer, 2003). 
c-FLIPl is an inactive homologue of caspase-8. It contains not only the tandem DEDs but 
also the protease like domain in which several amino acids important for the catalytic 
activity are mutated (Peter & Krammer, 2003; Peter, 2004). The mechanism of c-FLIPl 
inhibition is more complex then c-FLIPs or v-FLIP. It has been shown that c-FLIPl can 
inhibit or activate procaspase-8 depending on the level of its expression; low levels of 
expression (close to physiological condition) enhance Fas induced capsase-8 activation 
within the DISC, while high levels (as found in certain tumor cells) inhibits caspase-S 
activation (Chang et ai., 2002). 
This double function of c-FLIPl resides in the ability of this protein to form active 
heterodimers with caspase-S. According to the proximity induced dimerization model, 
association between c-FLIPl and procaspase-8 induces a change in the conformation of 
procaspase-S which acquires its enzymatic active form (Chang et ai., 2002, Micheau et 
ai., 2002). Because c-FLIPl is enzymically inactive, only the procaspase-8 in the 
heterodimer forms an active site (Chang et ai., 2002). 
Although c-FLIPl can induce activation of procaspase-8, its role in apoptosis remains 
elusive (Peter et ai., 2004). It has been shown that at physiological low concentration c-
FLIPl can enhance Fas mediated apoptosis but at high concentration inhibits it (Chang et 
ai., 2002). In contrast with this result, Micheau and co-workers have shown that even at 
low concentration, c-FLIPl inhibits apoptosis (Micheau el ai., 2002). The dimerization 
event between procaspase-8 and c-FLIPl promotes the initial processing of procaspase-8 
but the heterodimer is retained in the DISC, preventing the release of mature caspase-8 
into the cytosol and apoptosis (Micheau et ai., 2002). In the same paper, the authors 
show that this heterodimer cleaves substrates in close proximity to the DISC (like RIP-I 
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and c-FLIPL itself which is processed into N-terminal p43 and C-terminal p12 subunits). 
The preference for these "local substrates" is not due to different substrate specificity 
between the mature caspase-8 and the caspase-8/c-FLIPL heterodimer, but it is 
determined by the localization of this heterodimer in the DISC (Boatright et al., 2004). 
In conclusion, in the absence of c-FLIPL, mature caspase-8 is release from the DISC into 
the cytosol where it mediates a downstream apoptotic signal. In contrast, if c-FLIPL is 
present in the DISC at a sufficient concentration, it will dimerize and activate pro-
caspase-8 allowing the first cleavage in the processing of caspase-8; however this 
heterodimer will be retained in the DISC and will not induce apoptosis. 
The role of the caspase-8/c-FLIPL heterodimer is still not known. It is possible that the 
function of this heterodimer is to activate a survival and/or proliferative pathway 
explaining the non apoptotic function of caspase-8. In line with this hypothesis, a recent 
paper has shown that the processed c-FLIPL p43 is able to induce the activation ofNF-KB 
pathway (Kataoka & Tschopp, 2004). Despite this result, a role for the caspase-8/c-FLIPL 
heterodimer in survival and proliferative pathways needs further confirmations. 
1.18 THE MITOCHONDRIAL PATHWAY 
The mitochondrial (or intrinsic) pathway is used to eliminate cells following 
mitochondrial damage, ionizing radiation and chemotherapeutic drugs (reviewed in 
Green & Reed, 1998; Desagher & Martinou, 2000; Green & Kroemer, 2004; Jiang & 
Wang, 2004). These and other apoptogenic stimuli promote the release of several pro-
apoptotic proteins from the mitochondria to the cytosol, including cytochrome c, second 
mitochondria-derived activator of caspases (Smac, also known as direct lAP binding 
protein with low pi or DIABLO), and apoptosis inducing factor (AIF) (Figure 1.3; 
reviewed in Van Loo et al., 2002; Van Gurp et al., 2003). 
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Once in the cytosol, cytochrome c binds and induces oligomerization of Apaf-l, the 
mammalian homologue of CED-4 and an essential component of the vertebrate 
apoptosome (reviewed in Wang, 2001). Apaf-I is a 130 kDa protein consisting of three 
distinctive domains: an N-terminal domain that functions as a CARD element, a central 
CED-4 homologous region containing Walker's A and B boxes required for nucleotide 
binding and a C-terminal domain containing 12-13 WD-40 repeats (Zou et al., 1997). 
Under physiological conditions, Apaf-l is a compact molecule with the head (the CARD 
domain) tucked between its feet (the WD repeats). Cytochrome c binds to the WD 
repeats displacing the CARD domain and allows the molecule to stretch out into a more 
linear structure. In the presence of A TP Apaf-l oligomerizes, forming a heptameric 
complex which then recruits procaspases-9. This complex is called apoptosome (Figure 
1.11; reviewed in Wang, 200 I; Cain et al., 2002). 
A model of the apoptosome at 27 A resolutions predicts that this complex is a wheel-like 
structure comprising a central hub, connected with seven radial spokes (Acehan et al., 
2002). The central hub is composed of seven Apaf-l CARD domains held together in 
close proximity. The CED-4 homologous regions form the spokes of the wheel 
connecting the core of the apoptosome with the Y shaped tail formed by the WD-40 
repeats. The caspase-9 molecules occupy a dome-like position sealing the top of the 
apoptosome hub (Acehan et aJ., 2002; Shi, 2002). 
1.18.1 Mechanisms ofcaspase-9 activation. 
The mechanism of caspase-9 activation within the apoptosome is still controversial. 
Caspase-9 retains its N-terminal domains suggesting that this caspase may function as 
part of the apoptosome (Rodriguez & Lazebnik, 1999). In addition, structural analysis of 
the mature form of caspase-9 reveals that homodimerization results in the formation of 
only one functional site (Renatus et aJ., 2001). These observations are highly reminiscent 
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of the caspasc-8/c-FLIPL dimer which has one functional site and is retained in the DISC. 
Moreover, it has been shown that the interdomain cleavage is neither required nor 
sufficient to activate the procaspase-9 but still occurs. Is it possible that, like caspase-8, 
this event represents a change in the substrate specificity from the pro to the active fonn 
of caspase-9? This is not known but it is noteworthy that this cleavage represents a 
means for inactivation by X-lAP (X-chromosome linked-inhibitor of apoptosis protein). 
The proximity induced dimerization model predicts that the function of the apoptosome 
is to facilitate the dimerization and consequently the activation of caspase-9 (Renatus et 
al., 2001; Boatrigt el al., 2003). Based on this model, Shi and co-workers have suggested 
that the activity of the homodimeric caspase-9 should be the same as that of caspase-9 
bound to the apoptosome. In a recent paper, these authors have demonstrated that this is 
not the case. Using an engineered dimeric caspase-9, which dimerized at the specific 
interdimer interface and not through heterologous domains, they demonstrated that the 
activity of this dimer was only a small fraction of the Apaf-l activated caspase-9 (Chao 
et aI., 2005). 
Alternative models have been proposed for the activation of pro-caspase-9. It is possible 
that the apoptosome assembles the dimeric caspase-9 in a high order complex. 
Alternatively, the apoptosome may induce a confonnational change that directly activates 
monomeric procaspase-9, which remains associated with the apoptosome, or stabilizes 
and enhances the activity of homo-oligomeric caspase-9 (homodimer, homotetramer or 
dimer of homodimers). The last two mechanisms of activation are based on the induced 
confonnational model (Shi, 2004b; Chao et al., 2005). 
The full activation of caspase-9 does not depend entirely on its recruitment into the 
apoptosome; an additional step is required which involves cytosolic as well as 
mitochondrial proteins. 
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1.18.2 X-lAP and inhibition of caspase-9. 
The enzymatic activity of caspase-3, -7 and -9 can be inhibited by endogenous proteins 
named inhibitors of apoptosis (lAP). The lAP family proteins were originally identified 
as baculovirus proteins capable of inhibiting apoptosis in infected cells (review in 
Deveraux & Reed, 1999). Homologues of the viral lAP (vIAP) have been found and 
characterized in mammals including X-lAP (X-linked lAP), c-IAPI (cellular-IAPl) and 
2, ML-IAP (melanoma-lAP), N-IAP (neuronal-lAP), Bruce/Apollon and survivin 
(Deveraux & Reed, 1999; Vaux & Silke, 2003). 
The lAP family proteins are characterized by one or more -70 amino acid zinc binding 
motifs called baculoviral lAP repeat (BIR) domains and, in some cases, a C-terminal 
RING zinc finger domain (review in Deveraux & Reed, 1999). 
The anti-apoptotic activity has been demonstrated only for subset of lAPs, in particular 
for X-lAP, c-IAPI and 2 and ML-IAP (Vaux & Silke, 2003). Among these lAPs, the 
most extensively studied is X-lAP. To prevent apoptosis, X-lAP binds directly to and 
inhibits processed caspase-9, caspase-3 and -7. The ability of X-lAP to inhibit caspase-9 
resides on the BIR-3 domain (Takahashi et al., 1998). Within the apoptosome, 
procaspase-9 undergoes a rapidly autocatalytic cleavage generating the large p35/34 and 
the small pl2 subunits. This cleavage exposes an ATPF motif at the N-tenninal of the 
p12 subunit which binds the BIR-3 of the X-lAP. This interaction is essential to X-lAP 
mediated inhibition of caspase-9 (Srinivasula et al., 2001). X-lAP inhibition of processed 
caspase-3 and -7 is mediated by a distinct domain, in particular by the BIR-2 and a few 
residues in the linker region between the BIR-l and BIR-2 domains (Huang et al., 2001). 
It has been shown that X-lAP can inhibit both processed caspase-9 and caspase-3 
forming a complex (X-IAP/caspase-9/caspase-3) that is retained in the apoptosome 
(Bratton et al., 2002; Twiddy et al., 2004). 
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The components of the native apoptosome have been recently characterized in vitro using 
an activated cell free extract system (Twiddy et al., 2004). In these experiments, the 
apoptosome is purified as a large complex of about 700 kDa. The protein compositions 
of this complex change depending on the cell free extract preparation. Under conditions 
that do not preserve the integrity of the mitochondria, the apoptosome consists of two 
proteins: Apaf-l and caspase-9. The procaspase-9 is rapidly recruited into the complex 
and undergoes the autocatalytic processing leading to the formation of the p35/p34 large 
subunit (Twiddy et al., 2004). In contrast, under conditions that preserve the integrity of 
the mitochondria, thus preventing the release of apoptogenic proteins from these 
organelles, the apoptosome complex contains Apaf-l, processed caspase-9 (p35/p34 
large subunit), partially processed caspase-3 and more importantly, X-lAP. It should be 
noted that while the first complex is enzymatically active, the second is completely 
inactive and possesses only very low activity in the presence of exogenous cytochrome c. 
These data suggest that in addition to cytochrome c, another protein( s) is required for the 
full activation of the apoptosome. Two mitochondrial proteins can overcome the anti-
apoptotic activity of X-lAP: Smac/Diablo and HrtA2 (high temperature requirement 
serine protein A2, also known as Omi). Both Smac/Diablo and HrtA2/0mi are encoded 
by nuclear genes and after their synthesis they are sequestered into the mitochondria 
through a classical mitochondrial targeting sequence at the N-terminal domain (reviewed 
in Van Loo et al., 2002; Van Gurp et ai., 2003; Vaux & Silke, 2003). In the 
mitochondria, the targeting sequence is proteolytically removed so that the mature 
Smac/Diablo exposes a tetrapeptide motif in its N-terrninal domain which interacts with 
the BIR-3 domains of X-lAP. 
During the intrinsic pathway, Smac/Diablo is released from the mitochondria to the 
cytosol where it binds the BIR-3 domain of X-lAP thereby competitively displacing 
caspase-9 (Riedl & Shi, 2004). Since the inhibition of caspase-3 by X-lAP is mediate by 
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another domain, the binding of Smac/Diablo to the BIR-3 domain probably induces the 
release of caspase-3 due to steric clash (Huang et al., 2003). HrtA2/0mi functions in a 
similar manner to Smac/Diablo to remove the inhibition of X-lAP from caspases 
(reviewed in Van Loo et al., 2002). In addition, it has been proposed that HrtA2/0mi can 
induce apoptosis by a caspase-independent pathway due to its serine protease activity, 
but this mechanism is not well known (Wolf & Green, 2002). 
In conclusion, activation of caspase-9 requires its recruitment into the apoptosome and 
the removal of X-lAP inhibition. These two events depend on the release of apoptogenic 
proteins (cytochrome c, Smac/Diablo and HrtA2/0mi) from the mitochondria to the 
cytosol, a process that is highly regulated by the members of the Bcl-2 family (Section 
1.20). 
1.19 EFFECTOR CASPASES 
The activation of both caspase-8, by the death receptor pathway, and caspase-9, by the 
cytochrome clApaf-1 pathway, converge on the activation of the effector caspases-3, -6 
and -7. While the effector caspases exert the same type of effects in response to various 
apoptotic stimuli, different initiator caspases mediate distinct sets of signals. This model 
explains how different apoptotic signals induce the same biochemical and morphological 
changes. 
Effector caspases are activated by the initiator caspases or other proteases (hetero-
activation), such as granzyme B (Stennicke & Salvesen, 2000). The hetero-activation is a 
two step process (reviewed in Chang & Yang, 2000). The first cleavage is carried out by 
initiator caspases (or other proteases) and occurs in the interdomain linker region 
between the small and the large subunit to generate a partially processed p20/p 12 form. 
In the second step, this active intermediate form processes itself to produce the fully 
active, mature p 17 Ip 12 caspase (Figure 1.12). 
67 
Introduction 
INACTIVE 
DlMER 
INITIATOR CASPASES 
GRANZYMEB 
I ~ 
INTRACHAIN 
CLEAVAGE 
•• 
SELF 
PROCESSING 
I ~ 
PRODOMAIN 
CLEAVAGE 
o 0 
o 
o 
LARGE SUBUNIT • INTRACHAIN LINKER 
SMALL SUBUNIT o PRODOMAlN 
ACTIVE 
DIMER 
I-i gurc 1.12 : lI eter o-acth a ti o ll of effector ca pases. Effector caspases e,ist as inacti\e dimer under 
non-apoptollc condItions. \ctl\ allon of effector caspases requires t\\O sequential cleavages. The first 
clea\ age is paformed b) Illltwtor caspa. es or other proteases and results in the removal of the 
IIltrachaln lInker bet\\een the large and the small subunit leading to the produc tion of a partia lly 
proce sed fonn . The second c1ea\age conSISh of an autocatalytic cleavage that remo\es the prodomain 
to ylcld the mature acti\e form Adapted from tennicke & ahe -en.2000. 
6( 
Introduction 
Caspase-3 and -7 have the same substrate and inhibitor specificity. In contrast, the N-
terminal domain presents the largest difference and this region could be involved in 
distinct subcellular localization (Fuentes-Prior & Salvesen, 2004). Based on the N-
terminal prodomain, caspase-6 is considered an effector caspase but the substrate 
specificity differ from that of caspase-3 and -7 and is more similar to that of the initiator 
caspases (Nicholson, 1999). 
Once activated, the effector caspases can initiate a positive feedback loop to amplify the 
activation of initiator caspases. It has been shown that caspase-3 activates caspase-6 
which in turn cleaves and activates caspase-8 (Slee et al., 1999). In a similar way, 
caspase-3 directly performs a feedback cleavage of caspase-9 to generate a p35/plO or 
p37/p10 form which seem to be more active then the p35/p12 generated by autocatalytic 
processing (lou et al., 2003). 
The effector caspases are responsible for the cellular changes that occur during apoptosis. 
To date, more than 60 proteins have been shown to be cleaved in vivo and in vitro by 
effector caspases and this list is growing (reviewed in Cohen, 1997; Earnshaw et al., 199; 
Fuentes-Proor & Salvesen, 2004). Caspase death substrates include proteins involved in 
DNA metabolism, cellular signaling, cellular repair, macromolecular synthesis as well as 
structural proteins such as actin, gelsolin and fodrin (reviewed in Chang & Yang, 2000). 
The cumulative effects resulting from the cleavage of these death substrates are to disable 
homeostatic and repair processes, cell cycle arrest, inactivate inhibitor of apoptosis, 
mediate the structural disassembly and morphological changes and mark the dying cell 
for engulfment. 
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1.20 THE 8cl-2 F AMIL Y PROTEINS 
1.20.1 Structure of BC/-2 family proteins. 
The mitochondrial outer membrane permeabilization (MOMP) is a necessary step for the 
release of apoptogenic factors that lead to the activation of caspase-9. Several death 
signals converge on mitochondria to induce MOMP (reviewed in Green & Reed, 1998; 
Bratton & Cohen, 2001; Green & Kroemer, 2004). Although the precise mechanism of 
MOMP is controversial, it is now clear that the release of pro-a pop to tic proteins from the 
mitochondria is controlled by members of the Bcl-2 family (Gross et ai, 1999; Degli 
Espositi & Dive, 2003; Scorrano & Korsmeyer, 2003; Danial & Korsmeyer, 2004). 
The Bcl-2 family of proteins represent a critical intracellular checkpoint that resides 
immediately upstream of mitochondria (Scorrano & Korsmeyer, 2003; Danial & 
Korsmeyer, 2004). Members of this family direct apoptotic signals from either intrinsic 
or extrinsic stimuli towards the mitochondrial surface and control, directly or indirectly, 
the integrity of the mitochondrial outer membrane (Degli Espositi & Dive, 2003; Danial 
& Korsmeyer, 2004). 
The Bcl-2 family proteins are characterized by four conserved Bel-2 homology (BH) 
domains designated BH1, BH2, BH3 and BH4 (reviewed in Danial & Korsmeyer, 2004; 
Petros et al., 2004). Based on their pro-survival and pro-apoptotic nature and on the 
occurrence of the different BH domains, Bcl-2 family members are classified in three 
groups (Figure 1.13). Anti-apoptotic Bel-2-like proteins, including Bcl-2, Bel-XL, Mel-l 
and Bcl-w, display amino acid sequence homology in all BH domains; multidomain pro-
apoptotic members, Bax, Bak and Bok, show amino acid sequence conservation in BH 1-
3 domains and finally the BH3-only proteins , such as Bid, Bik, Bim and NOXA, have 
amino acid sequence homology only in the BH3 domain. Besides the BH domains, some 
Bcl-2 family members posses a C-terminal hydrophobic domain, which is probably 
responsible for membrane localization (Schinzel et aI., 2004). 
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Figure 1.13: BcI-2 famil~ members. The diagram illustrates members of the Bcl -2 family protein 
dJ\ Ided 11110 three categories. antJ-apoptotJc . multidomain pro-apoptotic and the BH3-only proteins . The 
BcI-2 homolog) (BI!) domains are also represented. TN! denote the C-temlinal hydrophobic region. 
darted from Gross {'luI .. 1999. Damal & Kormeyer. 2004. 
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The anti-apoptotic members inhibit the release of apoptogenic factors from mitochondria 
whereas the pro-apoptotic members induce it. Although their mechanisms of action are 
not completely known, heterodimerizaion between pro- and anti-apoptotic Bcl-2 family 
members is important. Structural studies have shown that a hydrophobic groove on the 
surface of anti-apoptotic Bcl-2 proteins is the binding site for the BH3 domain of the pro-
apoptotic counterparts (Petros et at., 2004). 
Pro- and anti-apoptotic proteins have different distributions in the cell (Degli Espositi & 
Dive, 2003; Petros et al., 2004). The anti-apoptotic proteins are localized in the 
mitochondria, endoplasmic reticulum and nuclear membrane. In contrast, the pro-
apoptotic members mostly reside in the cytosol and only after a death signal they 
undergo a conformational change that enables them to integrate in membranes, especially 
the mitochondrial outer membrane (Schinzel et al., 2004). 
1.20.2 BH3-only members. 
The BH3-only proteins reside upstream of anti- and multi domain pro-apoptotic members 
and act as sensors that selectively respond to specific death signals. The pro-apoptotic 
activity of BH3-only proteins depends in particular on the BH3 domain as mutations in 
this region block their ability to induce apoptosis (Danial & Korsmeyer, 2004). Some 
BH3-only proteins possess a buried BH3 and require a conformational modification to 
expose their BH3 domain (eg. Bid); some others have an exposed BH3 domain but it is 
kept in an inactive form by the binding of an inhibitory complex (eg. Bad, Bim). Finally, 
some others are under transcriptional control and they are not expressed under non-
apoptotic conditions (NOXA, PUMA). Following a death stimulus, the BH3-only 
proteins are activated by transcriptional up-regulation (NOXA and PUMA), post-
translational modification, including cleavage (Bid) and dephosphorylation (Bad), and 
translocation (Bim) (reviewed in Gross et al., 1999). The activated BH3-only proteins are 
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able to translocate to the mitochondrial outer membrane and activate the multidomain 
members Bax and Bak (Gross et al., 1999; Sharpe et al., 2004; Lucken-Ardjomande and 
Martinou, 2005). 
The mechanism by which the BH3-only proteins activate Bax and Bak is still 
controversial and it could be dependent on the particular member of this sub-family. 
Indeed, the BH3-only proteins can be divided in two classes based on their ability to 
activate Bax and Bak directly or indirectly (Letai et al., 2002). The Bid-like BH3 
molecules can activate Bax and Bak directly and they can be inhibited by the anti-
apoptotic Bcl-2 family members. On the other hand, the Bad-like BH3 only molecules 
seem to activate Bax and Bak by binding to and inhibiting the anti-apoptotic members of 
the Bcl-2 family. Thus, it is possible that during apoptosis Bax and Bak are activated by 
the simultaneous activation of distinct classes of BH3-only proteins, some of which bind 
to and inactivate the anti-apoptotic Bc1-2 proteins, setting the Bid-like molecules free to 
activate Bax and Bak (Letai et ai., 2002; Danial & Korsmeyer, 2004). However other 
mechanisms could be possible. It has been proposed that the Bad-like molecules bind to 
the anti-apoptotic Bcl-2 proteins chancing their conformations. This switched state of the 
anti-apoptotic Bcl-2 proteins would then induce a homotypic prion-like aggregation and 
activation of Bax and Bak (Puthalakath & Strasser, 2002). Although suggestive, this 
hypothesis requires further investigations. 
1.10.3 Multidomain pro-apoptotic proteins Bax and Bale. 
In healthy cells, Bax exists as a monomer in the cytosol or loosely attached to the 
mitochondrial outer membrane while Bak already resides in the mitochondrial outer 
membrane. Approximately 10-15% of Bax and Bak are also localized in the endoplasmic 
reticulum (Scorrano & Korsmeyer, 2003). In the inactive conformation, the C-terminal 
anchor domain of Bax, essential for mitochondrial targeting, is bound in the hydrophobic 
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pocket formed by BH I, 2 and 3 domains of the molecule (Schinzel et al., 2004). Since 
Bak is already integrated in the mitochondrial outer membrane, it is possible that its 
inactive conformation is regulated by other resident mitochondrial proteins. It has been 
shown that VDAC-2 (voltage dependent anion channel type-2), one of the three 
mammalian VDAC isoforms, is a specific inhibitor of Bak and it may function to 
maintain Bak in its inactive form (Cheng et at., 2003). Alternatively, Bak may be kept in 
an inactive conformation through its interaction with the anti-apoptotic members of Bcl-2 
family. In a similar way, it has been proposed that several cytosolic proteins, like 14-3-3 
and humanin can sequester and keep Bax in its inactive conformation (reviewed in 
Lucken-Ardjomande & Martinou, 2005). Although this represents an attractive 
mechanism for Bax regulation, it has often been questioned because down-regulation of 
these proteins never led convincingly to spontaneous apoptosis and the phenotype 
knockouts do not suggest massive apoptosis. 
All the BH3-domain-only proteins tested and several types of apoptotic stimuli that 
induce the intrinsic pathway, even those that operate at the ER level, require Bax and 
Bak activation, suggesting that these two multi domain pro-apoptotic proteins represent 
an essential gateway to the intrinsic pathway (Wei et al., 2001b; Scorrano et al., 2003; 
Danial & Korsmeyer, 2004). Following a death stimulus, Bax and Bak undergo a 
conformational change, including the exposure of their N-terminal domain and their 
homo-oligomerization in the mitochondria (Degli Espositi & Dive, 2003). Since Bax is a 
cytosolic protein, it needs additional steps prior to its homo-oligomerization which 
consist in the displacement of its C-terminal membrane anchor domain from the 
hydrophobic pocket and the translocation to the mitochondrial outer membrane. 
The exposure of the N-terminal domain seems to be an important step in the activation of 
Bax and Bak. It has been proposed that the N-terminal region of the pro-apoptotic Bcl-2 
family members acts as an inhibitor domain by blocking the exposure of the BH3 domain 
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which is essential for their killer activity (Gross et al., 1999). According to this 
hypothesis, the proteolytic removal of the N-terminal domain of Bax and Bid enables 
their targeting into the mitochondria. In a similar way, the removal of the N-terminal 
domain of Bim, which keeps this protein bound to the cytoskeleton, converts it into a 
more potent killer (Dania} & Korsmeyer, 2004). Interestingly, the removal of the N-
terminal BH4 domain of Bcl-2 by caspase-3, converts this anti-apoptotic protein in a pro-
apoptotic factor capable of releasing cytochrome c from mitochondria (Kirsch et al., 
1999). 
1.20.4 Activation oj Bax and Bak by BH3-only members. 
A number of mechanisms have been proposed for Bax activation by the Bid-like 
molecules. The BH-3 domain of active Bid can bind to the pocket of Bax suggesting that 
Bid may act as a chaperone for Bax driving its translocation to the mitochondria (Gross 
et al., 1999). Alternatively, in the "kiss and run" hypothesis, Bid can form a transient 
complex with Bax in which it induces a conformational change that activates Bax 
(Sharpe et al., 2004). Recently, it has been shown that active Bid promotes lipid transfer 
processes and has the ability to destabilize planar lipid membranes. In this context, Bid 
could alter the composition of the mitochondrial lipid bilayer to allow Bax to bind and 
permeabilise the membrane (Degli Espositi & Dive, 2003; Sharp et ai., 2004). It should 
be noted that all these proposed mechanisms are not mutually exclusive and they may 
cooperate to activate Bax. Moreover the scenario is complicated by the fact that other 
proteins can activate Bax and Bak. For example, it has been shown that p53 can induce 
the activation of Bax and Bak independently of its transcriptional activity even though a 
direct interaction between p53 and BaxlBak has not been found (Chipuk et al., 2004). 
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Another important issue that remains controversial is how the cytochrome c and other 
apoptogenic factors sequestered in the mitochondrial intennembrane space are released 
into the cytosol and how the Bcl-2 proteins control this process. 
1.21 MECHANISM OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION 
In general two classes of mechanism have been proposed to explain MOMP 
penneabilization, those in which the mitochondrial inner membrane (MIM) participates 
and those involving only the mitochondrial outer membrane (MOM) (reviewed in 
Donovan & Cotter, 2004; Green & Kroemer, 2004). It should be noted that. these two 
mechanisms are not mutually exclusive and they may occur in a sequential fashion or 
independently from each other depending on the cell type, the nature and the level of the 
apoptotic stimulus. Both of these mechanisms can be regulated by the members of the 
Bcl-2 family. 
1.21.1 The permeability transition pore. 
In the first type of mechanisms, it has been postulated that during apoptosis a pore opens 
in the MIM allowing water and solutes up to 1.5 kDa to pass through. This event would 
cause the expansion of the MIM and the subsequent breaking of the MOM. Several 
hypotheses have been suggested to describe the nature of these pores. It is postulated that 
the mitochondrial swelling is the result of the opening of the permeability transition pore 
(PTP). The PTP is a compositive conductance channel that evolves in the mitochondria 
following an apoptotic signal (reviewed in Halestrap et 01., 2002; Zoratti et 01., 2005). 
The precise molecular composition of the PTP is still unknown. It has been proposed that 
this channel is composed or influenced by the clustered components of the matrix, the 
inner and outer membrane including VDAC, the cyclophilin D (CycD) and the adenine 
nucleotide translocator (ANT) (Green & Kroemer, 2004). Opening of the PTP results in a 
76 
Introduction 
rapid increase of the permeability the MIM to solutes with a molecular mass of about 1.5 
kDa. This event induces a loss of mitochondrial membrane potential (~('P)m), and 
swelling of the mitochondria (reviewed in Green & Kroemer, 2004). The Bcl-2 family 
proteins could regulate the activity of the PTP. Several lines of experimental evidence 
suggest an interaction between the BcI-2 family members with different components of 
the PTP (reviewed in Waterhouse et al., 2002; Lucken-Ardjomande & Martinou, 2005). 
In addition, it has been shown that the cyclosporine A (CsA), which induces closure of 
the PTP inhibiting the CycD, can block, in some circumstances, Bax-induced apoptosis 
(Shimizu et al., 1998). 
Alternatively, it has been proposed that BcI-2 family proteins can regulate only the 
opening of the VDAC channel. In particular, Bax would induce closure of the VDAC 
channel leading to a hyperpolarization of the MIM as the exchange of the mitochondrial 
A TP for the cytosolic ADP would no longer occur. This event is predicted to cause an 
osmotic swelling of the mitochondria (Waterhouse et al., 2002). 
1.21.2 Box and Bak pores. 
The second type of mechanisms does not involve the MIM and the swelling of the 
mitochondria does not occur. One hypothesis holds that Bax and Bak, following their 
oligomerization in the MOM, could form pores large enough to release the cytochrome c 
and other apoptogenic factors. This hypothesis is based on the observation that Bax, Bcl-
XL and Bid resemble the structure of the transmembrane domain of the bacterial colicins 
and diphtheria toxin (Muchmore et al., 1996). These toxins can insert into lipid bilayers 
and form channels capable of conducting ions (Senzel et al., 1998) thus it was 
hypothesized that BcI-2 family members could be pore forming proteins. Subsequently, 
this was confirmed by the observation that recombinant BcI-XL, Bcl-2 and Bax can form 
ion channels in artificial membranes with distinct properties. Bcl-2 and Bcl-XL were 
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shown to form cation specific channels (Minn et al., 1997; Schendel et al., 1997) while 
Bax formed anion channels (Antonsson et af., 1997). According with these results, it has 
been shown that tetramers of Bax are capable of forming pores of 22 A in liposomes, 
large enough to allow the release of cytochrome c (Korsmeyer et al., 2000). 
Using patch clamping of mitochondria and proteoliposomes formed from MOM of 
mammalian cells, Palvov and coworkers identified the presence of a novel ion channel, 
named the mitochondrial apoptosis-induced channel (MAC) (Palvov et al., 2001). The 
activity of this channel correlates with the onset of apoptosis and with the presence of 
Bax in the MOM of apoptotic cells. In addition, the channel activity is absent in 
mitochondria from cells over-expressing anti-apoptotic Bcl-2 and is very similar to that 
found in the MOM of yeast expressing human Bax. 
In addition to the Bax-only pore hypothesis, it has been proposed that Bax and VDAC 
interact to form a hybrid channel during apoptosis. In particular, Bax stimulates the 
release of cytochrome c from liposomes reconstituted with VDAC, apparently through a 
widening of the VDAC pore (Shimizu et al., 2000). However, although Bax 
oligomerized in apoptotic cells, the presence of VDAC in these Bax oligomers was not 
found (Antonsson et al., 2000). 
Another hypothesis holds that Bax could form pores indirectly by destabilizing the lipid 
bilayer. In this model, Bax interacts specifically with lipids to induce a deformation in 
the lipid bilayer structure and the formation of "lipid pores" (reviewed in Sharpe et al. 
2004, Hardwick & Poister, 2002). In line with this hypothesis, it has been shown that 
Bax, following activation by t-Bid (truncated Bid, the activated form of Bid), induces the 
release of 10 kDa or 2000 kDa dextrans from free-proteins liposomes derived from 
MOM (Kuwana et al., 2002; Terrones et al., 2004). This event does not require 
mitochondrial matrix, MIM nor other proteins except t-Bid, but it is influenced by the 
lipid composition of the liposomes since Bax can induce the release of dextran molecules 
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only in liposomes prepared from extracted mitochondria (Kuwana et al., 2002). 
Interestingly, this process is inhibited by the addition of Bcl-XL and it was not induced by 
Bim, suggesting that this BH3-only protein acts with a different mechanism (Terrones et 
al.,2004). 
Although all the mechanisms described above represent elegant explanations on how the 
Bcl-2 family proteins may regulate the release of apoptogenic factors from the 
mitochondria, they lack clear evidence in vivo. Moreover, inside the cells these processes 
are certainly more complex and likely involve other events such as mitochondrial cristae 
remodelling and/or mitochondrial organelle fission (Scorrano & Korrneyer, 2003; 
Perfettini et al., 2005a). 
Since the mechanism of action of the multidomain pro-apoptotic and the BH3-only 
members of the Bcl-2 family is not known, consequently how the anti-apoptotic 
members can counteract their antagonists is not clear. Hypothetically, the anti-apoptotic 
members could function in the opposite way to that of pro-apoptotic members. Although 
this may represent the most probable mechanism, it needs further investigation. 
The perrneabilization of MOM is a complex event and members of Bcl-2 family regulate 
this process probably through diverse mechanisms depending on the cell death stimulus. 
Despite all the different interpretations about the nature of these mechanisms, one thing 
seems to be unquestionable; the relative ratio between anti- and pro-apoptotic members 
of the Bcl-2 family can decide the fate of the cells. 
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1.22 BID AND THE CROSSTALK BETWEEN THE INTRINSIC AND EXTRINSIC 
PATHWAY 
The death signal downstream of the DISC is not the same among different type of cells. 
In particular, in type I cells such as thymocytes, the activation of caspase-8 rapidly leads 
to the maturation of caspase-3 and apoptosis in a mitochondria-independent pathway. In 
contrast, in type II cells such as hepatocytes, the activation of caspase-3 requires a 
mitochondrial amplification loop and it is inhibited by Bel-2 and Bel-XL (Yoon & Gores, 
2002; Bratton & Cohen, 2003). 
The crosstalk between the death receptor and mitochondrial pathway is mediated by the 
activation of Bid (reviewed in Gross et al., 1999). Following its activation by a death 
receptor signal, caspase-8 cleaves Bid at its N-terminal domain generating a p15 C-
terminal fragment. The truncated p15 Bid (t-Bid) is then N-myristoylated in a newly 
exposed glycine residue and trans locates to the MOM where it activates BaxiBak, 
inducing the release of apoptogenic factors from the mitochondria and the activation of 
mitochondrial pathway (Gross et al., 1999; Danial & Korsmeyer, 2004). 
It has been proposed that in type II cells the DISC is formed quite poorly and there is not 
enough active caspase-8 to induce the maturation of caspase-3. Therefore, type [[ cells 
require both caspase-8 and the apoptosome to activate caspase-3 (Peter & Krammer, 
2003). However, it has been demonstrated that cytochrome c-I-, Apaf-l -1- or caspase-9-
1- type II cells are not resistant to CD95-mediated apoptosis (Yin et ai., 1999). These data 
suggest that in type II cells the apoptosome formation is not essential to induce apoptosis 
and another factor may be involved. Bid induces the release of cytochrome c and other 
apoptotic proteins such as SmaclDiablo which antagonizes the inhibitory effects of X-
lAP. It has been demonstrated that X-lAP prevents CD-95 mediated apoptosis through 
the inhibition of caspase-3, and Bel-2/Bel-XL exerts the same effect through the 
inhibition of Smac/Diablo release from the mitochondria (Bratton et al., 2002; Sung et 
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al., 2002). In this context, the type 1111 phenotype could be determined by the ratio 
between the level of X-lAP expression and the amount of active caspase-3 produced. In 
type I cells, a high level of caspase-3 activation, due to an efficient DISC formation and 
caspase-8 activation, overcomes the inhibitory effects of X-lAP. In contrast, in type II 
cells, inefficient activation of caspase-8 leads to low production of active caspase-3 
which is inhibited by X-lAP. The activation of Bid and the release of Smac/Diablo from 
the mitochondria remove the X-lAP inhibition inducing an efficient activation of 
caspase-3 (Bratton & Cohen, 2003). In addition, the caspase-3-caspase-6-caspase-8 
feedback loop provides an amplification pathway for high production of active caspase-8 
(Slee et al., 1999). 
1.23 CALPAINS 
1.23.1 Family members and structure. 
Cal pains are a family of cytoplasmatic cysteine proteases that require calcium ions for 
their activation. At present, 16 mammalian calpain genes have been identified; 14 of 
these genes encode 14 specific isoforms of a catalytic subunit which contains the 
cysteine protease domain, the other two genes encode two isoforms of a small subunit 
that associate with some but not all of the catalytic subunits to form a heterodimer (Goll 
et ai., 2003). Several calpain isoform are ubiquitously expressed, whereas many display 
tissue specific expression patterns. Based on amino acid sequence, mammalian calpains 
can be classified into two groups; classical or conventional cal pains and atypical cal pains 
(Table 1.2) (Sorimachi & Suzuki, 2001). Classical calpains (calpain-I, -2, -3, -8, -9, -II, 
-12, -13) are composed of four domains (I-IV). Domain I is the N-terminal region of the 
calpains and consists of a single a-helix. Domain II represents the protease domain and is 
further divided into IIa and lIb subdomains. 
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CALPAIN GENE OTHER TISSUE ASSOCIATION PROTEIN NAMES DISTRIBUTION WITH30K 
Calpain-l CAPNI Il-calpain large Ubiquitous + 
subunit 
Calpain-2 CAPN2 m-calpain Ubiquitous + 
n large subunit 
r-
> Calpain-3 CAPN3 p94, nCL-l Skeletal muscle 
-til 
til 
-n Calpain-8 CAPN8 nCL-2 Stomach > -r-
n Calpain-9 CAPN9 nCL-4 Digestive tract + > r-
"'C 
> Calpain-II CAPNll - Testis ND 
-Z 
til 
Calpain-12 CAPN12 - Hair follicle ND 
Calpain-13 CAPN13 
-
Ubiquitous ND 
Calpain-14 CA PNI 4 - ND ND 
Calpain-5 CAPN5 nCL-3, Ubiquitous -> hTRA-3 
-l 
0( 
"'C Calpain-6 CAPN6 CAPNX Placenta, 
-
-("'} 
> embryonic muscle r-
n Calpain-7 CAPN7 Ubiquitous > PalBH -r-
"'C 
> Calpain-IO CAPNJO 
-Z 
-
Ubiquitous ND 
til 
Calpain-15 SOLH SOLH Ubiquitous ND 
~("'}tIl Calpain small 
Ubiquitous 
CAPNS-I CAPN4 subunit I, + 
=>:: 30K ~r-> ~;:r-
~-r- Cal pain small Ubiquitous tIl Z CAPNS-2 CAPNS-2 + 
subunit 2 
Table 1.2: The calpain famUy. Calpains are classified into classical calpains, atypical calpains and 
small calpain subunits. The classical caipains display the typical structure of the prototype calpain-
1 and -2, consisting of the N-terminal domain (domain I), the catalytic domain (domain II), the C2-
like domain (domain III) and the calmodulin-like domain (domain IV). The calpain-14 mRNA 
could not be detected in any tissue examined, thus the significance of the calpain-14 gene is not 
clear. In the atypical calpains, the calmodulin-like domain is absent or replaced with unique 
structures such as the PalB homologous (PaIBH) domain in calpain-7 or the small optic lobe 
homology (SOLH) domain in calpain-15. The small calpain subunits are composed of two domain 
called domain V and VI. The function of the small calpain subunit 2 is not known. The calpain 
small subunit I (also known as 30 K) heterodimerizes with calpain-I, -2 and -9. The association 
between calpain-I and -2 with the 30 K form the 11- and m-calpain respectively. Adapted from 
Suzuki el al., 2004. 
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The IIa subdomain contains the active cysteine while the other amino acid residues of the 
catalytic triad (histidine and aspartic acid) are located on the llb subdomain. Domain III 
links the protease domain (II) with the calcium binding domain (IV); this domain shows 
no significant amino acid homology with any other sequences, however the overall 3D-
structure of domain III resembles the C2 domain found in several calcium-regulated 
proteins such as protein kinase C (Sorimachi & Suzuki, 2001). Like the C2 domain, 
domain III is able to bind phospholipids in a calcium-dependent manner (Tompa et al., 
2001). Domain IV contains five sets of EF-hands calcium binding structures similar to 
those found in calmodulin and is thus designated as a calmodulin-like domain (Carafoli 
& Molinari, 1998). Atypical calpains (calpain-5, -6, -7, -10 and -15) are characterised by 
the absence of the calmodulin-like domain and the presence of unique structures (Table 
1.2). A third group of calpains consists of the two small calpain subunits. The small 
subunit 1 (also known as 30 K regulatory subunit) is a 30 kDa polypeptide that contains 
two domains named domain V and VI. The N-terminal domain V is glycine rich and it 
has been suggested that this domain binds phospholipids. Domain VI contains five sets of 
EF-hand calcium binding motifs similar to those found in domain IV. The fifth EF-hand 
motif of domain IV and VI cannot bind calcium but interact to each other to form a 
heterodimer (Suzuki el al., 2004). Within the classical calpains, only calpain-l, -2 and -9 
have been proven to interact with the small subunit 1 to form heterodimers (0011 et al., 
2003). In particular, the interaction between calpain-l and -2 with the small subunit 1 
generates two heterodimeric proteins called ~- and m-calpain respectively, which will be 
further discussed in a separate section. Atypical calpains lack domain IV important for 
the heterodimerization thus they do not interact with the small subunit 1. The second 
small subunit is a 27 kDa polypeptide and has 63 % amino acid sequence identity with 
the small subunit I. The role of the small subunit 2 is still unknown. 
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Not all the cal pains have been characterized at the protein/enzyme level and for some 
calpains the protease activity has not yet been proven (Suzuki et al., 2004). Most of the 
calpains have been identified only as genes or mRNAs having sequence homology to the 
prototypal calpain-l and -2 and only calpain-l, -2 and calpain-3b, which is a splice 
variant of the calpain-3 gene, have been isolated in protein form (Goll et al., 2003), thus 
the functions and the substrates of each member of the calpain family have not been yet 
addressed. 
1.23.2 f.J- and m-ca/pain. 
The most extensively studied members of the calpain family are calpains-l and -2. These 
calpains are polypeptides of about 80 kDa ubiquitously expressed in mammalian tissues 
that share 55-65% amino acid sequence homology within a given species and similar 
structure (Goll et al., 2003). Calpains-l and -2 do not function as monomeric 
polypeptides, instead they heterodimerize with the 30 K regulatory subunit to form f..l-
and m-calpains, respectively. Thus calpain-l and -2 are always referred to in the 
literature as the Il- and m-Iarge catalytic subunit. The large subunit of Il- and m-calpains 
is responsible for their catalytic activity while the role of the 30 K regulatory subunit is 
less clear. It has been proposed that this subunit functions as a molecular chaperone to 
fold properly the large subunit and regulates the calcium sensitivity of Il- and m-calpains 
(Sorimachi et al., 1997). Although the precise function of this subunit is still unknown, it 
seems to be essential for the activity of Il- and m-calpains as knocking-out the 30 K 
regulatory subunit gene is embryonically lethal in mice; in addition the embryonic 
fibroblasts derived from these mice proliferate normally in tissue culture cells but they do 
not display any calpain activity (Arthur et al., 2000; Zimmerman et al., 2000). 
Micro- and m-calpains take their name from the different range of calcium concentration 
required for their activation in vitro. In particular millimolar and micromolar 
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concentration of calcium is required for the activation of m- and 11- calpain respectively. 
In vivo, in addition to calcium, the activity of 11- and m-calpains is also regulated by an 
endogenous inhibitor called calpastatin (reviewed in Goll et al., 2003). This polypeptide 
contains four domains of about 140 amino acids. Each of these domains can inhibit the 
proteolytic activity of calpains, hence theoretically four calpains could be inhibited by 
one calpastatin. These four domains display three conserved regions or subdomains 
named A, Band C which are important for the inhibition. The subdomains A and C 
interact with the calpain domain IV and VI in a calcium-dependent manner whereas 
subdomain B probably binds near the calpain active site (Suzuki et al., 2004). Because 
the calpain domains IV and VI are necessary for the effective inhibition by calpastatin, 
this polypeptide inhibits only dimeric calpains (11-, m- and calpain-9). 
In vitro studies have shown that in the presence of calcium J.l.- and m-calpains undergo a 
proteolytic process that removes domain I from the large subunit and domain V from the 
small subunit to produce 78 and 18 kDa polypeptides respectively (reviewed in Carafoli 
& Molinari, 1998; Goll et al., 2003; Suzuki et ai., 2004). The removal of the N-terminal 
prodomain from an inactive zymogen is a common mechanism of activation for many 
proteolytic enzymes such as caspases; however this process may have unique features in 
the case of calpains. The availability of X-ray crystallographic structures of recombinant 
rat and human m-calpain in a calcium free state has led to important informations on the 
molecular mechanism of cal pain activation (Strobl et al., 2000). Based on these 
structures, domain VI of the small subunit interact with domain IV and the N-terminal 
domain I of the large subunit. In this inactive state, the subdomain IIa containing the 
active cysteine and the subdomain lIb containing the other amino acid residues of the 
catalytic triad are too far apart to form an active site. It has been proposed that the 
binding of calcium on the calpain molecule will release the constraints imposed by 
domain interactions and induce a rearrangement of domain II to form the active site 
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(Suzuki et al., 2004). This proposed mechanism of activation has important 
consequences. First of all, the removal of the N-tenninal prodomain from the large 
subunit is not necessary for calpain activation as this domain does not block the active 
site; however this event still occurs in cultured cells and its function is not known. The 
removal of the N-terrninal domain from the large subunit of the calpain molecule will 
predict to disrupt the interaction between the large and small subunit causing their 
dissociation (Pal et al., 2001). However, it has been demonstrated that these subunits co-
localize in cultured cells (Gil-Parrado et al., 2003) and they can be co-
immunoprecipitated under conditions where calpains are proteolytically active (Zhang & 
Mellgren, 1996), thus dissociation of the large and small subunit may not occur in vivo 
even after autolysis of the N-terrninal domain of the large subunit. In addition, 
dissociated cal pains rapidly loose their proteolytic activity (Pal et al., 2001), thus the 
physiological role, if any, of the dissociation process in unknown. Another important 
problem concerns the calcium requirement for calpain activation. The calcium 
concentration necessary to activate Jl- and m-calpains in vitro is much higher than the 
concentrations that exist in living cells (nonnally 50-300 nM). Thus it has been suggested 
that in cells there must be a mechanism to reduce the concentration of calcium required 
for the activation of Jl- and m-calpains. It has been hypothesised that calpains interact 
with phospholipids or proteins of the plasma membrane or other cellular compartments in 
the close proximity of a calcium channel so that the local concentration of calcium would 
activate calpains (Goll et al., 2003; Suzuki et aI., 2004). Although this is a suggestive 
hypothesis, clear evidence of this mechanism of activation is still missing. 
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1.13.3 Physiological role of jI- and m-calpain. 
The physiological role of ~- and m- calpains have been investigated in different cell 
systems mainly using calpain inhibitors (reviewed in Goll et al., 2003; Suzuki et al., 
2004; Franco & Huttenlocher, 2005). With this approach, calpains have been implicated 
in the regulation of the cell cycle, gene expression and cytoskeleton and membrane 
remodelling during cell fusion and migration. Although a possible role of calpains in 
these processes cannot be excluded, serious doubts have arisen on the specificity of the 
calpain inhibitors used and many effects attributed to calpains may represent the results 
of the activity of other proteolytic systems such as the proteasome. For example using an 
inhibitory approach, different studies have suggested that calpain activity is required for 
progression through the G 1 to the S phase of the cell cycle (Goll et al., 2003); however 
embryonic fibroblasts from the Capn 4 -/- mice proliferate normally without any 
detectable calpain activity (Arthur et al., 2000) suggesting that some calpain inhibitors 
may have unexpected effects. It cannot be excluded that calpains have some effects on 
cell proliferation depending on the cell system studied. However the role of calpains in 
this process in poorly understood. 
One of the best characterized functions of calpains which has been confirmed in 
embryonic Capn 4 -/- mouse fibroblasts is the remodelling of the cytoskeleton and 
plasma membrane during cell migration (reviewed in Franco & Huttenlocher, 2005). 
Calpains cleave several substrates involved in plasma membrane remodelling and cell 
motility including spectrin, tal in and p-integrins. Calpain cleavage of 
integrinlcytoskeletal proteins in the focal adhesions breaks the interaction of these 
proteins, resulting in cell rounding, loss of submembraneous actin filament networks and 
increased rates of cell spread and motility (Glading et al., 2002). In addition, the 
embryonic Capn4 -/- mouse fibroblasts do not generate the calpain-mediated degradation 
of spectrin and talin, they have an abnormal cytoskeleton and display decreased rates in 
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integrin-mediated cell motility (Dourdin et al., 2001). Thus, this result further supports 
the role of calpains in cell migration. Another important aspect of ~- and m-calpains is 
their involvement in cell death and apoptosis. 
1.13.4 Role of p- and m-calpain in cell death and apoptosis. 
Initially, it was thought that activation of calpains was correlated with a necrotic type of 
cell death which is characterized by lost of membrane integrity, dissolution of the DNA 
and finally swelling of the cells. This concept was based on the fact that calpain 
activation was usually found in different types of injury models associated with necrosis 
such as myocardial infarction, neuronal ischemia, acute renal and liver failure (Harwood 
et ai., 2005). However, increasing observations and studies have now changed this view 
as they have demonstrated that calpains can play an important role during apoptosis. 
Calpains are activated in response to etoposide in 2B4 murine T cells hybridoma 
(Varghese et ai., 2001), ionomycin in human large cell lung carcinoma (Gil-Parrado et 
al., 2002), cisplatin in melanoma cell lines (Mandic et al., 2002) and calcium ionophore 
A23187 in a mouse photoreceptor cell line (Sharma & Rohrer, 2004). In these 
experimental systems, cal pains act upstream of the mitochondrial pathway, promoting 
the release of cytochrome c through the direct cleavage of Bid and specific calpain 
inhibitors can block or delay apoptosis. Calpains can also promote the release of 
cytochrome c through the cleavage of the pro-apoptotic member of the Bcl-2 family 
protein Bax. In lurkat cells treated with etoposide, calpains cleave Bax into an 18 kDa 
fragment which is able to promote the release of cytochrome c from the mitochondria 
and the subsequent activation of caspase-3 (Gao & Dou, 2000). This event occurs early 
during etoposide-induced apoptosis as a specific inhibitor of calpains, calpeptin, blocks 
the cleavage of Bax and the apoptotic phenotype. Cleavage of Bax by calpains also 
occurs during apoptosis induced by topoisomerase I inhibitor 9-AC in human leukaemia 
88 
Introduction 
cells although in this case, inhibition of calpains using different inhibitors, including 
calpeptin, efficiently blocks Bax cleavage but not apoptosis, suggesting that in this 
system, activation of calpains is a late event and is not essential for the apoptotic process 
(Wood et al., 1998). Calpains are also able to activate caspases by direct cleavage, 
without the involvement of the mitochondria. Activation of caspase-12 by m-calpain has 
been reported during endoplasmic reticulum stress in neurons (Nakagawa & Yuan, 
2000). During neonatal hypoxia-ischemia in 7 day old rats, m-calpain cleaves caspase-3 
producing a 29 kDa fragment which in turn undergoes an autocatalytic process to lead to 
formation of the active 17 kDa form (Blomgren et al., 2001). In a similar manner, during 
apoptosis of B cell lymphoma induced by anti-IgM cross linking treatment, J..l-calpain 
cleaves procaspase-7 at a no-canonical site producing a 30 kDa catalytic active fragment 
(Ruiz-Vela et al., 1999). 
Despite all this evidence for an active role of calpains during apoptosis, other studies 
have shown different results. It has been demonstrated that cleavage of caspase-3, -7 and 
-9 by J..l-calpain leads to the inactivation of these caspases both in vitro and in vivo using 
Hela, MCF-7 and SH-SY5Y human neuroblastoma cell line (McGinnis et al., 1999; 
Chua et al., 2000). In line with these observations, it has been shown that during 
myocardial ischemia, reperfusion injury and excitotoxic neuronal death, calpains engage 
a caspase-independent cell death despite the release of cytochrome c from the 
mitochondria (Lankiewicz et al., 2000; Chen et al., 2001; 2002). In these systems, 
calpains most probably inactivate caspase-3 and -9, thus preventing the entry of cells into 
a caspase-dependent cell death after the mitochondrial release of cytochrome c. 
The role of calpains in apoptosis is further complicated by the fact that caspases can 
regulate calpain activity through the cleavage of calpastatin, the specific endogenous 
inhibitor of calpains. Several studies have demonstrated that caspase-I, -3 and -7 mediate 
89 
Introduction 
calpastatin degradation both in vitro and in vivo (Wang et al., 1998b; Porn-Ares et al., 
1998). 
Finally, calpains can have a different role in apoptosis even in the same cell system 
depending on the initial apoptotic stimulus. A remarkable example of this phenomenon is 
represented by neutrophils. It has been shown that during constitutive apoptosis of 
human neutrophils, calpains are activated downstream of caspases and, in combination 
with the proteasome, they are responsible for the development of the morphological 
apoptotic features including rearrangement of the structure and protein composition of 
the cytoskeleton, PS exposure and ingestion by macrophages (Knepper-Nicolai et ai., 
1998). In contrast, during neutrophil apoptosis induced by TNF-a, calpains playa more 
important role as they control the activation of caspase-3 through the direct cleavage of 
X-lAP (Kobayashi et al., 2002). Finally, during neutrophil apoptosis induced by grow 
factor withdrawal and Fas-L, ~-calpain is activated and plays an upstream role in the 
apoptotic cascade controlling the release of cytochrome c and Smac/Diablo from the 
mitochondria through the cleavage ofBax (Altznauer et al., 2004). 
In conclusion, although several studies have clearly demonstrated the involvement of 
calpains in apoptosis, it is difficult to delineate a precise function for calpains in 
apoptosis. The role of calpains during apoptosis is strictly dependent on the cell system 
and the apoptotic stimulus, thus in some models they can act as initiators of apoptosis but 
in many others as regulators, effectors or even inhibitors of the apoptotic process. 
1.24 THE ENDOPLASMA TIC RETICULUM STRESS RESPONSE 
The endoplasmic reticulum (ER) is the principal site for protein synthesis and folding, 
calcium storage and biosynthesis of steroids, cholesterol and other lipids. Several 
pharmacological agents as well as other stimuli such as viral infections affect the ER 
functions and cause ER stress. The cells respond to the ER-stress inducing a specific 
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signaling pathway conserved throughout the eukaryotic kingdom called the unfolded 
protein response (UPR) (reviewed in Rutkowski & Kaufman, 2004). The UPR is largely 
mediated by the activation of glucose regulator protein-78 (GRP-78), also known as 
immunoglobulin binding protein (Bip), which is a chaperone protein that reside in the ER 
lumen (Momoi, 2004; Rao et al., 2004). In non-stressed conditions, Bip binds three ER 
stress "sensor" proteins, the activating transcription factor-6 (ATF-6), inositol requiring-
I (IRE-I) and the double stranded RNA-activated protein kinase like-ER kinase (PERK). 
Under ER stress conditions, Bip dissociates from ATF-6, IRE-I and PERK and 
preferentially binds unfolded proteins whereas the free sensors induce the UPR (Bratton 
& Cohen, 2001; Rao et al., 2004). ATF-6 induces the expression of chaperones that 
mediate protein folding while IRE-l induces the expression of proteins that enhance the 
degradation of misfolded proteins through a ubiquitin-proteasome system called the ER-
associated degradation system (ERAD) (Tardif et al., 2005). Activation of PERK leads to 
the phosphorylation of the a-subunit of the eukaryotic initiation factor-2 (eIF-2u) which 
in tum inhibits protein synthesis. The cumulative effects of the UPR remove the ER 
stress by reducing the amount of newly synthesized proteins translocated in the ER 
lumen, increasing the degradation of ER-Iocalized misfolded proteins and enhancing the 
protein folding capacity of the ER. However, if all these responses are not sufficient to 
remove the ER stress, the UPR can ultimately kill the cell, triggering several pro-
apoptotic pathways. 
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1.25 ER STRESS-MEDIATED APOPTOSIS 
At present, the exact mechanism involved in ER stress-induced apoptosis is poorly 
understood as ER-stress can trigger different apoptotic pathways which could be related 
to the nature of the apoptotic stimuli as well as the cell type. 
1.25.1 lRE-l mediated apoptosis. 
During UPR, lRE-1 can recruit TRAF-2 which in turn binds and activate the apoptosis 
signal-regulating kinase-l (ASK-I) the proximal component of c-Jun N-terminal kinase 
(JNK) pathway. Once activated, JNK can stimulate the phosphorylation and activation of 
Bim which in turn induces Bax translocation and cytochrome c release (Momoi, 2004). 
In addition, IRE-I upregulates the transcription factor GADD-153 (growth arrest and 
DNA damage inducible gene-IS3, also known as C-EBP homologous protein, CHOP) 
which may amplify the apoptotic signal (Bratton & Cohen 2001; Momoi, 2004; Rao et 
al., 2004). GADD-IS3/CHOP seems to downregulate the expression of Bcl-2 altering the 
balance between pro-and anti-apoptotic members of the Bcl-2 family; this event may 
facilitate the apoptotic signal through Bim and the caspase dependent mechanism. 
1.25.2 Caspase-12. 
One of the best known mediators of the ER stress-induced apoptosis is caspase-12 
(reviewed in Szegezdi et al., 2003). This caspase belongs to the ICE caspase subfamily 
and possesses a CARD domain in its N-terminal prodomain. Functional caspase-12 has 
been cloned only in mouse and rat. A human homologue of murine caspase-12 has been 
found but analysis of the human caspase-12 gene has revealed that nine alternatively 
spliced mRNAs are produced but all of them contain a frame shift mutation and 
premature stop codons which preclude the expression of the full length protein (Fischer 
et al., 2002). For this reason, the presence of such a caspase with similar function 
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remains controversial, although it has been suggested that caspase-4 can replace caspase-
12 function during ER stress-mediated apoptosis in humans (Hitomi et al., 2004; Momoi, 
2004). 
It has been shown that caspase-12 is activated following several ER stress stimuli 
including brefeldin A, thapsigargin and during viral infection (Bikto & Barik, 200l).The 
precise pathway of caspase-12 activation is still not clear and many mechanisms have 
been proposed. Caspase-12 can be processed by the m-calpain at its N-terminal domain 
(Nakagawa & Yuan, 2000). The resulting p30 fragment of caspase-12 is then 
autoprocessed to generate the full mature p20/p 1 0 caspase. In this scenario, the calcium 
release from the ER (a process also controlled by Bax and Bak) would play an upstream 
role during ER stress-induced apoptosis, coupling the activity of calpains and caspases 
(Nakagawa & Yuan, 2000). Alternatively, it has been shown that Bip, following its 
dissociation from the ER sensors, trans locates from the ER lumen to the cytosol as well 
as to the ER membrane as a transmembrane protein (Rao et aZ., 2002b, Reddy et aZ., 
2003). In the ER surface, Bip recruits caspase-7 and caspase-12, preventing their 
activation and inhibiting apoptosis during the initial phase of the UPR. Upon excess ER 
stress, caspase-7 associates with caspase-12, inducing its activation (Rao et aZ., 2001). 
The final hypothesis holds that caspase-12 could be recruited at the IRE-lITRAF-2 
complex via CARD domains where it would be activated by dimerization (Yoneda et ai., 
2001). 
The events downstream of the activation of caspase-12 are also controversial. In 
particular, it is unclear whether caspase-12-induced apoptosis is dependent or not on 
cytochrome c release. It has been shown that caspase-12 is able to process and activate 
caspase-9 and caspase-3 directly (Morishima et al., 2002). However, the processed 
caspase-9 has a low activity and only acquires its full catalytic activity as a part of the 
apoptosome. In addition processed caspase-3 and -9 are subjected to the inhibition of X-
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lAP thus the mitochondrial pathway may represent an essential activation loop in 
caspase-12 mediated apoptosis. 
1.26 THE DOUBLE STRANDED RNA-ACTIVATED PROTEIN KINASE 
1.26.1 Structure andfunction. 
The double stranded RNA-activated protein kinase (PKR) plays an important role during 
the interferon-mediated antiviral response (Kaufman, 1999). PKR is expressed at low 
levels in all mammalian tissues and is transcriptionally induced by interferons (IFNs). 
PKR is composed of an N-terminal regulatory domain and a C-terminal protein kinase 
catalytic domain (Gale et ai., 2000). This enzyme is activated following binding of 
double stranded RNA (dsRNA), an intermediate of viral replication frequently present in 
the cytosol of the infected cells. The dsRNA binds PKR at its two N-terminal regulatory 
domain-binding motifs and promotes dimerization and subsequently trans-
autophosphorylation on several critical serine and threonine residues rendering the kinase 
active (reviewed in Gale et ai., 1998; Kaufman, 1999; Gale et ai., 2000). The canonical 
substrate for activated PKR is the a. subunit of eIF-2. eIF-2 is a heterotrimeric protein 
that binds GTP and the initiator tRNA met. This ternary complex binds the small 40S 
ribosomal subunit to form the 43S complex. The 43S complex binds the mRNA and then 
the 60S ribosomal subunit joins with the concomitant hydrolysis of GTP (Gale et at., 
2000). To promote another round of initiation, GDP bound to eIF-2 must be exchanged 
for GTP in a reaction catalyzed by the eukaryotic initiation factor-2B (eIF-2B). 
Phosphorylation of eIF-2a on S51 by PKR inhibits this reaction leading to the formation 
of an eIF-2a-GDP-eIF-2B stable complex. In this manner PKR inhibits cellular as well as 
viral translation (Kaufman, 1999). 
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1.26.2 PKR and apoptosis 
In addition to its role in the IFN response, PKR is involved in different other processes as 
cellular growth, differentiation and apoptosis (reviewed in Jagus et al., 1999). It has been 
shown that PKR is required to induce apoptosis in response to lipopolysaccharide (LPS), 
dsRNA, TNF-a and serum deprivation (Kaufman, 1999; Jagus et al., 1999). In addition, 
over-expression of wild-type PKR in Hela cells is sufficient to induce apoptosis (Lee & 
Esteban, 1994). The mechanism by which PKR induces apoptosis is still not clear but 
seems to require the phosphorylation of eIF-2a since over-expression of non-
phosphorylatable eIF-2a inhibits PKR-induced apoptosis (Srivastava et al., 1998; Gil et 
al., 1999). How the phosphorylation of eIF-2a influences the apoptotic pathway is not 
known. It has been proposed that phosphorylation of eIF-2a may induce preferential 
translation of selective mRNAs that provide apoptotic function (Jagus et al., 1999). On 
the other hand, the translational inhibition imposed by eIF-2a. phosphorylation may 
deplete the cell of short-lived proteins with anti-apoptotic functions (Kaufman. 1999). 
PKR can also lead to the activation ofNF-KB. PKR promotes the phosphorylation of the 
inhibitor ofKBa. (IKBa.) which in tum leads to the proteasomal-dependent degradation of 
IKBa. allowing NF-KB to translocate into the nucleus (Gil et al., 1999). Over-expression 
of a non-phosphorylatable form of IKBa. or inhibition of IKBa. degradation with 
proteasome inhibitors blocks PKR-induced apoptosis, suggesting a role of NF-KB 
activation in this process (Gil et al., 1999). Activation ofNF-KB may contribute to PKR-
induced apoptosis through the regulation of several pro-apoptotic factors such as p53, 
Fas, Fas-L and TRAIL (Kaufman, 1999). 
Despite the involvement of eIF-2a. phosphorylation and NF-KB activation, PKR-induced 
apoptosis seems to proceed through the activation of caspase-8 (Gil et ai, 2002; Iordanov 
et al., 2005a). Interestingly, PKR-mediated activation of caspase-8 requires FADD but is 
independent of the death receptors (Gil & Esteban, 2000). Recently, it has been 
95 
Introduction 
demonstrated that transfection of dsRNA induces the formation of a DISC complex 
containing F ADD, TRADD and caspase-8 (Iordanov et al., 2005b). Importantly, the 
production of this complex is independent of death receptors and protein synthesis. 
Although in this study the activation of PKR was not examined, it is possible that the 
same complex is involved in PKR-induced apoptosis. 
In summary, PKR can induce apoptosis through different mechanisms including 
phosphorylation of eIF-2a, activation of NF-JCB and caspase-8. However, whether these 
pathways are integrated or independent to each other is still unknown. 
1.27 VIRUSES AND APOPTOSIS 
Virus infection of vertebrate hosts inevitably triggers a complex defence response 
mediated by the immune system to prevent viral dissemination, viral replication or 
persistent viral infection of the cell (Barber, 2001). It is now clear that many of these 
defence mechanisms involve the induction of apoptosis in the infected cells. 
There are two fundamental mechanisms to induce apoptosis in infected cells (O'Brien, 
1998; Barber 2001). One is based on the immune response. Phagocytic cells and 
cytotoxic lymphocytes, such as natural killer and cytotoxic T cells, provide a powerful 
defence mechanism that eliminates infected cells by apoptosis (Krajcsi & Wold, 1998; 
Barber 2001). The other mechanism is cell autonomous. The viruses interact and 
manipulate the host cell to ensure virus entry, replication and dissemination of the viral 
progeny. During this process, the viruses can activate, directly or indirectly, pro-
apoptotic "cellular sensors" (such as death receptors, p53, PKR) which initiate apoptosis 
in the infected cells (Everett & McFadden, 1999). 
The induction of apoptosis by viral infection is inevitably associated with the 
pathogenesis of the viruses (reviewed in Dockrell, 2001). This correlation is more 
evident if virus-induced apoptosis leads to massive cell death or occurs in critical organs 
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like heart, central nervous system and immune system. More difficult is to establish the 
effects of apoptosis on viral replication. Apoptosis could represent a very efficient 
mechanism by which viruses promote their own dissemination by limiting the 
inflammatory response. The release of the progeny virions within the apoptotic bodies 
provides an efficient protection against neutralizing antibodies and facilitates infection of 
neighbouring cells (Teodoro & Branton, 1997; Everett & McFadden, 1999). This 
hypothesis is supported by the observations that viruses can efficiently replicate in 
apoptotic cells (Koyama et al., 2000) and indeed viral particles associated with apoptotic 
bodies have been found during Chicken Anaemia virus and Sindbis virus infection 
(Teodoro & Branton, 1997). 
Although apoptosis can be an efficient mechanism used by the viruses to disseminate the 
viral progeny, some viruses are greatly harmed by apoptosis. Direct interference of virus 
replication by apoptosis has been observed in baculovirus-infected insect cells. Mutant 
baculovirus that was unable to inhibit apoptosis in the host cells, gave rise to a reduction 
in viral progeny, suggesting that infected cells undergo apoptosis to prevent virus 
replication (reviewed in Clem, 2001). 
The role of apoptosis during animal virus infection seems to be different. Animal viruses 
can grow efficiently in apoptotic cells with an only a slight reduction of the viral 
multiplication (Koyama et al., 2000). Based on these observations, it seems likely that in 
mammals the primary role of virus-induced apoptosis is not the premature lysis of the 
infected cells, but is the activation of macrophage-mediated phagocytosis of infected 
cells (Koyama et al., 2000). Apoptotic cells expose phosphatidylserine on the cell surface 
as a signal that mediates the recognition and engulfment of these apoptotic cells by 
macrophages (Martin et al., 1995). Thus, if virus-infected cells undergo apoptosis, 
phagocytosis of apoptotic cells could represent an efficient mechanism to block virus 
multiplication in these infected cells (Koyama et al., 2000). However, apoptosis can also 
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have a direct role in the host defence system under certain conditions, such as the 
presence of inflammatory cytokines. It has been shown that pretreatment of cells with 
TNF-a before infection can potentiate virus-induced apoptosis, resulting in a reduction in 
virus production (Koyama et al., 1998). 
To avoid the adverse effects of apoptosis, viruses have acquired various strategies that 
can be classified into three categories. The first one is typical of many RNA viruses (such 
as Influenza virus and Vescicular Stomatitis virus) and involves the completion of the 
viral replication before the onset of apoptosis, a process called rapid multiplication 
(Koyama et al., 2000; Hay & Kannourakis, 2002). In the second one, called "cryptic 
infection", a virus may infect a cell and remain undetected, avoiding host cell destruction 
and allowing a productive infection only under certain conditions. Epstein-Barr virus, a 
large double-stranded DNA virus of the Herpesviruses family, adopts such a strategy. 
This virus belongs to the lymphocryptovirus subgroup and infects B and epithelial cells, 
normally establishing a latent infection (Lagunoff & Carroll, 2003). In vivo, Epstein-Barr 
virus remains latent in resting memory B cells and is not detected by the immune system. 
This may be due to the expression of few viral proteins in vivo which is limited to 
Epstein-Barr nuclear antigen-l (EBNA-l), important for viral replication, and latent 
membrane protein-2 (LMP-2) essential to maintain the latent state (Cohen, 1999). This 
event restricts the number of epitopes presented to the immune system and allows the 
virus to go undetected during latent infection. 
Finally, some viruses express viral proteins with an anti-apoptotic function (reviewed in 
Teodoro & Branton, 1997; O'Brien, 1998; Everett & McFadden, 1999; Hay & 
Kannourakis, 2002). Selected examples of viruses that can interfere with the apoptotic 
pathway are described in section 1.28, 1.29 and 1.30. 
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1.28 VIRUSES THAT INDUCE APOPTOSIS 
1.28.1 Human Immunodeficiency virus-I (HIV-I). 
One clinically significant example of virus-induced apoptosis relates to the replication of 
HIV-l. This virus is a member of the lentivirus subfamily of the Retroviridae. HIV-I 
principally infects T helper cells and cells of the monocyte/macrophage lineage that 
express the CD4+ and CXCR4 chemokine co-receptor cell surface proteins. HIV-I 
infection is characterized by a progressive depletion of the circulating CD4+ T-
lymphocyte population, a central feature of HIV -I pathogenesis (reviewed in Gougeon, 
2005). Apoptosis induced by HIV-I occurs in infected cells as a consequence of the viral 
cytopathic effects (direct killing) and also in uninfected bystander cells (bystander 
killing) (Perfettini & Kroemer, 2005). It has been found that at least three viral proteins 
are involved in bystander-cell apoptosis. The HIV-I coat glycoprotein 120 (gp 120) 
mediates the entry of HIV-I into target cells through the interaction with CD4 and the 
CXCR4 chemokine co-receptor. It has been shown that soluble, as well as membrane-
anchored, gp 120 expressed on the surface of infected cells is capable to induce apoptosis 
in cells expressing CD4 and CXCR4, including lymphocytes, neurons, cardiomyocytes, 
kidney epithelial cells and hepatocytes (reviewed in Perfettini et al., 2005b). The 
mechanism of gp 120-induced apoptosis proceeds through BaxiBak activation, loss of 
L\('¥}m, release of cytochrome c from the mitochondria and activation of caspases 
(Ohnimus et al., 1997; Perfettini et al., 2005b). Two other viral proteins, the transcription 
factor Tat (trans-acting transcription factor) and the accessory protein Nef (negative 
factor), induce bystander killing, increasing the expression of Fas-L on the surface of 
infected cells, which in turn binds in trans to Fas of activated bystander lymphocytes. It 
should be noted that while Tat and Nef can induce apoptosis of uninfected bystander 
lymphocytes, the expression of these proteins provides protection of HIV -I infected cells 
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from Fas- and gp 120-mediated cell death, allowing the completion of viral replication 
(McCloskey et al., 1997; Muthumani et al., 2005; Perfettini & Kroemer, 2005). 
Apoptosis in HIV-I infected cells is mainly due to the expression of a 14 kDa structural 
protein named viral protein r (Vpr). Vpr is implicated in virus assembly, induction of 
host cell cycle arrest in the G2/M transition phase and stimulation of viral gene 
expression. Vpr is able to induce apoptosis in different cell line including human 
fibroblast, neurons and peripheral blood T cells (reviewed in Muthumani et ai., 2003). 
Vpr was the first viral pro-apoptotic protein described to act directly on mitochondria 
(Jacotot et al., 2000). This protein localizes in the mitochondria where it induces a loss of 
~('¥)m, release of cytochrome c and finally activation of caspase-9 (Muthumani et al., 
2002; Muthumani et ai., 2003). It has been shown that Vpr interact with the 
intennembrane face of ANT to induce MOMP in isolated mitochondria (Jacotot et ai., 
2000). This interaction seems to be crucial for the induction of apoptosis as Vpr mutants 
that fail to interact with ANT are not able to induce apoptosis. In addition to Vpr, it has 
been shown that the HIV -I protease induces apoptosis by directly cleaving pro-caspase-8, 
which in tum activates Bid and the mitochondrial pathway (Nie et ai., 2002). This 
pathway could represent an additional mechanism by which HIV induces apoptosis in 
infected cells. 
1.18.1 Reoviruses. 
Reoviruses are non-enveloped dsRNA viruses that infect a wide variety of mammalian 
species including humans. They are associated with various diseases including upper 
respiratory infection, diarrhoeal illnesses and rare cases of central nervous system 
infection. Reoviruses induce apoptosis in cultured cells in vitro and in target tissues in 
vivo, including the heart and the central nervous system (reviewed in Clarke & Tyler, 
2003). It has been shown that the apoptotic response can be induced by UV -inactivated 
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vlflons and cannot be prevented by the viral RNA synthesis inhibitor ribavirin 
demonstrating that reovirus-induced apoptosis is dependent on the binding of the virion 
to the cell surface receptor and does not require viral replication (Connolly et at., 2001). 
The ability to induce apoptosis in Reovirus-infected cells depends on the presence of the 
attachment protein 01 (Clarke & Tyler, 2003). This protein is a homotrimer consisting of 
an elongated fibrous domain (tail) inserted into the virions and a virion distal globular 
domain (head) (reviewed in Barton et ai., 2001). Reovirus 01 contains two receptor 
binding domains, one in the head that binds junctional adhesion molecule (JAM), and 
another in the tail that binds a-linked sialic acids. These two domains are both required 
for Reovirus-induced apoptosis. Reovirus infection is associated with activation of 
caspase-8, which in turn cleaves Bid and activates the mitochondrial pathway, with 
selective release of cytochrome c and Smac/Diablo but not AIF and without any decrease 
of ~('¥)m (Kominsky et ai., 2002a, Kominsky et ai., 2002b). In particular, the release of 
Smac/Diablo, rather then cytochrome c, seems to be the key mitochondrial event in 
Reovirus-induced apoptosis; while the mitochondrial pathway is required for the 
activation of caspase-3, a dominant negative caspase-9 isoform fails to block this process 
(Kominsky et ai., 2002b). It has been suggested that Reovirus-induced apoptosis is 
mediated by the expression and the release of TRAIL as antibodies against TRAIL or 
soluble TRAIL receptors completely prevented Reovirus-induced apoptosis (Clarke et 
ai., 2000). The up-regulation of TRAIL is probably due to the activation of NF-KB 
following the interaction of 01 with JAM and sialic acid as inhibition of NF-KB 
activation blocks apoptosis in Reovirus-infected cells (Clarke & Tyler, 2003). 
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1.28.3 Sindbis virus (SINV). 
SINV, the prototype member of the Alphaviruses, is a small single-stranded, positive 
sense RNA virus which causes encephalitis in mice. This virus replicates lytically in 
various types of mammalian cells and the lytic replication seems to be due to the 
induction of apoptosis. Apoptosis induced by SINV occurs during the uncoating phase as 
UV-inactivated SINV is still able to induce apoptosis. Apoptosis can also be inhibited by 
lysosomotropic agents such as monensin (Jan & Griffin, 1999). It has been shown that in 
neuroblastoma cells, fusion of SINV with the endosomal membranes induces the release 
of the pro-apoptotic mediator C2-ceramide which is probably responsible for the 
apoptosis associated with SINV infection (Jan et al., 2000). In vitro, apoptosis induced 
by SINV can be inhibited by the cowpox cytokine response modifier A (CrmA) which is 
an inhibitor of caspase-8 and -1, the pan-caspase inhibitor z-VAD-fmk and over-
expression of Bel-XL (Nava et al., 1998). Consistent with these results, it has been shown 
that apoptosis induced after SINV infection of rat pheochromocytoma PC-12 cells can be 
blocked by over-expression of human herpesvirus-8 vFLIP, indicating that caspase-8 
may play an important role in SINV-induced apoptosis (Sarid et al., 2001). In an animal 
model, CrmA or Bcl-2 expressed as transgenes by a recombinant SINV increases the 
survival of infected mice, suggesting that apoptosis plays an important role in the 
pathogenesis of SINV infection (Levine et al., 1996, Nava et al., 1998). In addition, 
over-expression of Bcl-2 in BHK, N 18 neuroblastoma and rat prostate adenocarcinoma 
AT -3 cells shifts the viral cyele from lytic to persistent infection (Levine et al., 1993). 
Notably, SINV infection of rat-6 embryo fibroblasts, mouse fibroblast and human 
premonocytic cells over-expressing Bcl-2 induces apoptosis and caspase-dependent 
cleavage of Bcl-2, which inhibits its anti-apoptotic activity (Grandgirard et al., 1998). 
The different response to SINV infection probably reflects the different genetic 
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background of cells used in these experiments and highlights the importance of the cell 
type in the study of viruses-induced apoptosis. 
1.28.4 Vesicular Stomatitis virus (VSV). 
VSV is the prototype and the best characterized member of the Rhabdoviridae, a family 
of non-segmented, negative stranded RNA viruses. Natural hosts of VSV include cattle 
and horses, although pigs and sheep can also be infected. VS V induces apoptosis in 
several cell lines including Hela, Jurkat and human H4 neural cells (reviewed in Licata & 
Harty, 2003). Apoptosis associated with VSV infection cannot be blocked by the addition 
of the protein synthesis inhibitor cycloheximide and UV -inactivated VSV retains the 
ability to induce apoptosis (Gadaleta et al., 2002). In contrast, lysosomotropic agents 
inhibit VSV -induced apoptosis, demonstrating that induction of apoptosis in infected 
cells does not require de novo proteins synthesis. It has been shown that VSV induces 
activation of caspase-3, cleavage of PARP, DNA fragmentation and nuclear 
condensation in infected cells (Hobbs et at., 2001; Licata & Harty, 2003). Activation of 
caspase-9 but not caspase-8, cytochrome c release and dissipation of ~('I')m have also 
been observed during VSV-infection (Gadaleta et at., 2005). It has been shown that the 
VSV matrix protein, a structural component of the virion, plays an essential role in VSV-
induced apoptosis (Licata & Harty, 2003; Gaddy & Lyles, 2005). The matrix protein is 
involved in virus assembly and also mediates many cytopathic effects in VSV-infected 
cells, including inhibition of host gene expression, cell rounding and apoptosis (Kopecky 
& Lyes, 2003; Licata & Harty, 2003; Gaddy & Lyles, 2005). In Hela and in simian 
kidney fibroblast Vero-76 cells the ability of the matrix protein to induce apoptosis is 
associated with the inhibition of host genes expression as recombinant VSV expressing a 
mutant matrix protein (rM51R-M ) that is unable to inhibit host transcription, fails to 
induce apoptosis (Kopecky et aJ., 200 I). Surprisingly, infection of BHK and L929 mouse 
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fibroblasts with the rM51 R-M virus induces apoptosis more rapidly then the wild-type 
virus (Kopecky & Lyes, 2003; Gaddy & Lyles, 2005). In these cells, apoptosis occurs 
through the activation of caspase-8 and the subsequent activation of the mitochondrial 
amplification pathway as an inhibitor of caspase-8 blocked activation of caspase-9 
(Gaddy & Lyles, 2005). 
1.28.5 Feline Calicivirus (FCV). 
FCV is the best characterized member of the calicivirus family as for along time it was 
the only member of this family with the ability to grow well in a cell culture system. 
Recently, it has been demonstrated that cells infected with FCV undergo apoptosis (Al-
Molawi et al., 2003). During infection caspase-3, -2 and -6 are activated, chromatin 
condensation occurs and cleavage of P ARP is detected. In addition, in the late stage of 
apoptosis the viral capsid protein is cleaved by caspase-2 and -6. Although the molecular 
mechanism of FCV -induced apoptosis is not well understood, it seems that the induction 
of apoptosis requires the synthesis of viral proteins (Sosnovtsev et al., 2003). 
1.29 VIRUSES THAT INHIBIT APOPTOSIS 
1.29.1 Epstein-Barr Virus (EBV). 
EBV belongs to the y-Herpesviruses, a family of large double-stranded DNA viruses 
which can establish lytic as well as latent infection in the host cells. EBV is the causative 
agents of infectious mononucleosis and is also associated with the development of 
Burkitt's lymphoma, nasopharyngeal carcinoma and Hodgkin's disease (Hammerschmidt 
& Sugden; 2004). EBV normally establishes a latent infection in circulating B 
lymphocytes. In vitro, EBV can establish latency and immortalize primary B cells which 
acquire a new phenotype and are referred to as lymphoblastoid cell line (LCL). EBV 
induces cell cycle progression of LCL and promotes their survival by inhibiting 
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apoptosis. Immortalization and inhibition of apoptosis in B cells requires the expression 
of the EBV latent membrane protein-l (LMP-I) (reviewed in Lagunoff & Carroll, 2003). 
It has been shown that this protein is a constitutively activated receptor that mimics CD-
40 signals to up-regulate anti-apoptotic proteins like Bcl-2 and A-20 through the 
activation ofNF-KB (O'Brien 1998; Uchida et al., 1999; Lagunoff & Carroll, 2003). 
EBV also encodes a protein called BamHI fragment rightward ORF 1 (BHFRI) which 
can inhibit apoptosis induced by serum deprivation, c-myc over-expression, DNA 
damage or chemotherapeutic agents (Cuconati & White, 2002). Although the overall 
structure of BHRFI is similar to Bcl-2 and Bcl-XL' one important difference is that this 
protein does not contain the hydrophobic groove that mediates binding with the pro-
apoptotic BH3-domain-only members, indicating that its action may be different from 
those of Bcl-2 and Bcl-XL (Boya et al., 2004). The infection is usually latent in lymphoid 
cells; however EBV may establish a lytic cycle in a small population of B cells as well as 
in epithelial and fibroblast cells that appear to die by apoptosis. BHRF 1 is expressed 
during the EBV lytic replication cycle and may function to promote viral replication by 
preventing premature death of the host cell. 
1.29.2 Baculoviruses. 
The Baculoviruses are large DNA viruses that infect arthropods. Autographica California 
nuclear capsid polyhedrosis virus (AcMNPV) was one of the first viruses shown to 
interfere with apoptosis. This virus replicates in lepidopteran insects over a period of 
several days, ending in necrotic cell death and release of viral progeny (reviewed in 
Clem, 200 I). A spontaneous mutant known as annihilator mutant was identified because 
of its rapid cytolytic phenotype. In particular, this mutant was found to induce apoptosis 
in a lepidopteran insect cell line (Sf-21) resulting in a dramatic decrease of viral progeny 
production, suggesting that inhibition of apoptosis is necessary for a productive viral 
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replication (Clem, 2001). The products of two viral genes have been implicated in the 
inhibition of apoptosis in baculovirus-infection. The p35 gene, which is the genetic 
determinant for the annihilator phenotype, encodes a caspase inhibitor (reviewed in 
Hardwick, 1998; O'Brien, 1998; Tschopp et al., 1998). The baculovirus p35 protein 
contains a sequence that acts as a substrate for many caspases. After cleavage, p35 
becomes an irreversible inhibitor of caspases forming a stable complex with the active 
enzyme (Hardwick, 1998; Shi, 2002). The second class of anti-apoptotic proteins are the 
viral lAPs which are homologues of the mammalian lAPs and function in a similar 
manner. 
1.19.3 Poxviruses. 
All the known apoptosis modulators in poxviruses, large double-stranded DNA viruses, 
have been shown to act as inhibitors of apoptosis (reviewed in Everett & McFadden, 
2002). The cowpox CnnA gene product is a potent and specific inhibitor of caspase-l, -8 
and can inhibit Fas-L- and TNF-a-induced apoptosis (Hardwick, 1998, O'Brien, 1998). 
Like p35, CnnA functions as a pseudo-substrate that is cleaved during inhibition, 
undergoing a transition to a more stable form that stably complexes capsase-l and -8. 
Vaccinia virus encodes a homologue of CnnA, SPI-2, which can block apoptosis 
induced by TNF or Fas (Hardwick, 1998). In addition, vaccinia virus FIL viral protein 
specifically targets mitochondria and inhibits MOMP and cytochrome c release induced 
by staurosporine and Fas-L, thus blocking apoptosis at the mitochondrial level (Boya et 
al., 2004). 
Other strategies that poxviruses use to prevent apoptosis include the production of 
several soluble orthologues ofTNF-R, like the Cowpox Crm B, Crm C, Crm D and Crm 
E, which prevent the engagement of TNF-R and induction of apoptosis, and the synthesis 
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of c-FLlPs homologous to those in Molluscum contagious virus (reviewed in Benedict et 
al., 2003). 
1.30 VIRUSES THAT INHIBIT AND INDUCE APOPTOSIS 
1.30.1 Human Adenovirus. 
Human Adenovirus is an excellent example of how viruses can use different viral 
proteins to inhibit or induce apoptosis at different stages of their replication. 
Adenoviruses are double-stranded DNA viruses which infect a wide range of mammalian 
and avian hosts and cause various diseases such as mild upper respiratory tract infection 
in young children. The early region lA (EIA) product of adenovirus drives the host cell 
into S phase of the cell cycle through the interaction with the tumor suppression protein 
of the retinoblastoma family (pRb). This event induces the accumulation of p53 and 
apoptosis in infected cells (reviewed in Teodoro & Branton, 1997; O'Brien, 1998). 
Adenovirus encodes several viral proteins that are able to prevent apoptosis induced by 
EIA. The viral proteins EIB 19k and EIB 55k are expressed at the same stage of viral 
replication; E 1 B 55k can interfere with p53-mediated apoptosis by directly binding p53 
(Teodoro & Branton, 1997), while EIB 19k acts as a Bcl-2 homologue (Cuconati & 
White, 2002). Like BHRF1, the adenoviral EIB-19k protein inhibits apoptosis following 
different death stimuli such as TNF-a, Fas-L, DNA degradation and p53-mediated 
apoptosis (Polster et al., 2004). The mechanism by which EIB-19k inhibits apoptosis is 
not clear but it seems that its anti-apoptotic function is linked to its ability to bind Bak 
(Cucconati & White, 2002; Polster et al., 2004). 
During the late stage of infection, human adenovirus expresses a protein called 
adenovirus death protein (AdP) that is required for efficient viral spread. This protein can 
induce cell death, overcoming the protective effect of EIB-19k, and allowing viral 
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progeny to spread to neighbouring cells (Teodoro & Branton, 1997). However, it is still 
unclear whether cell death is due to apoptosis. 
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PROJECT AIMS 
Thirty years ago, Studdert and O'Shea reported that Fey infected cells undergo nuclear 
and cytoplasmic changes during infection; in particular, the nucleus becomes pyknotic 
and the chromatin appears to be condensed (Studdert and O'Shea, 1975). Now we know 
that these changes are related to the apoptotic process. Recent studies have shown that 
Fey triggers apoptosis in cultured feline cells from about 8 h pj (AI-Molawi et at., 
2003; Sosnovtsev et ai., 2003). In infected cells, Fey induces chromatin condensation, 
DNA fragmentation, PARP cleavage and activation of caspase-2, -3, -6, -7, -8, -9. 
Although it has been shown that Fey -induced apoptosis requires the synthesis of the 
viral proteins (Sosnovtsev et ai., 2003), the molecular events that lead to apoptosis and 
the role of this process in Fey replication cycle are not known. 
The aims of the present study were to further define and characterise the apoptotic 
process in Fey infection, focusing in particular on the role of mitochondria. Thus, 
several mitochondria-related apoptotic events such as release of cytochrome c, Bax 
translocation and the loss of the mitochondrial membrane potential were analysed. In 
addition, different types of apoptotic signals that converge to or function independently 
from the mitochondrial pathway such as caspase-8 activation, oxidative stress and 
calpain activation were investigated. Finally the role of apoptosis in the context of Fey 
replication was explored using inhibitors of caspases and calpains/proteasome. 
We believe that this approach will allow us to further clarify the following points: 
~ What is the major pathway of apoptosis activated by Fey infection? 
~ What is the role of the mitochondria in Fey -induced apoptosis? 
~ What is the event(s) that triggers apoptosis in cells infected with Fey? 
~ What is the role and the function of apoptosis in the Fey replication cycle? 
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2 MATERIALS AND METHODS 
2.1 GROWTH OF CRFK CELLS 
Crandell-Rees Feline Kidney (CRFK; from European Collection of Cell Culture, catalog 
number 86093002) cells were grown in modified Eagle's medium (MEM; Invitrogen) 
supplemented with 10% (v/v) heat-inactivated foetal bovine serum (FBS; Invitrogen), 
penicillin (l00 Vlml; Invitrogen), streptomycin (l00 Ilg/ml; Invitrogen) and 1 % (v/v) 
non-essential amino-acids (Invitrogen). CRFK cells were maintained at 37°C in a 
humidified incubator with 5% CO2 (Incubator Galaxy S; Wolf Laboratories). 
When cells were approximately 80-90% confluent, the medium was removed and the 
cells were washed with 5 ml of I: 10 (v/v) trypsiniversene (Invitrogen). The cells were 
incubated with 5 ml of I: 10 trypsinlversene for 5 min at 37°C in humidified incubator 
with 5% CO2• After incubation, the cells were collected in a universal tube containing 5 
ml of growth medium to neutralize the trypsin and centrifuged at 2500 rpm for 2 min. 
The supernatant was removed and the pellet was resuspended in 10 ml of growth 
medium. One ml of the resuspended cells was added to IS ml of growth medium in a 75 
cm2 flask. The cells were maintained in culture as before until the next passage. 
2.2 VIRUS GROWTH 
A confluent 75 cm2 flask ofCRFK cells was infected with 400 III of FCV-F9 strain stock 
in 4 ml of2% (v/v) FBS MEM and rocked for I hat R.T. After incubation, the virus was 
removed and 8 ml of fresh growth medium was added to the flask. The cells were 
incubated at 37°C until the cytopathic effects were evident (6 h post infection, p.i.) and 
then the flask was frozen at -20°C overnight. The next day, the cells were thawed at R.T., 
the supernatant was collected in a universal tube and centrifuged at 2500 rpm for 2 min 
110 
Materials and Methods 
to remove all cell debris. After centrifugation, the supernatant was filtered through a 0.2 
11m minisart filter, aliquoted in bijoux (1 ml) and stored at -80°C. 
2.3 PLAQUE ASSAY 
FCV-F9 titre was determined using the plaque assay. CRFK cells were grown in 6 well 
plates until confluent. Tenfold serial dilutions of FCV -F9 were prepared in PBSa (see 
appendix; Invitrogen) and 400 111 of each dilution were added to the appropriate well 
containing the cells. The cells were incubated on a rocking table for 1 hat R.T. to allow 
the adsorption of virus. After incubation, the inoculum was removed and 2 ml of double 
strength MEM (see appendix) containing 50% (v/v) of soft agar (0.8% w/v in dH20; 
Sigma) were added to each well to restrict the diffusion of the virus and prevent 
secondary plaque formation from viral progeny released into the medium. The cells were 
incubated for 24 h at 37°C. After incubation, the cells were fixed with 2 ml of 10% (v/v) 
formal saline (see appendix; Fischer Scientific) at R.T. After 2 h, the agar plugs were 
removed and the cells were stained with I ml of crystal violet (see appendix; Sigma) for 
30 min at R.T. The cells were washed with dH20 and the number of plaques was 
counted. The viral titre was expressed in plaque forming units (pfu)/ml and was 
calculated using the following equation: 
pfulml = numbers of plaques x dilution factor x 2.5 
2.4 TIME COURSE OF FCV INFECTION 
CRFK cells (approximately 80% confluent) were inoculated with FCV-F9 at a 
multiplicity of infection (moi) of 100 pfulcell in 2% FBS MEM (Table 2.1) and 
incubated on a rocking table for 1 hat R.T (absorption time). A mock infected CRFK cell 
control was also prepared in which the same procedure was followed using 2% FBS 
MEM instead of virus. After I h, the inoculum was removed and replaced with fresh 
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growth medium (Table 2.1) and the cells were allowed to incubate further at 37°C in 
humidified incubator with 5% CO2 (incubation time). At specific times post infection 
(absorption + incubation time), the cells were analysed as described below for specific 
end points. In some experiments, the cells were infected in the presence of different types 
of chemicals including caspase, calpain and proteasome inhibitors and antioxidants. The 
concentrations and conditions used for each chemical are summarized in Table 2.2. 
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DISHES or FLASKS 
75 cm2 Flasks 
35 mm dishes (diameter) 
60 mm dishes (diameter) 
6 well plates 
2% FBSMEM 
4ml 
500 III 
I ml 
500 III (per well) 
GROWTH MEDIUM (10% 
FBSMEM) 
10 ml 
2 ml 
4ml 
2 ml (per well) 
Table 2.1: Cell culture vessels. The table shows the total amount of medium and the type of dishes or 
flasks used in the experiments. 
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CHEMICALS 
z-VAD-fmk 
(pan-caspase inhibitor) 
ac-LEHD-CHO 
(caspase-9 inhibitor) 
Trolox 
(antioxidant) 
DPPD 
(antioxidant) 
ALLN 
( calpainlproteasome 
inhibitor) 
EGTA 
(calcium chelator) 
Calpeptin 
(calpain inhibitor) 
MG 132 
(proteasome inhibitor) 
FINAL 
CONCENTRATION PRETREATMENT FCV 
IN THE 
FLASKIWELL 
100 IlM 
2.4mM 
2.4mM 
(1 h) 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
Yes 
Yes 
CO-TREATMENT 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Table 2.2: Cbemicals and conditions used in combination witb FCV infection. The table shows the 
final concentration and the type of treatments of the chemicals used in combination with FCV infection. 
FCV cotreatment denotes the treatment during the absorption (1 h) + incubation time. The incubation 
time varies among different experiments. Abbreviation: z-Val-Ala-DL-Asp-fluoromethylketone (z-
V AD-fink); (ac-LEHD-CHO); 6-hydroxy-2, 5, 7, 8-tetramethylchroman-2-carboxylic acid (TroIox); N, 
N'-diphenyl-p-phenylenediamine (DPPD); N-acetyl-Ieucinyl-Ieucinyl-norleucinal (ALLN); ethylene 
glycol-bis (l3-aminoethylether)-N, N, N', N'-tetraacetic acid (EGTA); calcium chloride (CaCh); 
benzyloxycarbonyldipeptidyl aldehyde (calpeptin); carbobenzoxy-Ieucyl-Ieucyl-Ieucinal (MG 132). 
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2.5 FLOW CYTOMETRY ANALYSIS 
2.5.1 Cell Culture. 
CRFK cells were grown in 35 mm dishes until they were approximately 80% confluent. 
The cells were infected or mock infected as described in section 2.4. At each time pj., 
the medium containing floating cells was collected in a universal tube and the cell 
monolayer was trypsinized with 1 ml of 1: 10 trypsinlversene. After trypsinization, the 
cells were mixed with their previous medium and centrifuged at 2500 rpm for 2 min. At 
this point, the samples were treated according to the type of analysis described below. 
2.5.2 Annexin V Binding Assay. 
After the procedure described in section 2.5.1, the supernatant was discarded and the 
pellet was resuspended in 1 ml of Annexin V binding buffer (see appendix) to get a cell 
density of lx106 cells/ml. Five hundred ~l of the cell suspension were transferred into a 
clean eppendorfand incubated with 1.25 ~l of Annexin V-FITC (Calbiochem) in the dark 
for 15 min at R.T. After incubation, 10 ~l ofpropidium iodide (Calbiochem) were added 
to each sample in the dark. The samples were placed on ice, wrapped with aluminium 
foil and analyzed (10000 events) immediately by flow cytometry using Beckman-Coulter 
Epics XL using FLI (Annexin V-FITC detection) and FL3 (propidium iodide detection) 
channel. 
2.5.3 Detection of caspase 3 activation. 
After the procedure described in section 2.5.1, the supernatant was removed and the 
pellet was resuspended in 500 ~l of cold CytofixiCytosperm solution (BD Pharmingen, 
see appendix). The samples were transferred to clean eppendorfs and incubated for 20 
min on ice. After incubation, the samples were centrifuged at 2500 rpm for 2 min at R.T, 
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the supernatant was discarded and the cells were washed twice with 500 III of cold 
Perm/Wash buffer (BD Pharmingen, see appendix). After washing, the cells were 
resuspended in 100 I.d of cold Perm/Wash buffer and incubated with 20 III of PE-
conjugated monoclonal rabbit anti-active caspase-3 antibody (BD Pharmingen) for 30 
min at R. T. in the dark. After incubation, the cells were washed once with 1 ml of 
Perm/Wash buffer, centrifuged at 2500 rpm for 2 min and resuspended in 0.5 ml of 
Perm/Wash buffer (all procedures in the dark). The samples were wrapped with 
aluminium foil and analyzed (10000 events) by flow cytometry using Beckman-Coulter 
Epics XL using FL3 channel. 
2.6 CONFOCAL MICROSCOPY ANALYSIS 
2.6.1 Mitochondrial membrane potential analysis. 
Round coverslips (32 mm diameter, thickness nO I, BDH) were sterilized by autoclaving 
at 121°C for 2 h and placed in 6 well plates. The coverslips were incubated with I ml of 
Poly-L-Lysine (lOO Ilg/ml in dH20, Sigma) for 10 min. at R.T. After incubation, the 
coverslips were washed with 1 ml of dH20 and incubated at 37°C for 3 h to dry. 
CRFK cells were grown on round covers lips in 6 well plates until they were 
approximately 80% confluent. The cells were infected or mock infected as described in 
section 2.4. At each time pj., the medium was removed and replaced with 1 ml of PBS 
supplemented with D-glucose (1 gil; Sigma). The cells were incubated with 
tetramethylrhodamine ethyl ester (TMRE, 100 nM; Molecular Probes) and Mito Tracker 
Green FM (50 nM; Molecular Probes) in the dark for 40 min at 37°e. After incubation, 
the cells were washed with I ml of PBSa, the coverslips were mounted on PCO Chamber 
(Bachofer) with I ml of PBS supplemented with D-glucose (l gil) and the cells were 
analysed using confocal inverted microscope (LSM 510 META, Zeiss). 
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2.7 WESTERN BLOT ANALYSIS 
2.7.1 Preparation of total cell extracts. 
CRFK cells were grown in 35 mm dishes until they were approximately 80% confluent. 
The cells were infected or mock infected as described in section 2.4. At each time pj., 
the medium containing floating cells was collected in a universal tube and the cell 
monolayer was trypsinized with I ml of I: 10 trypsinlversene. After trypsinization, the 
cells were mixed with their previous medium and centrifuged at 2500 rpm for 2 min. The 
supernatant was removed and the pellet was resuspended in 100 I-li of cold lysis butTer 
(see appendix) and left on ice for 20 min. After incubation, the samples were briefly 
vortexed and centrifuged at 14000 rpm for 5 min at +4°C. After centrifugation, the 
supernatant was collected in a clean eppendorf and stored at -80°C. Total cell extracts 
were used to detect the processing of caspase-8 and caspase-9, fodrin cleavage and eIF-
2a phosphorylation. 
2.7.2 Preparation of cell extracts for cytochrome c and Bax detection. 
CRFK cells were grown in 60mm dishes until they were approximately 80% confluent. 
The cells were infected or mock-infected as described in section 2.4. At each time pj., 
the medium containing floating cells was collected in a universal tube and the cell 
monolayer was trypsinized with 2 ml of 1: 10 trypsinlversene. After trypsinization, the 
cells were mixed with their previous medium and centrifuged at 2500 rpm for 2 min. The 
supernatant was removed, the pellet was resuspended in 1ml of cold buffer A (see 
appendix) and transferred to a clean eppendor( The samples were centrifuged at 2500 
rpm for 2 min at +4°C and washed with 1 ml of cold buffer A. To obtain the cytosolic 
fraction, the samples were centrifuged as before, the supernatant was discarded and the 
pellet was resuspended in 60 I-li of cold butTer A supplemented with 600 I-lg/ml of 
digitonin to permeabilise the plasma membrane. The cell suspension was left for 2-5 min 
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until approximately 95% of cells were permeabilised. For confirmation, 2.5 ~I of the 
samples were added to 1 00 ~I of 1: 1 (v/v) 0.4% Trypan Blue/PBS and I 0 ~I of this 
solution were placed on a haemocytometer chamber. The cells were examined for plasma 
membrane permeabilization (blue cells) using a light inverted microscope. After 
permeabilization, the samples were centrifuged at 2500 rpm for 5 min at +4°C, the 
supernatant was collected in a clean eppendorf and stored at -80°C. To obtain the 
mitochondrial fraction, the remaining pellet was resuspended in I 00 ~I of lysis buffer and 
left on ice for 20 min. After incubation, the samples were briefly vortexed and 
centrifuged at 14000 rpm for 5 min at +4°C. After centrifugation, the supernatant was 
collected in a clean eppendorf and stored at -80°C. 
2. 7.3 Protein Quantification. 
According to the manufacturer's instructions, the Bio-Rad DC protein assay was used to 
determine the concentration of proteins in cell extracts. 
2.7.4 SDS-PAGE and Immunoblot Analysis. 
Fifty ~g of protein from each sample were mixed with an appropriate volume of loading 
buffer (see appendix) to give a final volume of 20 ~I for loading. The samples were 
boiled for 5 min and then loaded on the stacking gel (see appendix) along with a 
prestained protein marker (broad range 6-175 kDa, Biolabs). Resolving gels (see 
appendix) with different percents of acrylamide were used according to the size of the 
protein analysed (Table 2.3). 
The proteins were electrophoresed at 100 V, 0.2 A for 2 h in running buffer (see 
appendix) and then transferred onto a nitrocellulose membrane (lmmobilion TMP, 
Millipore) by electroblotting at 100 V, 0.4 A for 90 min in transfer buffer (see appendix). 
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The membrane was blocked with blocking buffer (see appendix) for 3 h at +4°C and then 
incubated with primary antibody. Incubation conditions, concentrations and types of 
primary antibody used to detect the specific antigens are summarized in Table 2.3. 
After incubation with the primary antibody, the membrane was washed three times in 1 
X TBS-O.l % (v/v) Tween 20 (see appendix) for 10 min at RT and then incubated with 
appropriate anti-igG peroxidase conjugate secondary antibody for 1 h at RT. The 
membrane was washed as before and detection was performed by enhanced 
chemiluminescence using SuperSignal® West-Pico chemiluminescent substrate (Pierce). 
In some experiments, the membrane was reprobe to detect the cytochrome c oxidase 
subunit IV (COX IV), heat shock cognate protein 70 (Hsc 70) or actin for loading 
controls. The reprobing procedure was carried out by washing the membrane three times 
in I X TBS-O.l % (v/v) Tween 20 for 10 min at RT and then one time in PBS containing 
I mM of NaN3 for 2 h at + 4°C. After three washes in PBS, the membrane was incubated 
with blocking buffer for 3 h at + 4°C, washed as before and then incubated with mouse 
anti-COX IV monoclonal antibody (Molecular Probes; 1: 1 000), rat anti-Hsc 70 
polyclonal antibody (Stressgen; 1: 1000) or rabbit anti-actin polyclonal antibody 
(SIGMA, 1: 1000). The membrane was washed as before and incubated with appropriate 
anti-IgG peroxidase conjugate secondary antibody (as described before). Washes and 
detection were performed as described before. 
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ANTIGEl'I MW °1. ANTIBODY ISOTYPE DlLUITlON INCUBATION (kDa) ACRYLAMIDE 
Anti-cytochrome c 
Cytochrome c 15 15 monoclonal antibody Mouse IgG 1/1000 OIN 
clone 7H8.2C12 
BO Pharmingen™ 
Anti-Bax polydonal 
Bax 23 15 antibody (N-20) Rabbit IgG 1/500 I h 
Santa Cruz Biotechnology 
Anti-COX IV monoclonal 
COX IV 19.6 Loading Control antibody clone 20E8 Mouse IgG 1/1000 OIN 
Molecular Probes 
Anti-Hsc 70 monoclonal 
Hsc 70 70 Loading Control antibody RatlgG 111000 OIN 
Stressgen 
Proform Anti-caspase-9 
47 monoclonal antibody 
Caspase-9 Active 10 from PTofessor Yuri Mouse IgG 1/500 OIN 
form Lazebnik, Cold Spring 
32117 Harbour Laboratory. USA; 
Proform 
53 Anti-caspase-8 polyclonal 
Caspase-8 Active 10 antibody Rabbit IgG 1/500 OIN 
form Calbiochem 
18/10 
Anti-a fodrin monoclonal 
Fodrin 240 6.4 antibody Mouse IgG 1/1000 I h Affiniti Research 
Products Ltd 
Anti-actin polyclonal 
Actin 42 Loading Control antibody Rabbit IgG 1/10000 I h 
Sigma 
Anti-p.eIF-2a 
p-e1F-2a 36 10 monoclonal antibody Rabbit IgG 1/1000 OIN 
ResGen Invitrogen 
Table 2.3: Antibodies. The table shows the characteristic of the antibodies and the conditions used to detect 
each specific antigen. The dilutions of the antibodies were made in 10 ml of blocking buffer. All the 
incubations were performed at + 4 °C. Abbreviation: molecular weight (MW); cytochrome c oxidase subunit 
IV (COX IV); heat shock cognate protein 70 (Hsc 70); phosphorylated-eukaryotic initiation factor-2 subunit 
a (p-eIF-2a); overnight (OIN). 
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2.8 DETECTION OF CASPASE-9 ACTIVITY 
CRFK cells were grown in 35 mm dishes until they were approximately 80% confluent. 
The cells were infected or mock infected as described in section 2.4. At each time p.i., 
the medium containing floating cells was collected in a universal tube and the monolayer 
cells were trypsinized with 1 ml of 1: 10 trypsinlversene. After trypsinization, the cells 
were mixed with their previous medium and centrifuged at 2500 rpm for 2 min. The 
supernatant was removed and the pellet was resuspended in 1 ml of prewarmed growth 
medium to achieve a cell density of lx106/ml. One hundred ).11 of each sample (lx105 
cells/ml) were place in 96 well plates and mixed with an equal volume of Caspase-Glo 9 
reagent (Promega). An additional control included 100 III of medium + equal volume of 
Caspase-Glo 9 reagent to calculate the inherent luminescence of the reagent. The samples 
were incubated for 1 h at RT and then analysed using a luminometer (LumiCount 
Packard Bioscience). The inherent luminescence of the Caspase-Glo 9 reagent was 
subtracted from the luminescence of all the samples and the caspase-9 activity of each 
sample was presented as the mean ± standard error ofthree independent experiments. 
2.9 DETECTION OF CASPASE-3/-7 ACTIVITY 
CRFK cells were grown in 75 cm2 flasks until they were approximately 80% confluent. 
The cells were infected or mock infected as described in section 2.4. At each time p.i., 
the medium containing floating cells was collected in a universal tube and the cells were 
trypsinized with 1 ml of 1: 10 trypsinlversene. After trypsinization, the cells were mixed 
with their previous medium and centrifuged at 2500 rpm for 2 min. The supernatant was 
removed and the pellet was washed 3 times with 1 ml of pre warmed PBS. After washing, 
the pellet was resuspended in 30 J.lI of caspase-3 lysis buffer (see appendix). The cells 
were lysed by snap freezing the pellet in ethanol/dry ice and thawing in water bath at 
42°C for three times and centrifuged at 13000 rpm for 30 min at +4°. After the 
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centrifugation, the supernatant was collected in a clean eppendorf and protein 
concentration was determined for each sample. Eighty Ilg of total protein were mixed 
with caspase-3/-7 assay buffer (see appendix) containing 40 11M of benzyloxycarbonil-
Asp-Glu-Val-Asp-7-amino-4-trifluoromethylcoumarin (z-DEVD-AFC; Bachem) 
fluorogenic substrate (total volume per samples 100 Ill). This substrate contains the 
specific caspase-3/-7 recognition sequence (DEVD) conjugated with the fluorophore 
AFC. After the cleavage of the DEVD sequence by caspase-3/-7, the fluorophore AFC 
dissociates from the tetrapeptide and emits fluorescence at 505 nm when exited at 400 
nm. An additional control included the ac-DEVD-AFC alone to calculate the inherent 
fluorescence of the substrate. The samples were placed on 96 well plates and the 
fluorescence liberate by the cleavage of the ac-DEVD-AFC substrate was measured with 
a micro fluorometer (SPECTRAmax 340PC384 System; Gemini XS) using a 355 nm 
excitation and 538 nm emission filters. The measurements were recorded at intervals of 5 
min for 2 hat 37°C. The caspase-3/-7 activity was calculated as follow. The inherent 
fluorescence of ac-DEVD-AFC was subtracted from the fluorescence recorded at each 
interval for all the samples. The resulting fluorescence of the samples was plotted against 
the time of the analysis (2 h, 5 min intervals) and the slope (representing the caspase-3/-7 
activity) was obtained applying the linear regression analysis in the linear range (first 40 
min). The caspase-3/-7 activity of the samples in the presence of FCV-F9 was normalised 
for the activity of the mock control and presented as mean ± standard error of three 
independent experiments. 
2.10 DETECTION OF CALPAIN ACTIVITY 
CRFK cells were grown in 75 cm2 flasks until they were approximately 80% confluent. 
The cells were infected or mock infected as described in section 2.4. At each time pj., 
the medium containing floating cells was collected in a universal tube and the cell 
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monolayer was trypsinized with I ml of 1: 1 0 trypsinlversene. After trypsinization, the 
cells were mixed with their previous medium and centrifuged at 2500 rpm for 2 min. The 
supernatant was removed and the pellet was washed three times with 1 ml of prewanned 
PBS. The cells were pellet by centrifugation at 2500 rpm for 3 min. and resuspended in 
100 III of calpain assay buffer (see appendix). Samples were splitted in two series of 50 
III each: 50 III of calpain assay buffer + the calpain cell permeable fluorogenic substrate 
Suc-Leu-Leu-Val-Tyr-Amido-4-methylcoumarin (Suc-LLVY -AMC, final concentration 
70 J..lM; Alexis) were added in one series (series I) while 50 J..lI of calpain assay buffer + 
Suc-LL VY -AMC + the calpain inhibitor I ALLN (50 J..lM, final concentration) were 
added in the other one (series II). Series II represented a control to ensure that 
fluorescence activity was calpain specific. Additional controls included Suc-LL VY-
AMC and Suc-LLVY -AMC + ALLN alone to calculate the inherent fluorescence of the 
substrate and the substrate + calpain inhibitor I. The calpain substrate consists of the 
calpain tetrapeptide recognition sequence (LL VY) conjugated with the fluorophore 
AMC. After calpain cleavage, the AMC dissociates from the tetrapeptide sequence and 
emits fluorescence at 460 nm when exited at 380 nm. The samples were placed in 96 
well plates and the fluorescence liberate following the cleavage of the Suc-LL VY -AMC 
substrate was measured with a micro fluorometer (SPECTRAmax 340PC384 System; 
Gemini XS) using a 355 nm excitation wavelength and 460 nm emission filters. The 
measurements were recorded at intervals of 5 min for 2 h at 37°C. Calpain activity was 
calculated as follow. The inherent fluorescence of Suc-LLVY-AMC and Suc-LLVY-
AMC + ALLN was subtracted from the fluorescence recorded at each interval of series I 
and II, respectively. The net fluorescence of the samples was calculated by subtracting 
the residual fluorescence in the presence of ALLN (series II) from the total fluorescence 
(series I). The net fluorescence of the samples was plotted against the time of the analysis 
(2 h, 5 min intervals) and the slope (representing the calpain activity) was obtained 
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applying the linear regression analysis in the linear range (first 40 min). The calpain 
activity of the samples in the presence of FCV -F9 was normalised for the activity of the 
mock control and presented as mean ± standard error of three independent experiments. 
2.11 DETERMINATION OF CELL ASSOCIATED VIRUS AND VIRAL RELEASE 
Approximately 80-90% confluent CRFK cells were infected with FCV-F9 at 100 pfu/ml 
in 35 mm dishes as described in section 2.4. After 1 h incubation, the viral inoculum was 
removed and the cell monolayer was washed with 500 ~l of PBSa containing mouse anti-
capsid protein monoclonal antibody (1: 1000, Carter 1982) for 30 min. at R. T. on a 
rocking table. This procedure was necessary to remove any unbound or unattached viral 
particles which might interfere with the assay. After incubation, PBSa was removed and 
replaced with 2 ml of growth medium and the cells were allowed to incubate further at 
37°C. At different time p.i., the medium was carefully removed from the cell monolayer 
and centrifuged at 3000 rpm for 5 min. to remove any trace of cells. After centrifugation, 
the supernatant was filtered through a 0.2 J-lm minisart syringe filter and stored at -80°C. 
This fraction was used to measure the release of infectious viral particles from the 
infected cells (virus released). The remaining cell monolayer was overlaid with 2 ml of 
fresh growth medium and frozen at -20°C overnight. The next day, the cells were 
thawed at R.T to break the plasma membrane and promote the release of viral particles 
into the medium. Broken cells and medium were collected and centrifuged at 3000 rpm 
for 5 min. to remove cell debris. After centrifugation, the supernatant was collected and 
store at -80°C. This fraction was used to measure the viral particles inside the cells (cell-
associated virus). As the production of new viral particles depends on the viral protein 
synthesis, the viral titer of this fraction gives a good estimation of the viral replication. 
The viral titer of both fractions was determined by plaque assay described in section 2.3. 
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2.12 STATISTICS 
The results of the caspase-9 luminogenic substrate assay, calpains and caspase 3/7 
fluorogenic substrate assay and viral growth experiments in the presence of EGT A, z-
Y AD-fmk and ALLN are reported as mean ± standard error. Means of the caspase-9 
luminogenic substrate assay and means of the viral growth experiments in the presence z-
YAD-fmk and ALLN were compared using one way ANOYA and Bonferroni post hoc 
test with a significance level of p < 0.05 (GraphPad Prism version 4.00). 
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3 THE MITOCHONDRIAL PATHWAY OF APOPTOTIS IS 
TRIGGERED DURING FELINE CALICIVIRUS INFECTION 
3.1 INTRODUCTION 
There are two well defined yet cross-talk mechanisms that can induce activation of 
distinct initiator caspases: the death receptor (extrinsic) and the mitochondrial pathway 
(intrinsic) pathway. In the first one, the binding of death ligands, such as Fas-L, to their 
specific cell surface death receptors, such as Fas, triggers activation of caspase-8 which 
in turn cleaves and activates the effector caspases (reviewed in Peter & Krammer, 2003). 
In the mitochondrial pathway, several apoptogenic stimuli including UV radiation and 
drugs, promote the release of apoptogenic proteins such as cytochrome c from the 
mitochondria (Kroemer & Reed, 2000; Green & Kroemer, 2004; Jiang & Wang, 2004). 
Once in the cytosol, cytochrome c bind to Apaf-l and, in the presence of ATP, induces 
its oligomerization to form the apoptosome (Jiang & Wang, 2004). Recruitment of pro-
caspase-9 into the apoptosome leads to activation of caspase-9, which mediates the 
activation of downstream effector caspases. 
It has been shown previously that FCY induces apoptosis in CRFK cells (AI-Molawi et 
01., 2003; Sosnovtsev et 0/., 2003). Activation of the effector caspases, caspase-3 and -7 
(AI-Molawi et 0/., 2003), and of the initiator caspases, caspase-8, -9 (Sosnovtsev et ai., 
2003) and -2 (AI-Molawi et 0/., 2003), has been shown to occur during the infection. It 
has been shown that synthesis of viral protein is required for FCY -induced apoptosis, but 
the molecular mechanism and the nature of events leading to apoptosis are not well 
understood. 
Here the molecular mechanism of FCV -induced apoptosis was studied in more detail by 
analysing the early apoptotic events upstream activation of effector caspases. 
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3.2 FCV INDUCES PHOSPHA TIDYLSERINE EXPOSURE AND ACTIVATION OF 
CASPASE-3 IN CRFK CELLS. 
To detennine the molecular mechanism of FeV -induced apoptosis, we first analyzed the 
course of apoptosis during FCV infection by measuring phosphatidylserine (PS) 
exposure on the cell surface and the activation of caspase-3. 
The exposure of PS on the cell surface is an early feature of apoptotic cells (Fadok et ai., 
1992). In vivo, phagocytes recognize PS as a signal to remove apoptotic cells preventing 
an inflammatory response. In vitro, detection of PS can be achieved using the 
anticoagulant Annexin V (AV), which, in the presence of calcium, interacts specifically 
with PS. The fluorescein isothiocyanate conjugate of Annexin V can be used to detect 
apoptotic cells by flow cytometry. Since membrane penneabilization is observed in 
necrosis, A V can interact with PS in the inner layer of plasma membrane of necrotic 
cells. In the absence of phagocytosis, this effect occurs in vitro during the late stage of 
apoptosis due to the necrotic-like disintegration of the cells. In combination with 
propidium iodide (PI), a nucleic acid stain that can not penetrate the membrane of viable 
cells, A V binding assay is a powerful method to distinguish between viable cells (A V -, 
PI -), early apoptotic cells (A V +, PI -), late apoptotic and necrotic cells (AV +, PI +). 
The activation of caspase-3 was measured by flow cytometry using a phycoerythrin (PE)-
conjugated anti-active caspase-3 antibody specific for the neo-epitope generated as a 
result of the cleavage of the pro-caspase-3 to the p17/p12 fragment. 
A V -FITC and PI analysis of CRFK cells infected with FCV (Figure 3.1) showed that 
apoptosis occurred at 8 h post-infection (pj.) and was correlated with the appearance of 
activated caspase-3 (Figure 3.2). Both PS exposure and caspase-3 activation were 
sensitive to the pancaspase inhibitor z-V AD-fink confinning that apoptosis induced by 
FCV is caspase dependent. 
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Interestingly, a population of AV - PI + cells was observed at 8 hpj. (Figure 3.1) and 
was also sensitive to Z-VAD-fmk. This population may represent cells that during 
infection undergo plasma membrane modifications due to the combination of apoptosis 
and viral infection. This observation was supported by the fact that cells treated with the 
general apoptotic inducer staurosporine did not show this type of population (Figure 3.3). 
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3.3 FCV INDUCES LOSS OF A('I')m IN CRFK CELLS. 
In order to define the molecular events upstream of caspase-3 activation, we analyzed 
FeY-infected cells for any changes in the mitochondrial membrane potential ~('¥)m. The 
loss of ~('¥)m is an early event in cells undergoing apoptosis (Decaudin et ai., 1997; 
Bossy-Wetzel et ai., 1998) and it has been observed in other virus infections (Tropea et 
al., 1995; Eleouet et ai., 1998; Summerfield et al., 1998; Jacotot et al., 2000). The 
molecular mechanism is not well understood, but it is a clear indication of the 
involvement of mitochondria in apoptosis. The ~('¥)m was measured by confocal laser 
microscope using tetramethylrhodamine ethyl ester (TMRE), a mitochondrial probe 
which does not form aggregates in the cell membrane and does not interact with 
membrane proteins, thus the mitochondrial localization and the level of fluorescence 
emitted by this probe depends directly on ~('¥)m. The correct subcellular localization of 
TMRE was confirmed by co-localization with Mito Tracker green FM. This dye 
selectively stains mitochondria becoming fluorescent once it accumulates in the 
mitochondrial lipid environment but unlike TMRE the fluorescence emission does not 
depend on the ~('¥)m. In cells with normal levels of ~('¥)m, TMRE and Mito Tracker 
green FM co-localize in the mitochondria while after loss of ~('¥)m, only Mito Tracker 
green FM can be detected due to the decrease ofTMRE fluorescence emission. 
As shown in figure 3.4, a near complete loss of TMRE staining was recorded at 6 h p.i. 
with Fey, demonstrating a substantial decrease in ~('¥)m during FeV infection. 
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3.4 FCV INDUCES BAX TRANSLOCATION AND CYTOCHROME C RELEASE IN 
CRFKCELLS. 
Previous reports have shown that Bax translocation and cytochrome c release coincide 
with a major collapse of Ll('¥)m that probably involves the rapid opening of the 
permeability transition pore (PTP) in the mitochondria (Green & Kroemer, 2004; Jiang & 
Wang, 2004; Sharpe et al., 2004). We therefore analyzed the location of Bax and 
cytochrome c during FCV infection. At 4 h p.i., the cytochrome c was still in the 
mitochondrial fraction (P; Figure 3.5 A). The appearance of cytochrome c in the 
cytosolic fraction (S) was clearly detected at 6 h p.i. and was almost complete at 8 h, 
therefore preceding the activation of caspase-3 and PS exposure. The release of 
cytochrome c also correlated with the translocation of the pro-apoptotic Bcl-2 protein 
family member, Bax, from the cytosol to the mitochondria at 6 h p.i. (Figure 3.5 B). 
The detection of cytochrome c oxidase subunit IV (COX IV) was used as a control for 
the mitochondrial fraction. This protein resides in the mitochondrial inner membrane and 
catalyzes the transfer of electrons from reduced cytochrome c to molecular oxygen. 
During apoptosis, COX IV does not translocate from the mitochondria to the cytosol thus 
it can be used as an indicator for the quality and specificity of the perrneabilization 
procedure. No bands were detected in the cytosolic fraction when the membrane was 
probed with COX IV specific antisera, indicating that the permeabilization procedure did 
not affect the mitochondria, thus the release of cytochrome c is due specifically to FCV-
infection. Detection of Hsc 70 was used as a control for the cytosolic fraction. This 
protein is a molecular chaperone involved in protein folding, maturation and degradation. 
Hsc 70 resides in the cytosol and it can be used as a control for the cytosolic fraction. At 
8h pj. the amount of Hsc 70 was decreased in the cytosolic fraction; however, this was 
probably due to the general permeabilization of the plasma membrane late in infection. 
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igure 3.5: ytochrome c relea e and Bax translocation du r ing FCV infection. CRFK cells were 
infe ted ilh F -F9 (100 pfu/cell). At the indicated time p.i., uninfected and FCV-infected cells were 
harve ted and their pIa rna membrane perrneabili ed with digitonin. Following separation of the 
cyto olic ( ) and mitochondrial (P) fraction, amples were analysed by Western blot for cytochrome c 
relea e (A) and Ba tran location (B). ontrol were achieved by reprobing the blots for COX IV (for 
the rnitoch ndrial fracti n) and H c 70 (for the cyto olic fraction). Results shown are representative of 
three independent e. periment . 
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3.5 FCV INFECTION INDUCES ACTIVATION OF CASPASE-9. 
Once in the cytosol, cytochrome c interacts with Apaf-l to form the apoptosome. 
Recruitment of procaspase-9 into the apoptosome leads to the activation of caspase-9 
which mediates downstream events such as activation of caspase-3. Therefore we 
analyzed the timing of caspase-9 processing during FCY infection. Although we were 
unable to detect the active form of caspase-9 (p35/p12), a clear disappearance of the pro-
caspase-9 (p47) was detected at 6 hpj. (Figure 3.6.) which coincided with the release of 
cytochrome c but preceded activation of caspase-3. Activation of caspase-9 was also 
measured using a proluminogenic substrate for luciferase containing the LEHD sequence 
which is selective cleaved by caspase-9 (Caspase-Glo 9, Promega). Following caspase-9 
cleavage at the LEHD sequence, a substrate for luciferase (aminoluciferin) is released, 
resulting in a luciferase reaction and the generation of a luminescent signal which is 
proportional to the amount of caspase-9 activity present in the sample. As shown in 
Figure 3.7 a large increase in caspase-9 activity was detected at 8 hpj., in line with the 
increase in activity seen in CRFK cells treated with 1 f.1M of staurosporine for 8 h. 
To further investigate the role of caspase-9 in FCY -induced apoptosis, we infected 
CRFK cells in presence of ac-LEHD-CHO, a specific inhibitor of caspase-9, and we 
analyzed the cells for PS exposure. Figure 3.8 shows that the inhibitor was not able to 
block apoptosis induced by FCY at 8 hpj.; however this effect was probably due to the 
inability of CRFK cells to retain the tetrapeptide inhibitor as the same inhibitor did not 
block apoptosis induced by staurosporine (Figure 3.9). 
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Figure 3.6: We tern blot analysis of caspase-9 during FeV infection. CRFK cells were infected 
with FC -F9 (100 pfulcell). At the indicated time p.i., un infected and FCV-infected cells were lysed 
and 50 ~g of cell e tract were analysed by Western blot. A loading control was achieved by reprobing 
the membrane for Hsc 70. Result shown are representative of three independent experiments. 
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3.6 DISCUSSION 
FCY infection of CRFK cells results in the classical hallmarks of apoptosis such as 
chromatin condensation, PARP cleavage, DNA fragmentation and caspase activation 
(AI-Molawi et al., 2003; Sosnovtsev et al., 2003). In particular, the activation of the 
effector caspases, caspase-3, and -7 (AI-Molawi et al., 2003), as well as initiator 
caspases, caspase-8 and -9 (Sosnovtsev et al., 2003), has been reported but the molecular 
mechanism of FCY-induced apoptosis was not well characterized. In the present study, 
we extended previous observations and defined the molecular mechanism of FCV-
induced apoptosis. Consistent with previous reports, we showed that the executioner 
caspase-3 was activated at 8 hpj. and this event correlated with the exposure of PS on 
the cell's surface (Figure 3.1, 3.2; AI-Molawi et al., 2003; Sosnovtsev et al., 2003). In 
addition, the presence of the pancaspase inhibitor z-Y AD-fmk prevented the activation of 
caspase-3 and inhibited apoptosis, demonstrating that the execution of apoptosis during 
FCY infection is caspase-dependent. However, it should be noted that in all the analysis 
performed with A Y and PI, the presence of z-Y AD-fink was not able to completely 
inhibit FCV-induced cell death as a population of necrotic cells (AV +, PI + quadrant C 
in density plot figure 3.1), which was highly variable among different experiments, was 
always detected despite the complete inhibition of caspase-3 activation. The presence of 
this cell population could represent an additional necrotic-like cell death pathway 
induced during FCV infection. 
In order to understand the molecular events responsible for caspase-3 activation during 
FCY infection, we analyzed early apoptotic events preceding caspase-3 activation. We 
showed that FCV induced a loss on L\('¥)m at 6 h pj in correlation with Bax translocation 
to, and release of cytochrome c from, the mitochondria (Figure 3.4, 3.5 A and B). 
Release of cytochrome c was paralleled with procaspase-9 processing which is fully 
activated at 8 hpj. corresponding to the time of caspase-3 activation. This discrepancy 
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between processing and activity of caspase-9 could be explained by the fact that initially 
procaspase-9 binds to Apaf-l and is self-processed within the apoptosome to its active 
form. As soon as this event occurs, caspase-9 is inhibited by X-lAP and only after the 
release of Smac/Diablo from the mitochondria it becomes fully active. In our system we 
were unable to detect either the processed form of caspase-9 or the presence of 
Smac/Diablo in the cytosol using a different panel of commercial antibodies. However, 
the detection of a decrease in the pro-caspase-9 at 6 h p.i. (Figure 3.6) along with the 
increase in activity of caspase-9 at 8 hpj. (figure 3.7) supports this hypothesis. 
In conclusion, we extended previous observations regarding FCV -induced apoptosis (AI-
Molawi et al., 2003; Sosnovtsev et al., 2003) by showing that apoptosis is the major form 
of FCV -induced cell death and involves the mitochondrial pathway (Natoni et al., 2005). 
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4 CALPAINS AND PKR ARE ACTIVATED DURING FCV 
INFECTION 
4.1 INTRODUCTION 
The mitochondrial pathway is an essential component ofthe eukaryotic apoptotic system. 
Studies based on mice knocked-out for the essential components of the mitochondrial 
pathway, such as Apaf-l and caspase-9, have demonstrated an important role of this 
pathway during mammalian development (Kuida et al., 1998, Cecconi et al., 1998; 
Hakem et al., 1998; Yoshida et al., 1998). The mitochondrial pathway is also activated in 
differentiated cells and adult tissue under stress conditions such as DNA damage, serum 
starvation, oxidative and ER stress (reviewed in Jiang & Wang, 2004). 
Besides its essential role in animal development and stress-induced apoptosis, the 
mitochondrial pathway can be activated as an amplification loop in other apoptotic 
pathways (Bratton & Cohen, 2003). During death receptor pathway, active caspase-8 can 
cleave and activate the pro-apoptotic member of the Bcl-2 family, Bid. In tum, truncated 
Bid translocates to the mitochondria where it induces the release of cytochrome c in a 
Bax/Bak-dependent manner. This mitochondrial amplification loop seems to be very 
important in certain cell types, known as type II cells, where poor recruitment of caspase-
8 in the DISC or high expression levels of the lAP proteins prevent efficient activation of 
the executioner caspases (Yoon & Gores, 2002). In this context, release of pro-apoptotic 
proteins from the mitochondria following Bid cleavage, such as Smac/Diablo and 
cytochrome c, amplifies the death receptor signal and induces efficient activation of 
effector caspases. 
Recently, it has been proposed that this mitochondrial amplification loop can be engaged 
by cal pains, a cytoplasmatic family of cysteine proteases activated by calcium. It has 
been demonstrated that cleavage of Bax by calpains generates a truncated 18 kDa Bax 
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which shows potent pro-apoptotic activity and promotes release of cytochrome c and 
Smac/Diablo from the mitochondria to the cytosol (Wood et aI., 1998; Gao & Dou, 2000; 
Altznauer et al., 2004). In addition, calpains can cleave the pro-apoptotic BH3-only 
protein Bid to produce a 14 kDa cleaved fragment similar to that generated by caspase-8, 
which can promote the release of cytochrome c from the mitochondria (Chen et aI., 200 I, 
2002; Mandie et al., 2002; Sharma & Rohrer, 2004). Collectively, these results 
demonstrate that calpains can induce the mitochondrial pathway to promote and/or 
amplify the apoptotic process. 
Viruses that induce apoptosis have been shown to engage the mitochondrial pathway 
either directly, through the interaction between specific viral proteins and the 
mitochondria (reviewed in Boya et al., 2004), or indirectly through the activation of pro-
apoptotic "cellular sensors" such as double-stranded RNA-activated protein kinase 
(PKR), endoplasmic reticulum overload, p53 and surface receptors (reviewed in Everett 
& McFadden, 1999; 2001). During Vescicular Stomatitis virus and Reovirus-induced 
apoptosis, the mitochondrial pathway serves as an amplification loop for the death 
receptor pathway (Kominsky et al., 2002a; 2002b; Gaddy & Lyles, 2005). The 
mitochondrial pathway can also be activated by PKR during Influenza A virus infection 
(Balachandran et al., 2000) or by ER stress during Hepatitis C virus infection (Benali-
Furet et al., 2005; Tardif et al., 2005). 
To determine the trigger(s) and the role of the mitochondrial pathway during FCV 
infection, different apoptotic routes known to converge on and activate the mitochondrial 
pathway were analysed. 
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4.2 ACTIVATION OF CASPASE-8 IS A LATE EVENT DURING FCV-INDUCED 
APOPTOSIS 
Firstly, we decided to analyse the activation of caspase-8 III FeV infected cells to 
determine if the mitochondrial pathway functions as an amplification loop of the death 
receptor pathway. The activation of caspase-8 during FeV infection was monitored by 
Western blot analysis. Although we were unable to detect the active feline form of 
caspase-8 (p43/pI8), a decrease in procaspase-8 (p53) was detected at 8 h pj (Figure 
4.1). This event occurred after cytochrome c release and Bax translocation (detected at 6 
hpj., Figure 3.5), suggesting that the activation of caspase-8 is a late event during FeV 
infection and is not responsible for the induction of the mitochondrial pathway. 
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CTRL8 h Inf. 2 h Inf. 4 h Inf. 6 h Inf. 8 h 
Procaspase-8 
Hes 70 
Figure 4.1: We tern blot analy i of ca pase-8 during FCY infection. CRFK cells were infected 
with F -F9 (100 pfu/cell). At the indicated times p.i., uninfected and infected cells were lysed and 50 
~g of cell extract were analy ed by Western blot. A loading control was achieved by reprobing the 
membrane for H c 70. Re ult hown are representative of two independent experiments. 
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4.3 OXIDATIVE STRESS IS NOT INVOLVED IN FCV-INDUCED APOPTOSIS. 
The production of reactive oxygen species (ROS) and the subsequent induction of 
oxidative stress have been recognized as important mediators of the pathogenesis of 
many viruses (reviewed in Schwarz, 1996). In particular, it has been shown that HIV 
induces oxidative stress in infected cells and treatment with antioxidant compounds such 
as N-acetylcysteine inhibits apoptosis and viral replication in U937-infected cells 
(Malomi et aI., 1993). To assess the role of oxidative stress in FeV -induced apoptosis, 
we infected CRFK cells in the presence of two antioxidant agents, 6-hydroxy-2, 5, 7, 8-
tetramethylchroman-2-carboxylic acid (Trolox, 100 /lM) and N, N'-diphenyl-p-
phenylenediamine (DPPD, 1 J.lM), known to inhibit ROS-induced apoptosis (McClain et 
aI., 1995; Salgo & Pryor, 1996; Lee et aI., 2004). After 8 hpj., apoptosis was quantified 
in FeV -infected cells using the A V PI assay. Hydrogen peroxide (H202, 500 J.lM) was 
used as a positive control. The effect of Trolox on FeV -induced apoptosis was also 
monitored using flow cytometric analysis of caspase-3 activation. As showed in Figure 
4.2, Trolox and DPPD did not inhibit FeV-induced apoptosis; in addition, Trolox did not 
block or reduce the activation of caspase-3 in infected cells (Figure 4.3), suggesting that 
ROS do not play an important role in FeV -induced apoptosis. 
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4.4 CALPAIN INHIBITOR I PREVENTS PS TRANSLOCATION AND CASPASE-3 
ACTIVATION IN FCV-INFECTED CELLS 
It has been shown that Reovirus induces activation of calpains in infected cells and 
calpain inhibitors, such as N-acetyl-Ieucinyl-Ieucinyl-norleucinal (ALLN), prevent 
Reovirus-induced apoptosis of infected cells (Debiasi et aI., 1999). To analyse the role of 
calpains in FCV-induced apoptosis, we determined the level of caspase-3 activation and 
PS translocation in cells infected in the presence of ALLN (50 ~M). Z-VAD-fmk (100 
~M) was also included in this experiment to compare the relative contribution of 
caspases and cal pains in the apoptotic process. As shown in Figures 4.4 and 4.5, at 8 h 
pj. ALLN inhibited PS translocation and activation of caspase-3, almost at the same 
level of the pan-caspase inhibitor z-VAD-fmk suggesting that calpains are activated 
during FCV infection and may playa role in FCV-induced apoptosis. 
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4.5 CALPAINS ARE ACTIVATED IN FCV -INFECTED CELLS 
As ALLN prevented the activation of caspase-3 and the translocation of PS in FCV-
infected cells, we next wanted to confirm the activation of calpains during FCV 
infection. To detect calpain activation we first analysed the cleavage of fodrin in FCV-
infected cells. Fodrin is a cytoskeletal protein that can be cleaved during apoptosis by 
calpains and/or caspases (Wang, 2000). Cleavage of fodrin by calpains produces two 
fragments of about 150 kDa and 145 kDa, while caspases generate 150 kDa and 120 kDa 
cleavage products. Thus the 145 kDa and the 120 kDa fragments have been recognized as 
markers for calpain and caspase activation, respectively (Wang, 2000). In particular, the 
120 kDa fragment has been associated with activation of caspase-3 (Wang et ai., 1998a; 
Nath et aI., 2000). Cleavage of fodrin in FCV infected cells was monitored by Western 
blot analysis. As shown in Figure 4.6, the calpain specific 145 kDa fragment was 
detected at 6 h p.i., followed by the appearance of the 150 kDa and, more importantly, 
the 120 kDa caspase specific fragment at 8 h p.i. This result suggested that the calpains 
were activated during FCV infection and that this process occurred before the activation 
of effector caspases. To further confirm this observation, we measured calpain and 
caspase-3/-7 like activity in FCV -infected cells using the cell-permeable fluorogenic 
calpain substrate Suc-Leu-Leu-Val-Tyr-Amido-4-methylcoumarin (Suc-LL VY -AMC) 
and benzyloxycarbonil-Asp-Glu-Val-Asp-7 -amino-4-trifluoromethylcoumarin (z-DEVD-
AFC) fluorogenic caspase substrate. As presented in Figure 4.7, calpain activity started 
to increase at 4 h p.i. followed by a peak of activity at 6 h p.i. which represented a 3 fold 
increase in the FeV -infected cells compared to the uninfected cells. The calpain activity 
detected in this study is in correlation with what has been measured in other studies 
(Debiasi et aI., 1999; Sharma & Rohrer, 2004). In contrast, caspase-3/-7 activity became 
detectable at 6 h p.i followed by a peak of activity at 8 h p.i. These results correlated well 
with those obtained from the Western blot analysis of fodrin cleavage and were 
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indicative of a sequential activation of these proteases, with calpains being activated 
before caspase-3. 
155 
Result Calpains and PKR are activated during Feline Calicivirus infection 
CTRL 8 h lnf. 2 h Inf. 4 h Inf. 6 h Inf. 8 h 
Uncleaved fodrin 
.- 240kDa 
.- 150 kDa CaspaseslCalpains 
.-145 kDa Calpains 
.- 120 kDa Caspases 
Figure 4.6: Detection of fodrin cleavage during FeV infection. CRFK cells were infected with FCY-
F9 (100 pfulcell). At the indicated times p.i., uninfected and infected cells were lysed and 50 Ilg of cell 
extract were analy ed by We tern blot. The 150 and 120 kDa cleavage products can be produced by 
ca1pain and caspase while the 145 and 120 kDa fragments are specifically produced by ca1pains and 
ca pa e , re pectively. Re ults hown are representative of three independent experiments. 
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4.6 CALPAIN INHIBITOR I PREVENTS CYTOCHROME C RELEASE BUT NOT 
FODRIN CLEAVAGE 
The results obtained using the calpain inhibitor ALLN (section 4.4), together with the 
detection of calpain activation in FeV-infected cells (section 4.5), suggested a crosstalk 
between these two families of proteases in which calpains function as initiators of 
apoptosis upstream of caspases. As the mitochondrial pathway is activated during FCV-
induced apoptosis, we then investigated the role of calpains in this process. The effects of 
ALLN (50 JlM) and z-VAD-fmk (100 JlM) on the release of cytochrome c were analysed 
by Western blot at 8 h p.i. As shown in Figure 4.8, both ALLN and z-V AD-fmk 
completely inhibited the release of cytochrome c from the mitochondria. The inhibitory 
effect of z-V AD-fmk on the release of cytochrome c could be explained by different 
mechanisms. First of all, this result suggests that calpains may promote the release of 
cytochrome c from the mitochondria through the activation of a caspase upstream in this 
process. However, it is possible that an initiator caspase induces the activation of 
calpains through the cleavage of their endogenous inhibitor calpastatin, and in turn 
calpains mediate cytochrome c release. However, a direct inhibitory effect of z-V AD-
fmk on calpains which has been previously reported cannot be excluded (Wolf et al., 
1999). To further investigate and dissect the crosstalk between calpains and caspases, we 
analysed fodrin cleavage in FCV -infected cells at 8 h p.i. in the presence of z-V AD-fmk 
(100 JlM) and ALLN (50 JlM). As shown in Figure 4.9, z-VAD-frnk completely 
inhibited the formation of the caspase-mediated 150 and 120 kDa fodrin cleavage 
products and slightly inhibited the formation of the calpain-mediated 145 kDa cleavage 
fragment. In contrast, despite the inhibition of cytochrome c release and caspase-3 
activation, ALLN decreased the calpain-mediated fodrin cleavage to the same level of z-
V AD-fmk, but was not able to inhibit caspase-mediated fodrin cleavage. This result 
suggests that fodrin can be cleaved into the 120 kDa fragment by a caspase 
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independently of cytochrome c release and caspase-3 activation as ALLN did not inhibit 
this cleavage. However, the results do not help to distinguish between the three 
hypotheses mentioned above. 
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Figure 4.8: ALL and z-VAD-fmk inhibit cytochrome c release during FeV-induced apoptosis. 
CRFK cell were infected with FCV-F9 (100 pfu/cell) in the presence/absence of ALLN (50 /lM) and z· 
V AD-fmk (100 /lM) . At the 8 h p.i., uninfected and infected cells were lysed and 50 /lg of cell extracts 
were analy ed by We tern blot for cytochrome c release. COX IV subunit and actin were used as 
loading control. Results shown are representative of two independent experiments 
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Figure 4.9: Effect of ALL and z-VAD-fmk on fodrin cleavage during FeV-induced apoptosis. 
RFK cell were infected with FCV-F9 (100 pfu/cell) in the presence/absence of ALLN (50 JlM) and z-
V AD-fmk (100 JlM). At the h p.i., uninfected and infected cells were lysed and 50 Jlg of cell extracts 
were analy ed by We tern blot for fodrin cleavage. Results shown are representative of two 
independent e periments. 
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4.7 EXTRACELLULAR CALCIUM MEDIATES FCV-INDUCED CYTOTOXICITY 
BUT IS NOT REQUIRED FOR CASPASE-3 ACTIVATION 
To further analyse the role of calpains during FCV infection, we decided to use an 
alternative approach. Calpains are cysteine proteases that are activated by an increase in 
intracellular calcium levels which, under pathological conditions, is frequently associated 
with an influx of calcium from the extracellular pool across the plasma membrane 
(Orren ius et al., 2003). Based on this, we hypothesised that the extracellular calcium 
influx could represent the trigger for calpain activation during FCV infection. To test this 
hypothesis, we infected CRFK cells with FCV in the presence of the ethylene glycol-bis 
(j3-aminoethylether)-N, N, N', N' -tetraacetic acid (EGTA), a calcium chelator that at the 
concentration used in this experiment (2.4 mM) completely removed the calcium ions 
from the extracellular pool. It should be noted that under these conditions, viral 
replication was not inhibited as the titre of the cell-associated virus fraction in the 
presence of EGT A did not differ significantly from the control (Figure 4.10). As it has 
been reported that the extracellular calcium influx across the plasma membrane is 
required for PS exposure and that EGT A blocks this process (Hampton et al. 1996), cell 
death induced by FCV was analysed by measuring the loss of plasma membrane integrity 
using the PI assay. FCV -infected and mock-infected cells were harvested at 8 hpj., 
resuspended in 1 ml of PBS containing 15 J.lM of PI and immediately analysed by flow 
cytometry. The effect of EGTA on the activation of caspase-3 was also investigated. As 
shown in Figure 4.11, EGTA completely blocked plasma membrane permeabilization; 
addition of CaCh (2.4 mM) as a source of calcium ions in the medium buffered with 
EGT A, completely restored the PI uptake demonstrating that extracellular calcium was 
required for FCV -induced cytotoxicity in CRFK cells. It should be noted that EGT A or 
CaCh alone were not toxic in CRFK cells. Analysis of caspase-3 activation in FCV-
infected cells in the presence of EGTA (Figure 4.12) revealed that the extracellular 
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calcium was not required for the activation of this effector caspase, suggesting that the 
extracellular calcium, and possibly calpains, participate in Fev -induced cell death but 
they are not involved in the apoptotic process. 
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4.8 INHIBITION OF THE PROTEASOME BLOCKS FCV-INDUCED APOPTOSIS 
The calpain inhibitor ALLN and the calcium chelator EGT A showed different effects on 
the activation of caspase-3, as we observed inhibition of this caspase in the presence of 
ALLN (Figure 4.5) but not with EGTA (Figure 4.12). One possible explanation of these 
contrasting results is that ALLN may inhibit other proteases in addition to the calpains. 
Indeed, although ALLN has been used as a calpain inhibitor, a role of ALLN in the 
inhibition of the proteasome has also been demonstrated (Hong et al., 2004; Cooke & 
Patel, 2005). To test the possibility that during FCY infection ALLN inhibited apoptosis 
by blocking the proteasome, we infected CRFK cells in the presence of 
benzyloxycarbonyldipeptidyl aldehyde (calpeptin, 50 J.l.M) and carbobenzoxy-Ieucyl-
leucyl-Ieucinal (MG 132, 10 J.l.M) which are more specific inhibitors of calpains and the 
proteasome, respectively. Apoptosis of FCY -infected cells was assessed at 8 hpj. using 
AY PI assay. As shown in Figure 4.13, calpeptin caused only a slight decrease in the 
exposure of phosphatidylserine on the cell surface while MG 132 completely blocked 
this process, suggesting that the proteasome, and not calpains, are directly involved in 
FCV -induced apoptosis. 
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4.9 ACTIVATION OF PKR DURING FeV INFECTION 
Inhibitors of the proteasome usually induce or enhance apoptosis in different tumor cells 
and for this reason they have been entered into clinical trial studies as potential 
antineoplastic agents (reviewed in Mitsiades et ai., 2005). To date, only a few studies 
have reported an anti-apoptotic role of these agents, including the inhibition of apoptosis 
in thymocytes (Grimm et ai., 1996) and in sympathetic neurons upon nerve growth factor 
deprivation (Sadoul et al., 1996). It has been also reported that inhibitors of the 
proteasome can block PKR-induced apoptosis in cells overexpressing PKR (Gil et ai., 
1999). Based on this study, we next wanted to verify if PKR is activated during FCV 
infection. Once activated, PKR causes the inhibition of protein synthesis through the 
direct phosphorylation of the eIF-2a. For this reason, phosphorylation of eIF-2a is used 
as a general marker of PKR activation. As shown in Figure 4.14, eIF-2a became 
phosphorylated at 4 h p.i. and this process increased over time. This result demonstrated 
that PKR was activated during FCV infection. 
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4.10 DISCUSSION 
The aims of the present study were to identify and characterize the possible 
mechanism(s) responsible for the release of cytochrome c from the mitochondria during 
FCV -induced apoptosis. Firstly, we looked at the processing of procaspase-8 and the 
crosstalk between the death receptor and the mitochondrial pathways which has been 
demonstrated to be essential during Reovirus (Kominsky et al., 2002a; 2002b) and 
Vesicular Stomatitis virus (Gaddy & Lyles, 2005) infection. Procaspase-8 was processed 
during FCV-induced apoptosis (Figure 4.1), but this process occurred after cytochrome c 
release and Bax translocation to the mitochondria and most probably represents the result 
ofthe positive feedback loop due to the activation of the effector caspases. 
Oxidative stress was also examined during FCV infection. Production of reactive oxygen 
species has been reported to occur during many viral infections (Schwarz, 1996). In 
particular ROS have been shown to play an important role during HCV (Tardif et af., 
2005) and HI V-induced apoptosis (Malomi et al., 1993). Here, we showed that ROS 
were not involved in FeV -induced apoptosis as two potent anti-oxidants, the cell 
permeable derivative of vitamin E Trolox, and the free radicals scavenger DPPD, did not 
inhibit PS exposure on the surface of the plasma membrane (Figure 4.2). In addition, we 
showed that Trolox did not have any effect on the activation of caspase-3 (Figure 4.3). 
Collectively, these results suggest that oxidative stress is not involved in FCV -induced 
apoptosis. 
Several studies have demonstrated that calpains can engage the mitochondrial pathway 
promoting the release of cytochrome c (Varghese et al., 2001; Gil-Parrado et af., 2002; 
Sharma and Rohrer, 2004) and also that these proteases have an important role during 
Reovirus infection (Debiasi et af., 1999). Using the calpain inhibitor ALLN, we showed 
that during FCV infection this inhibitor blocked PS translocation (Figure 4.4) and 
171 
Results Calpains and PKR are activated during Feline Calicivirus infection 
prevented caspase-3 activation (Figure 4.5) suggesting a role of calpains in FCV-induced 
apoptosis. 
Activation of calpains during FCV infection was detected using two different 
approaches; the measurement of calpain activity using the cell permeable substrate Suc-
LLVY-AMC and the detection of the 145 kDa calpain-mediated fodrin cleavage product. 
With the first approach, we showed a three fold increase in calpain activity at 6 hpj. in 
cells infected with FCV (Figure 4.7). It should be noted that the calpain substrate used in 
this study can also detect proteasome activity, thus, the resulting increase in the 
fluorescence may represent a combinatorial effect of calpains and proteasome. However, 
this result correlated well with the detection of the 145 kDa fodrin cleavage (Figure 4.6) 
which is specifically due to the proteolytic activity of calpains (Wang, 2000). This 
confirms the activation of these proteases during Fev infection. In addition, we also 
demonstrated that calpains are activated before caspase-3, as evidenced by an increase of 
caspase-3/-7 specific activity at 8 hpj. using the z-DEVD-AFC substrate (Figure 4.7) 
and at the same time the appearance of the 120 kDa fodrin cleavage (Figure 4.6) which 
has been reported to be generated by caspase-3 (Wang et al., 1998a; Nath et al., 2000). 
All these results correlated well with the activation of caspase-3 at 8 hpj. detected by 
flow cytometry (Figure 3.2). Activation of calpains before caspase-3 and the inhibition of 
caspase-3 activation by ALLN suggested an upstream role of calpains in Fev -induced 
apoptosis. However, it has been reported that although ALLN inhibits calpain activation, 
this inhibitor is also able to block the proteasome activity (Hong et al., 2004; Cooke & 
Patel, 2005). Using more specific inhibitors of calpains (calpeptin) and proteasome (MG 
132), we showed that inhibition of the proteasome, and not calpains, efficiently blocked 
FeV-induced apoptosis (Figure 4.13). This indicates that ALLN exerted its inhibitory 
effects, including inhibition of cytochrome c release (Figure 4.8), by blocking the 
proteasome activity. It has been shown that the proteasome is involved in PKR-induced 
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apoptosis (Gil et al., 1999). Here we showed that PKR is activated during FCY infection 
(Figure 4.14), further suggesting a role of the proteasome in FCY -induced apoptosis. In 
addition, we showed that z-YAD-fmk also inhibited the release of cytochrome c from the 
mitochondria (Figure 4.8). As a direct inhibitory effect of z-V AD-fink on the proteasome 
activity has not been reported, it is possible that an initiator caspase and the proteasome 
are both required for the cytochrome c release. 
Interestingly, we showed that formation of the 120 kDa fodrin cleavage product could be 
inhibited by z-VAD-fmk, but not by ALLN (Figure 4.9). As caspase-3 activation was 
inhibited by ALLN, this result suggests that in addition to caspase-3, another caspase, 
which is activated independently of cytochrome c release, is responsible for this 
cleavage. Indeed, it has been demonstrated that in some systems the production of the 
120 kDa fragment cannot be inhibited by the presence of a caspase-3 specific inhibitor 
and another caspase may be implicated in this process (Cryns et al., 1996; Vanagas et al., 
1996). It has been shown that during FCY infection caspase-2 and -7 are activated, thus a 
role of these caspases in fodrin cleavage may be hypothesised (AI-Molawi et al., 2003). 
The nature of the caspase responsible for the cleavage of fodrin into the 120 kDa 
fragment needs further investigation but this result suggests that another pathway, other 
then the mitochondrial pathway, can be involved in FCY -induced apoptosis. 
Despite their activation, the role of calpains during FCV infection is not clear. Using the 
extracellular calcium chelator EGT A, we showed that extracellular calcium is required 
for the cytotoxicity induced by FCV (Figure 4.11) although is dispensable for activation 
of caspase-3 (Figure 4.13). As calpains are activated by calcium, a possible role of these 
proteases in a necrotic-like pathway induced by FCY can be hypothesised. However, 
calpeptin did not block the PI uptake during FCV-induced apoptosis (Figure 4.13), thus 
even in this process the role of calpains is not completely defined. 
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In conclusion, herein we reported that calpains and PKR are activated during Fey 
infection. We also showed that caspases and the proteasome are involved in the release of 
cytochrome c from the mitochondria to the cytosol in FeV-infected cells. Taken 
together, our results suggest that while calpains probably playa minor role during Fey-
induced apoptosis, caspases, the proteasome and possibly PKR, are most likely involved 
in the induction of the apoptosis through the mitochondrial pathway. 
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5 ROLE OF APOPTOSIS DURING FCV INFECTION 
5.1 INTRODUCTION 
Viral infection of animal as well as insect cells often results in apoptosis of the host cells 
(reviewed in Roulston el al., 1999). Although it is now generally recognized that 
apoptosis is a common response of the host cell to viral infection, the physiological 
significance of apoptosis in virus infection is not well understood. Apoptosis may 
represent a cellular defence mechanism against virus infection. By killing itself, the host 
cell may limit the viral replication and prevent virus spread into adjacent cells and 
tissues. In addition, apoptotic cells are phagocytosed by macrophages thus preventing 
viral replication in infected cells and initiating a specific immune response in infected 
animals (Koyama el al., 2000). Viruses have evolved different strategies to avoid the 
detrimental effects of apoptosis (Teodoro & Branton, 1997; O'Brien, 1998; Koyama et 
al., 2000). Some viruses (especially large DNA viruses) block the apoptotic process 
through the expression of specific anti-apoptotic genes. Other viruses (such as RNA 
viruses) avoid apoptosis by completing the viral replication cycle before the onset of 
apoptosis occurs. 
On the other hand, it has been proposed that apoptosis could be seen as a mechanism that 
facilitates viral spread into surrounding tissue (Koyama et al., 2000). According to this 
hypothesis, viruses induce apoptosis of infected cells to prevent the host inflammatory 
response and to promote the release of viral progeny into the apoptotic bodies. This 
mechanism may be particularly useful for non-enveloped viruses which may use the 
apoptotic bodies to escape from infected cells and to protect the viral particles from the 
extracellular host environment. 
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In order to explore the role of apoptosis during FeV infection, viral replication was 
examined in infected cells in the presence of two inhibitors; the pan caspase inhibitor z-
VAD-fmk and the calpain inhibitor ALLN. 
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5.2 FCV REPLICATION IN INFECTED CRFK CELLS 
To examine the effects of apoptotic inhibitors on the viral replication, first we determined 
the FCV growth curve in CRFK cells using the plaque assay. As shows in Figure 5.1, 
infectious viral particles increased inside the cells at 4 hpj. and viral replication was 
complete at 6 h p.i. reaching a plateau. On the other hand, the virus released did not reach 
a plateau over the time analysed as the titre seemed to increase even after 8 h. It is 
important to note that the virus released into the medium represented only a small 
fraction of the total virus. Figure 5.2 represents the relative amount of infectious virus in 
both fractions [cell-associated virus or virus released / (cell-associated virus + virus 
released)] at each time pj. Infectious viral particles increased in the media (virus 
released) at 6 hand 8 hpj. but only at 10 h could a substantial amount of infectious virus 
(::::: 20%) be detected. 
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5.3 EFFECT OF z-VAD fmk AND ALLN ON FCV REPLICATION 
We next wanted to assess if apoptosis is necessary for viral replication. In this respect, 
we measured the viral titre at 6 and 8 hpj. in the presence of z-V AD-fink and ALLN 
which inhibit caspase-3 activation and release of cytochrome c from mitochondria to the 
cytosol. Six and 8 hpj. represented good time points as we were able to test the effects 
of z-VAD-fmk and ALLN before and after activation of caspase-3. On the other hand, 
these time points were not suitable to measure the effects of the inhibitors on the release 
of virus into the medium because, as shown in Figure 5.2, at 6 and 8 hpj. this fraction 
represents only a small percentage of the total virus, rendering it difficult to make 
significant conclusions. Thus we decided to analyse the effects of the inhibitors only on 
the cell associated virus fraction which reflects the viral replication. As showed in Figure 
5.3, z-V AD-fink and ALLN did not alter the viral titre at 6 or at 8 h p.i. 
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5.4 DISCUSSION 
The viral replication in the presence of apoptotic inhibitors such as z-V AD-fmk or BcI-2 
over-expression has been investigated for a number of different viruses including 
Vesicular Stomatitis virus (Hobbs et al., 2001; 2003), Astrovirus (Guix et al., 2004; 
Mendez et al., 2004) and Sindbis virus (Levine et al., 1993; Grandgirard et al., 1998). 
The effects of these apoptotic inhibitors on viral replication are strictly dependent on the 
type of virus, the host cells and the types of studies (in vivo versus in vitro). Here we 
demonstrated that z-VAD-fmk and ALLN, which inhibited FeV-induced apoptosis by 
blocking cytochrome c release and caspase-3 activation, did not affect the viral 
replication as the viral titre in the cell-associated virus fraction was neither reduced nor 
increased by these inhibitors (Figure 5.3). Interestingly, we found that the viral 
replication, estimated by the viral titre of the cell-associated virus fraction, was nearly 
completed at 6 h p.i. (Figure 5.1) before the activation of caspase-3 and the exposure of 
PS on the cell surface (Figure 3.1 and 3.2). Thus, it could be possible that Fev completes 
the viral replication cycle by rapid multiplication before the execution phase of apoptosis 
takes place, avoiding the negative effects of apoptosis. In this respect, the inhibitors z-
VAD-frnk and ALLN would have no effects on the viral replication as it has already 
been completed. However, we cannot exclude a role of apoptosis in the release of the 
mature viral particles. At 6 and 8 hpj. the virus released represented only a small 
fraction of the total virus (Figure 5.2) rendering it difficult to study the effects of z-V AD-
fmk and ALLN on this process. To better understand the role of apoptosis in the release 
of the viral progeny, an analysis of this process at late time pj. is required. 
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6 GENERAL DISCUSSION 
The first association between apoptosis and calicivirus infection was made in 1998 by 
Alonso and coworkers who reported that RHDV infection causes apoptosis in different 
tissues of infected rabbits (Alonso et al., 1998). Using morphological and biochemical 
approaches, the authors demonstrated that RHDV induces apoptosis primarily In 
hepatocytcs and at the late stage of infection, but also in other cell types such as 
macrophages from lungs and liver, endothelial cells and tubular cells in the kidneys. 
Importantly, the authors suggested that the lethal, acute hepatitis associated with RHDV 
infection would be the consequence of the apoptosis induced in RHDV -infected 
hepatocytes, providing a functional relationship between apoptosis and the pathogenesis 
of this virus. 
A more detailed description of the apoptotic process associated with a calicivirus 
infection came from the studies on FCV replication in CRFK cells performed in our 
laboratory (Al-Molawi et al., 2003). In this report, it was demonstrated that during 
infection, FCV induces chromatin condensation, activation of caspase-2, -3, -7 and 
cleavage of PARP. In addition, activation of caspase-2 and possibly -6 lead to the 
cleavage of the capsid protein at the late stage of infection to produce a fragment of about 
40 kDa; however the functional significance of this event has not yet been addressed. An 
independent study has also confirmed that apoptosis occurs in FeV -infected cells 
(Sosnovtsev et al .• 2003). Furthermore, in this report the authors showed that apoptosis 
induced by FCV requires de novo protein synthesis and it is not associated with receptor 
binding or virus internalization. Despite all these important observations, the molecular 
mechanism and the nature of the events that lead to caspase activation and ultimately 
apoptosis were not well defined. In the present study we have sought to understand the 
mechanism of FCV -induced apoptosis in more detail by analysing the early molecular 
183 
General Discussion 
events that lead to caspase activation; in addition, the functional significance of apoptosis 
in the context of the FCV replication cycle was also examined. 
To gain insight as to which molecular apoptotic pathway is triggered during FCV 
infection, we first examined the time of caspase-3 activation and PS extemalization 
during FCV infection. The translocation of PS from the inner to the outer face of the 
plasma membrane is an early event in cells undergoing apoptosis and mediates the 
recognition and the engulfment of the apoptotic cells by macrophages and neighbouring 
cells (Fadok et al., 1992). The analysis of PS extemalization is particularly significant as 
it is functionally associated with caspase activation and it could represent the primary 
mechanism through which infected cells are recognized and removed in vivo by the 
immune system. We clearly demonstrated that PS extemalization occurred during FCV 
infection at 8 hpj. (Figure 3.1), correlating with the appearance of the active form of 
caspase-3 (Figure 3.2). This observation was further validated using of the pan-caspase 
inhibitor z-VAD-fmk which completely blocked the processing of caspase-3 and the PS 
extemalization. 
Interestingly, a cell population of AV negative and PI positive cells was detected at 8 h 
p.i. This A V /PI profile is characteristic of cells infected with Fev as CRFK cells treated 
with staurosporine display the typical AV/PI profile (Figure 3.3). In line with our results, 
Sosnovtsev and coworkers also reported the presence this population of cells at the same 
stage of infection (Sosnovtsev et al., 2003). In this report it was also shown that the A V 
negative/PI positive cells disappear at the late stage of infection when the virus has 
completed the replication cycle indicating that this particular cell popUlation is probably 
associated with the viral replication. The authors suggested that this A V negative/PI 
positive cell population may represent cells with defects in their plasma membrane that 
are not undergoing apoptosis but a virus-related lytic cell death. Indeed, it has been 
shown that viruses can alter the composition and the permeability of the plasma 
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membrane in infected cells (Carrasco, 1995; Aldabe et at., 1996; Charpilienne et aI., 
1997; Jecht et al., 1998). In addition, it has recently been demonstrated that transient 
expression of the Norwalk virus N-terminal non-structural protein p48 disrupts the 
intracellular vesicle traffic from the Golgi to the plasma membrane, a process that can 
potentially alter the composition and the structure of the plasma membrane (Ettayebi & 
Hardy, 2003). Thus it is possible that FCV replication induces such modifications in 
infected cells leading to this peculiar A V /PI profile. However, our results suggest that the 
A V negative/PI positive cell population does not represent an alternative death pathway 
as it was completely blocked by z-VAD-fink, demonstrating that the appearance of these 
cells depends on caspase activation. It could be that Fev induces a depletion of PS in the 
plasma membrane or perhaps indirectly blocks an enzyme necessary for the PS 
translocation leading to the paradoxical situation in which the infected cells become 
positive for PI before PS extemalization. Although this hypothesis needs further 
investigation, it could represent a potential mechanism for immune evasion. The delay in 
the PS extemalization could potentially block the phagocytosis of the infected cells by 
macrophages, preventing the adverse effects of the innate immune response. Despite the 
inhibition of PS extemalization and plasma membrane penneabilization by z-VAD-fmk, 
a minor population of A V and PI positive cells was detected in the presence of z-V AD-
fmk at 8 h p.i. As z-V AD-fink cannot inhibit necrosis, this popUlation of cells could 
effectively represent infected cells that undergo a necrotic-like cell death. 
Having demonstrated that caspase-3 was activated during FCV infection, we next wanted 
to define the possible molecular events that precede the activation of this executioner 
caspase. We initially focused on the mitochondrial pathway of apoptosis as this pathway 
can be activated directly by several apoptotic stimuli or as an essential amplification loop 
in other apoptotic pathways such as the death receptor pathway (Jiang &Wang, 2004). A 
key event in the mitochondrial pathway is the permeabilization of the mitochondrial 
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outer membrane, a process controlled by the Bcl-2 family members. In response to an 
apoptotic stimulus such as genotoxic damage, chemotherapeutic agents and oxidative 
stress, cytosolic Bax, a pro-apoptotic member of the Bcl-2 family proteins, trans locates 
to the mitochondria where, in cooperation with Bak, induces mitochondrial outer 
membrane permeabilization and the subsequent release of pro-apoptotic factors such as 
cytochrome c, Smac/Diablo and AIF (Kroemer & Reed, 2000; Green & Kroemer, 2004; 
Jiang & Wang, 2004). This event is usually, but not always, accompanied by a loss ofthe 
mitochondrial transmembrane potential. Translocation of Bax seems to be an essential 
step for the mitochondrial pathway as double knock-out embryonic fibroblasts for Bax 
and Bak fail to undergo apoptosis in response to different stimuli (Scorrano et ai., 2003). 
In this study we showed that during FCV infection Bax translocates from the cytosol to 
the mitochondria at 6 h p.i. (Figure 3.5 B) in parallel with the release of cytochrome c 
(Figure 3.5 A) and loss of mitochondrial transmembrane potential (Figure 3.4). To 
further confirm the role of mitochondria during FCV -induced apoptosis, we analysed the 
functional consequences of the cytochrome c release into the cytosol; the activation of 
caspase-9. Using Western blot analysis, we showed that the proform of caspase-9 
decreases at 6 h p.i. and further at 8 hpj (Figure 3.6). Importantly, the decrease of the 
caspase-9 proform was not a consequence of plasma membrane permeabilization as the 
level of the Hsc-70 protein used as a loading control remained stable during the time of 
the analysis. However, to further confirm the activation of cspase-9, we performed a 
luciferase-based enzymatic assay. Using this assay, we demonstrated that caspase-9 was 
catalytically active in infected cells at 8 hpj., at a level comparable to that of 
staurosporine treated-cells (Figure 3.7). Unfortunately, we could not examine the 
consequences of caspase-9 activation as the caspase-9 inhibitor used in this study, ac-
LEHD-CHO, failed to inhibit FCV-induced apoptosis (Figure 3.8). This effect was 
probably due to the inability of CRFK cells to retain the tetrapeptide inhibitor as ac-
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LEHD-CHO did not block apoptosis induced by staurosporine (Figure 3.9). However the 
results presented here strongly supports the involvement of the mitochondrial pathway in 
the induction of apoptosis by FCV infection. 
At this point, there was an important question that needed to be addressed- what 
apoptotic stimulus triggers the Bax translocation and the downstream events during FCV 
infection? The answer to this question is particularly relevant mechanistically as it will 
elucidate the role of the mitochondrial pathway in FeV-induced apoptosis, but also 
clinically as it will help to understand the pathogenesis of FeV and possibly of other 
caliciviruses. In order to address this question we analysed different apoptotic stimuli 
that can converge and activate the mitochondrial pathway. 
First of all, we examined the activation of caspase-8 during FeV infection. This apical 
caspase is nonnally activated during the death receptor pathway and can engage the 
mitochondrial pathway through cleavage of the BH3-only protein Bid (Luo et aI., 1998). 
The truncated fonn of Bid activates Bax, which in tum promotes the release of 
cytochrome c from the mitochondria. Many viruses such as Reovirus (Kominsky et at., 
2002a, 2002b), Vesicular Stomatitis virus (Gaddy & Lyles, 2005) and Sindbis virus (Jan 
& Griffin, 1999; Sarid et al., 2001) induce caspase-8 activation as a result of the binding 
of the virus particles on the cell surface, or as a consequence of the internalization 
process. Although it has already been demonstrated that apoptosis induced by FeV does 
not depend on receptor binding or internalization (Sosnovtsev et al., 2003), caspase-8 can 
also be activated through other routes such as ER stress or by PKR-induced apoptosis 
(Breckenridge et al., 2002; lordanov et al., 2005a). Using Western blot analysis, we 
showed that the profonn of caspase-8 decreased at 8 hpj. (Figure 4.1) when almost all 
the cytochrome c was already present in the cytosol. Thus this observation suggested that 
caspase-8 is not involved in cytochrome c release, although we can not rule out the 
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possibility that this caspase is involved in FCY-induced apoptosis as a post-
mitochondrial event through its activation by caspase-3 or as a mitochondrial 
independent event induced by PKR. The possibility that caspase-8 was activated by ER 
stress may be excluded by the fact that ER stress leads to the activation of a particular 
caspase-8 isofonn, called caspase-8L, of about 62 kDa in size (Breckenridge et al., 
2002), which was not detected in our analysis. 
Another event that can induce the mitochondrial apoptotic pathway is the production of 
ROS. It has been demonstrated that TNF-(l and other pro-apoptotic stimuli can induce 
production of ROS, which in tum result in Bax translocation, cytochrome c release and 
loss of mitochondrial membrane potential (reviewed in Fleury et al., 2002). Notably, 
antioxidant compounds such as thioredoxine or N-acetylcysteine can block these 
apoptotic events. In addition, many viruses including Hepatitis C virus and HIY can 
induce oxidative stress in infected cells which in tum results in apoptosis (Malomi et al., 
1993; Tardif et aI., 2005). Using two potent antioxidants, Trolox and DPPD, we 
demonstrated that production of ROS is not essential for FCY-induced apoptosis as pre-
treatment with these antioxidants did not prevent PS extemalization in Fey infected cells 
(Figure 4.2). Moreover, pre-treatment with Trolox did not prevent activation of caspase-3 
suggesting that oxidative stress does not play an essential role during FCY -induced 
apoptosis (Figure 4.3). 
Recently, many studies have highlighted the importance of calpains in apoptosis. In 
particular, in some cellular systems, calpains can act as upstream mediators of apoptosis, 
promoting the release of cytochrome c from the mitochondria through the cleavage of 
several pro-apoptotic members of the Bcl-2 protein including Bax, Bid and Bcl-XL 
(reviewed in Wang, 2000; Hardwood et al., 2005). In addition, it has been demonstrated 
that m-calpain can cleave and activate directly the ER-resident-caspase-12 providing a 
cross-talk between these two families of protease (Nakagawa & Yuan, 2000). In line with 
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these data, a recent paper demonstrated that murine embryonic fibroblasts double 
knocked-out for the gene encoding the calpain small subunit which is essential for the 
function of both fl- and m cal pains are more resistant to ER stress-induced apoptosis then 
the wild type fibroblasts (Tan el al., 2006). However, in the same paper the authors have 
shown that abrogation of calpain activity did not completely block ER stress-induced 
apoptosis, as activation of caspase-12 still occurs in these cells. Indeed, caspase-12 can 
be activated in the ER by other mechanisms. It has been demonstrated that in an 
embryonic kidney 293T cell line treated with ER-stress inducers thasparagine and 
brefeldin-A, caspase-12 is activated by caspase-7 (Rao et al., 200 I). In addition, caspase-
12 can also interact with Ire-Ia in the ER through the adapter molecule TRAF-2 
(Szegezdi et al., 2003; Momoi, 2004). Upon ER stress, TRAF-2 would be recruited on 
the ER surface by Ire-Ia; in tum TRAF-2 would recruit caspase-12 via a CARD-CARD 
interaction and promote its activation by homo-dimerization. Thus other calpain 
independent mechanisms can mediate caspase-12 activation and ER stress-induced 
apoptosis. Interestingly, it has been shown that calpains are activated during Reovirus 
infection and play an important role in Reovirus-induced apoptosis (Debiasi et at., 1999). 
In addition, the authors have shown that different calpain inhibitors can block apoptosis 
induced by Reovirus infection. In our studies, we demonstrated that calpains are 
activated during FCV infection. Using the cell permeable calpain fluorogenic substrate 
Suc-LL VY -AMC, we detected a peak in calpain activity at 6 hpj. in cells infected with 
FCV (Figure 4.7). Activation of calpains was confirmed by the analysis of cytoskeletal 
protein fodrin, a well characterized calpain substrate (Wang, 2000). Fodrin was cleaved 
at 6 h p.i. to yield the 145 kDa fragment which has been reported to be specifically 
generated by calpains (Figure 4.6). Moreover, analysis of fodrin cleavage revealed that 
the 145 kDa calpain specific fragment occurred before the appearance of the 120 kDa 
fragment generated by caspase-3, suggesting that activation of calpains preceded 
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caspase-3 activation (Figure 4.6). This observation was further confirmed by the analysis 
of caspase-3 activity using the fluorogenic substrate z-DEVD-AFC which showed a peak 
in the enzymatic activity of caspase-3 at 8 h p.i. (Figure 4.7). Although these results 
indicate that calpains are activated before caspase-3 and -9 during FCV infection, the 
functional implication of this event is not well defined. Here we clearly showed that the 
calpain inhibitor I ALLN blocks PS extemalization (Figure 4.4), the appearance of the 
active form of caspase-3 (Figure 4.5) and the release of cytochrome c from the 
mitochondria (Figure 4.8). These results strongly suggest an upstream role of calpains in 
FCV -induced apoptosis. However, several observations must be considered before 
drawing any conclusions. First of all, activation of calpains during apoptosis does not 
necessarily mean that these proteinases act as positive regulators of the apoptotic process 
as in many cellular systems calpains can inhibit caspases and switch the type of cell 
death from apoptosis to necrosis. Secondly, cal pains can act at different levels in the 
apoptotic pathway as initiators, regulators and executioners (reviewed in Wang, 2000; 
Hardwood et al., 2005). Finally the use of one pharmacological calpain inhibitor is 
usually not enough to address a specific function for calpains as most of the inhibitors 
available are not completely calpain specific and display some degree of inhibition for 
other proteolytic systems. In particular, the inhibitor used in this study, ALLN, has been 
reported to inhibit the proteasome in addition to calpains (Cooke & Patel, 2004; Hong et 
al., 2004). For these reasons, to further examine the role of cal pains during FCV-induced 
apoptosis, we analysed the inhibitory effects of calpeptin and MG 132 which are more 
specific inhibitors for calpains and the proteasome, respectively. Analysis of PS 
extemalization induced by FeV in the presence of ALLN, calpeptin and MG 132 
revealed that the MG 132 was the most potent inhibitor in preventing the PS 
extemalization while calpeptin was relatively ineffective, indicating a prominent role of 
the proteasome in the apoptotic pathway induced by FCV (Figure 4.13). This result is 
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very important as it suggests that despite their activation, calpains may not be the 
primary mediators of FCV -induced apoptosis. However, it should be mentioned that our 
results represent only preliminary data and further analysis needs to be conducted to 
clearly determine the precise role of calpains and proteasome. First of all, the efficiency 
of calpeptin in the inhibition of calpains has to be addressed with an appropriate positive 
control. It is possible that calpeptin did not function under our experimental conditions or 
it is not retained in the cells, as we observed for the caspase-9 inhibitor ac-LEDH-CHO. 
In addition, although PS extemalization depends on caspase .activation, direct analysis of 
caspase-3 and cytochrome c release in the presence of calpeptin and MG 132 will add 
stronger evidence to the role of the proteasome and calpains during FCV -induced 
apoptosis. MG 132 has been used mainly as a proteasome inhibitor, however it can 
inhibit calpains although to a lesser extent than ALLN and calpeptin (Lee & Goldberg, 
1998). Thus, analysis of fodrin cleavage in FCV -infected cells treated with the MG 132 
and calpeptin will be very valuable to assess the degree of calpain inhibition performed 
by these two compounds. For all these reasons it is not possible to completely exclude 
the upstream role of calpain in FCV -induced apoptosis. However, despite these 
considerations, we also found additional evidence which suggest that calpains may not 
play an essential role during Fev -induced apoptosis. Under pathological conditions, the 
calcium influx from the extracellular pool across the plasma membrane is often 
associated with activation of calpains (Orrenius el a/., 2003). As FeV may induce the 
permeabilization of the plasma membrane and thus promote a calcium influx from the 
extracellular pool, we investigated the role of extracellular calcium in FCV -induced 
apoptosis. We demonstrated that depletion of extracellular calcium pool by the calcium 
chelator EGTA did not inhibit caspase-3 activation (Figure 4.12) although the 
extracellular calcium is required for FCV -induced cytotoxicity (Figure 4.11). However, 
although the extracellular calcium could represent a source of calcium for calpains 
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activation, these proteinases can be also activated by other routes most probably through 
the release of calcium from the ER store. Thus, we cannot rule out the possibility that 
calpains were activated by other pathways. More evidence that calpains may not be 
involved as up-stream mediators of FCV -induced apoptosis came from the analysis of 
fodrin cleavage. We showed that the appearance of the 145 kDa fragment was not 
blocked by ALLN, suggesting that under our experimental conditions ALLN is a poor 
inhibitor of calpains. Indirectly, this observation indicates that ALLN blocks FCV-
induced apoptosis possible through the inhibition of the proteasome. So how can 
proteasome inhibition block apoptosis? There are two possibly mechanisms by which 
this effect can be achieved. It has been demonstrated that proteasome inhibition blocks 
apoptosis induced by different stimuli in neurons and thymocytes (Grimm et al., 1996; 
Sadoul et al., 1996; DaUaporta et al., 2000; Yang et al., 2000; Bobba et al., 2002). In 
particular, in cerebellar granule neurons and thymocytes, proteasome inhibition prevents 
apoptosis at the pre-mitochondrial stage (Dallaporta et al., 2000; Bobba et al., 2002). It 
has been shown that in thymocytes treated with different apoptotic agents including 
glucocorticoids and etoposide, lAPs are selectively lost in a proteasome-dependent 
manner at early stages of apoptosis (Yang et al., 2000). The authors have also shown that 
lAPs are able to catalyse their own ubiquitination through their RING domain which 
represents the signal for their degradation by the proteasome. Although the events 
leading to the ubiquitination of lAPs were not investigated, the author suggested that 
stabilization of the lAP levels through proteasome inhibition was the key event in the 
inhibition of thymocyte apoptosis. Another mechanism by which proteasome inhibition 
can block apoptosis is through the inhibition of PKR-mediated activation of NF-KB. It 
has been demonstrated that PKR could function as a pro-apoptotic factor when over-
expressed in cells or in response to multiple stimuli including, virus infection and 
transfection with synthetic double-stranded RNA (Lee & Esteban, 1994; Gil et al., 1999; 
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Barber, 2005). The ability of PKR to induce apoptosis depends on the phosphorylation of 
eIF2a and the activation ofNF-KB (Gil et al., 1999). When activated, PKR can promote 
the phosphorylation of IKBa, the cytoplasmic inhibitor of NF-KB (Gil et al., 1999; Gil et 
01., 200 I). This event leads to the proteasome-dependent degradation of IKBa, allowing 
NF-KB to trans locate into the nucleus where it exerts its transcriptional activity. 
Abrogation of IKBa degradation by proteasome inhibitors or by the expression of 
dominant mutant hcBa. blocks PKR-induced apoptosis in response to double stranded 
RNA, suggesting role for NF-KB in this process (Gil et al., 1999). In conclusion, 
inhibition of NK-KB and stabilization of lAPs could represent the potential mechanisms 
by which proteasome inhibition prevents FCV -induced apoptosis. The implication of 
these two events in FCV induced apoptosis will be further discussed below. 
Our study has also demonstrated that z-V AD-fink prevents cytochrome c release from 
the mitochondria. This represents an important result as it indicates that the mitochondria 
could act as an amplification loop of a pre-activated apoptotic pathway. Indeed, in a 
previous study from our lab it has been shown that caspase-3 was processed to its 
inactive p20 subunit between 4 and 6 hpj. and only at 8 h was the active p 17 subunit 
detected (AI-Molawi et al., 2001). This result correlated well with our flow cytometry 
analysis of caspase-3 which detects only the active form (p 17 /p 12). Interestingly, the p20 
intermediate subunit of caspase-3 is subjected to the inhibition of X-lAP which prevents 
the full activation of caspase-3 (Vaux & Silke, 2003). In addition, our analysis of 
caspase-9 activation showed that despite a decrease of the proform of caspase-9 at 6 h 
pj., this caspase only acquired its full catalytic activity at 8 hpj. when all the 
cytochrome c is present in the cytoplasm. This discrepancy between the processing and 
the activity of caspase-9 could be explained by an inhibitory effect of X-lAP. Thus, from 
our previous and present studies, we can deduce that the mitochondrial pathway may 
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function as an amplification loop to facilitate the activation of caspases and consequently 
FCV -induced apoptosis. 
Another important event during FCV infection is the activation of PKR. We 
demonstrated that this protein kinase was activated as evidenced by the phosphorylation 
of its canonical substrate elF-2a at 4 hpj. PKR may represent another pro-apoptotic 
mediator during FCV infection. PKR could exert its pro-apoptotic activity through the 
activation of NF-ICB as explained before, and also through the phosphorylation of eIF-2a 
by depleting the cells of proteins with anti-apoptotic function, such as X-lAP, or 
inducing preferential translation of selective mRNAs for proteins with pro-apoptotic 
function such as Bax (Gale et al., 1998; Kaufman, 1999). Moreover, it should be 
mentioned that in response to ER stress, eIF-2a can be phosphorylated by the PKR-like 
ER-kinase PERK., with potentially the same consequences induced by the 
phosphorylation ofPKR, adding a new level of complexity. 
In summary, our results indicate the involvement of three proteolytic systems in FCV-
induced apoptosis: the caspases, the calpains and the proteasome. To date, our data 
cannot clearly define the molecular relationship between these proteolytic systems as the 
crosstalk between them could potentially involve different members of the Bcl-2 family 
proteins as well as X-lAP, which can be regulated at the transcriptional-translational 
level by PKR and/or PERK.. However, based on our observations we can suggest 
preliminary models for future analysis. Initially, FCV infection could lead to an ER stress 
response which in tum can induce activation of calpains and the ER resident caspase- I 2. 
Calpains and caspase-12 could provide the first initial step for the activation of caspase-
3, -7 and possibly -9. However, these caspases could be initially inhibited by the 
presence of high levels of X-lAP. However, under apoptotic conditions, this endogenous 
caspase inhibitor would be subjected to a rapid degradation by the proteasome as 
observed in thymocytes (Yang et al., 2000). Thus its inhibitory activity would probably 
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depend on de novo protein synthesis. As the infection progresses, the phosphorylation of 
eIF2a by PKR or PERK would establish a persistent state of protein synthesis inhibition 
which in tum could lead to a depletion of X-lAP and possibly up-regulation of pro-
apoptotic proteins. The release of caspase inhibition allows executioner caspases, in 
cooperation with calpains, to feedback into the mitochondria directly or through the 
cleavage of pro- (Bid) and anti-apoptotic (BcI-Xd members of the BcI-2 family leading 
to the mitochondrial amplification. In particular, this fits with the recent observation that 
fibroblasts with a double knock-out for caspase-3 and -7 are resistant to different 
apoptotic stimuli and have impaired Bax translocation and cytochrome c release, 
indicating an essential role of the executioner caspases in the mitochondrial events 
(Lakhani el al., 2006). This preliminary model provides an explanation for the 
involvement of the proteasome and caspases in cytochrome c release and for the fact that 
inhibition of calpains is not enough to block apoptosis as other mediators such as the 
executioner caspases and probably caspase-12, could overcome calpain inhibition. 
However, other pathway might be possible. It has been shown that PKR activates the 
pro-apoptotic factor p53 (Kaufman et al., 1999). Thus activation of p53 and NF-KB by 
PKR could cooperate to induce apoptosis during FCY infection. In addition, it has been 
shown that one of the effector mediators ofp53-induced apoptosis is caspase-2 (reviewed 
in Zhivotovsky & Orrenius, 2005). Caspase-2 has the unique feature to act both as an 
initiator as well as an effector caspase (Thornberry & Lazebnik, 1998). Caspase-2 
possesses a long N-terminal pro-domain typical of initiator caspases but its substrate 
specificity is similar to that of effector caspases. Caspase-2 is resistant to X-lAP 
inhibition (Ho et al., 2005) and it can induce the release of cytochrome c through 
cleavage of Bid (Gao et 01., 2005). As caspase-2 is activated during FCY-induced 
apoptosis (AI-Molawi et al., 2003), it may be possible that this caspase is responsible for 
the release of cytochrome c observed during Fey infection. For these reasons it is 
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essential to determine if PKR is responsible for the activation of caspase-2 through the 
induction ofp53 and NF-KB and at what time p.i. this caspase is activated. 
The hypothesis and the data obtained from this study are summarised in Figure 6.1. 
Finally, we wanted to assess whether apoptosis is required for the replication cycle of 
FCV. Our analysis demonstrated that despite the inhibition of cytochrome c release and 
caspase-3, z-V AD-fmk and ALLN did not affect the endogenous production of infective 
mature particles (Figure 5.3). Thus, viral replication does not require apoptosis. 
Interestingly, we found that viral replication was almost complete at 6 hpj. before the 
execution phase of apoptosis takes place (Figure 5.1). This observation suggests that 
FCV may adopt a rapid multiplication strategy to avoid the potential negative effects of 
apoptosis. Such a strategy ensures that the viral replication takes place in a relatively safe 
endogenous environment in the pre-apoptotic infected cells but also it could represent an 
important mechanism to avoid the innate immune response in vivo. The completion of 
the viral replication cycle before PS extemalization could ensure that the viral particles 
are formed and assembled before the engulfinent of the infected cells by professional 
phagocytes such as macrophages. 
On the other hand, we were not able to study the effects of apoptosis on virus release as 
the amount of infective viral particles released at 6 and 8 h was too low to make any 
significant conclusions (Figure 5.2). It has been suggested that apoptosis could represent 
a potential mechanism that promotes the spread of the viral particles into surrounding 
tissue (Teodoro & Branton, 1997; Everett & McFadden, 1999). According to this 
hypothesis, apoptosis could be particularly beneficial for non-enveloped viruses which 
are more expose to the extracellular host environment. These viruses may induce 
apoptosis of infected cells to promote the release of the viral particles into the apoptotic 
bodies, facilitating spread of the viral progeny and avoiding the host immune response. 
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In this respect, it is possible that Fev uses a similar strategy. Thus FeV may replicate 
quickly in infected cells during the pre-apoptotic stage and then it may take advantage of 
the execution phase of apoptosis, when viral replication is no longer compromised, to 
spread the viral progeny through the apoptotic bodies. Interestingly, Alonso and 
coworkers have shown that infection with the calicivirus RHDV resulted in apoptosis in 
infected rabbits (Alonso el al., 1998). RHDV viral particles were detected not only in the 
hepatocytes, which represent the primary site of infection, but also in macrophages and 
other cell types. Thus, once viral replication is complete, apoptosis could represent an 
efficient mechanism to protect the viral progeny and facilitate the spread of the virus into 
surrounding tissues by the formation of apoptotic bodies. 
There are other possible mechanisms by which apoptosis and activation of caspases may 
facilitate viral spread. It has been shown that during infection with the Astrovirus, the 
inhibition of apoptosis greatly reduces the release of viral particles, although it does not 
affect the viral replication in infected cells (Guix el ai., 2004; Mendez et ai., 2004). It has 
been demonstrated that inhibition of the virus particle release was due to the inhibition of 
cleavage of the Astrovirus capsid protein by caspases (Mendez et al., 2004). In 
particular, inhibition of caspases prevents the maturation of the capsid precursor, 
suggesting that this process is required for viral release. Interestingly, the FeV capsid 
protein is also cleaved during infection by caspase-2 and -6, suggesting that this process 
could be involved in virus release (AI-Molawi et ai., 2003). However, although during 
Astrovirus infection the caspase-mediated capsid cleavage is essential for the production 
of the mature viral particles, there is no evidence that the capsid fragment generated by 
caspase cleavage during FeV infection is incorporated into the mature virion, suggesting 
that this cleavage may have other functions. It is possible that this cleavage could affect 
the assembly of viral particles as it has been suggested for other viruses such as influenza 
virus and transmissible gastroenteritis coronavirus (Zhimov el al., 1999; Eleouet et ai., 
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2000). If this is the case, it may represent a cellular defence mechanism against FCV 
infection and it may explain why FCV must replicate quickly in infected cells before the 
execution of apoptosis. However, this event could also enhance the penneabilization of 
the plasma membrane or apoptotic body fonnation to promote virus dissemination. In 
this respect, it has been demonstrated that the trypsin-mediated cleavage of the Rotavirus 
outer capsid protein can induce penneabilization of the plasma membrane (Charpilienne 
et al., 1997). Thus, the cleaved fragment of the FCV capsid protein may have the same 
function. 
Activation of the executioner caspases may also facilitate the localization and the 
distribution of the viral particles in particular regions of the infected cells. It has been 
demonstrated that inhibition of caspase-3 prevents the propagation of influenza virus as 
caspase-3 is essential for the export of the viral ribonucleoprotein complexes from the 
nucleus to the cytoplasm (Wurzer et al., 2003). Thus, activation of caspase-3 and the 
subsequent ultrastructural chances in FCV -infected cells could direct the viral particles in 
the proximity of the plasma membrane, promoting their integration into the apoptotic 
bodies or simply facilitating their release. 
In conclusion, we demonstrated that the mitochondrial pathway is activated during FCV 
infection which may function as an amplification loop of a pre-activated apoptotic 
pathway. Our study indicates that the caspases, calpains and proteasome are the possible 
activators of the mitochondrial pathway. The function and the role of these proteolytic 
systems can be regulated and modulated at the transcription-translational level by the 
activation of PKR and PERK. In addition, we showed that apoptosis is not required for 
the viral replication, although the execution phase of apoptosis could provide different 
mechanisms by which FCV could be released from the infected cells. Our results 
represent the starting point for further exciting studies that could provide new insight not 
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only into the interaction between FeV and the host cell but also on the pathogenesis of 
this family of viruses as well as the apoptotic field in general. 
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CHE:\IICALS 
• 30X Reducing Agent Dithiothreitol (DTT). Biolabs. 
• 3X SDS Sample Buffer. Biolabs. 
• Ac-LEDH-CHO. Bachem. Stock solution: 100 mM in DMSO. Store at - 20°C. 
• AlLN. Calbiochem. Stock solution: 10 mM in DMSO. Store at - 20°C. 
• Ammonium Persulfate. Sigma. 
• Aprotinin. Roche. Stock solution: I mg/ml in dH20. Store at - 20°C. 
• Calpeptin Calbiochem Stock solution: 10 mM in OMSO. Store at - 20°C. 
• CCCP. Sigma-Aldrich. Stock solution: to mM in DMSO. Store at - 20°C. 
• Cyclosporine A. Calbiochem. Stock solution: I mM in Ethanol. Store at - 20°C. 
• Digitonin. BOH. Stock solution: 60 mg/ml in dH20, boil at 95°C to dissolve. 
Prepare frcshly for each experiment. 
• Dimcthyl sulfoxide (OMSO). Sigma. Store at R.T. 
• DPPD. Sigma Stock solution: I mM in ethanol. Store at +4°C. 
• H;!O;! Sigma Stock solution: 500 mM in water. Store at +4°C. 
• Leupeptin. Roche. Stock solution: I mg/ml in dH20. Store at - 20°C. 
• MG 132. Stock solution: 10 mM in OM SO. Store at - 20°C. 
• Mito Tracker Green FM. Molecular Probes. Stock solution: 50llM in OMSO. 
• N, N, N', N' - tetramethylethylenediamine (TEMED). Sigma. 
• Pepstatin. Roche. Stock solution: I mg/ml in dH20. Store at - 20°C. 
• PMSF. Roche. Stock solution: 100 mM in DMSO. Store at R.T. 
• Poly-L-Lysinc. Sigma. Stock solution: 25 mg/ml in dH20. Store at -20°C. 
• Staurosporine. Alexis. Stock solution I mM in DMSO. Store at -20°C. 
• Suc-ALL Y -AMC. Alexis Stock solution: 4 mM in DMSO. Store at - 20°C. 
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• TMRE. Molecular Probes. Stock solution: 1 00 ~M in DMSO. Store at - 20°C. 
• Trolox Sigma Stock solution: 500 mM in ethanol. Store at +4°e. 
• Z-DEVD-AFC Sachem. Stock solution: 100 mM in DMSO. Store at - 20°e. 
• Z-VAD-fmk. Sachem. Stock solution: 100 mM in OMSO. Store at - 20°e. 
GE~ERAL. SOL.UTIO~ 
• 0.4% (w/v) Trypan Slue 
,. 0.4 g ofTrypan Slue (SOH) in 100 ml of dH20. 
• 10% (v/v) Fonnal-Saline 
~ 10 ml of Fonnaldahyde (Fisher Scientific) in 90 ml on 0.89% (w/v in 
dH20) NaCl. 
~ Store at + 4°C. 
• 20% (w/v) SOS 
~ 20 g of SOS in 100 rnl of H20. 
j.. Store at + 37°C. 
• SutTer A 
, 293 mg NaCl 
j.. 1.86 g KCI 
;. 102 mg MgCb· (6H2O) 
, 90 rng EGTA 
, 1.49 g HEPES 
, I J.1M Cyclosporine A 
,. Prepare in dHzO. pH 7.1, final volume 250 ml. 
, Prepare freshly for each experiment. 
• Crystal Violet 
j. 0.1 g of Crystal Violet in 100 ml of 20% (v/v in dH20) Ethanol. 
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~ Store at R.T. 
• Lysis Buffer 
~ 150 rnM NaCl. 
~ 50 rnM Tris-HCI pH 7.5. 
~ 0.2% of20% (w/v) SDS . 
~ 1% of 100% NP 40. 
~ ImM Na3V04. 
~ 2 Ilg/ml Leupeptin. 
~ 2 Ilg/ml Pepstatin. 
~ 2 Ilg/ml Aprotinin. 
~ 1 mM PMFS. 
~ Prepare in dH20. Final volume 10mi. Filter sterilize with 0.20 Ilm 
Minisart Filter. 
~ Prepare freshly for each experiment. 
• PBS 
~ 1 tablet of PBS (Oxoid) in 100 ml of H20. Autoclaved. 
~ Store at + 4°C. 
• PBSa 
~ 9.60 g of PBS (GIBCO). 
~ 100 mg/l ofCaCh. 
~ Prepare in dH20. Final volume 1 1. Filter sterilize with 0.20 Ilm Minisart 
Filter. 
» Store at + 4°C. 
• PBS + D-Glucose 
~ PBS + ) gil of D-Glucose. 
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)i> Store at + 4°C. 
• Caspase-3 lysis buffer 
j. 50 mM NaCl. 
)i> 40 mM sucrose. 
:... 2 mM MgCh (6 H20). 
~ 5 mM EGTA 
)0> 10 mM Hepes. 
~ pH 7.0 
)i> Prepare freshly for each experiment in dH20. 
• Caspase-3 assay buffer 
)i> 100 mMHepes. 
)i> 10 mM DTT. 
)i> CHAPS 0.1 % (v/v). 
)0> 10 %(w/v) Sucrose. 
)i> pH 7.25. 
)i> Prepare freshly for each experiment in dH20. 
• CaJpain assay buffer 
)i> 115 mM NaCI. 
)i> I mM KH2P04. 
)i> 5 mM KCI. 
)i> 2 mM CaCho 
)i> 25 mM NaHepes. 
)i> 1.2 mM MgS04. 
)i> ph 7.4 
)i> Prepare freshly for each experiment in dH20. 
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CELL CULTURE MEDIA 
• I : 10 (v Iv) T rypsinIV ersene 
,. 10 ml of Trypsin (GIBCO) in 100 mt ofVersene (GIBCO). 
• Agar Cell Gum 
j;. 0.8 g of Agar Cell Gum (SIGMA) in 100 ml of H20. Autoclaved. 
Jti' Store at + 4°C. 
• Double Strength Medium (50 ml) 
» 10 milO X Modified Eagle's Medium (Gibeo). 
,. 2 ml Fetal Bovin Serum (Gibeo). 
,. I ml Non Essential Amino-Acid (Gibeo). 
,. I ml Penicillin (100 U/ml)/Streptomyein (100 Ilg/ml) (Gibeo). 
,. I ml L-Glutamine (Gibeo). 
» 0.5 ml Gentamyeine (Gibeo). 
» 5 ml Sodium Bicarbonate (Gibeo). 
,. 29.5 ml dH 20. 
» Store at + 4°C. 
• MEM 2% FBS (100 ml) 
,. 96 ml Modified Eagle's Medium (Gibeo). 
,. 2 ml Fetal Bovin Serum (Gibeo). 
,. I ml Non Essential Amino-Acid (Gibeo). 
» I ml Penicillin (100 U/ml)/Streptomyein (l00 Ilg/ml) (Gibeo). 
,. Store at + 4°C. 
• MEM 10% FBS (100 ml) 
,. 88 ml Modified Eagle's Medium (Gibeo). 
,. 10 ml Fetal Bovin Serum (Gibeo). 
» I ml Non Essential Amino-Acid (Gibeo) 
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;,.. I ml Penicillin (100 U/ml)/Streptomycin (100 Ilg/ml) (Gibco). 
,. Store at + 4°C. 
GEL ELECTROPHORESIS SOLUTION 
• 10% (w/v) Ammonium Persulphate 
,. 0.1 g Ammonium Persulphate (SIGMA) in Iml dH20. 
,. Store at + 4°C. 
• 15 % Resolving Gel 
);> 3.2 ml dH20 
,. 10 ml AX2 buffer. 
,. 6.3 ml of 40 % Acrylamide/Bis-acrylamide. 
,. 100 III of 20 % SDS. 
,. 200 III of 10% Ammonium Persulphate. 
,. 50 I.d TEMED. 
• lOX TBS{fween 20 
,. 24.2 g Tris. 
,. 80 g NaCl. 
,. Add 800 ml of dH20. 
• I X TBSffween 20 
,. 100 ml of lOX TBS{fween 20 
,. 900 ml of dH2O. 
,. Store at + 4°C. 
• Acrylamide:Bis-Acrylamide (Ratio 37: 1,40 % stock) 
,. 40 g Acrylamide. 
,. 1.08 g Bis-Acrylamide. 
,. Dissolve in 100 ml dH20. 
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j.o> Store at + 4°C. 
• AX2 ButTer (0.75 M Tris) 
,. 45.3 g Tris . 
., Dissolve in dH10, pH to 8.8 with conc. HCI, final volume 500 mt. 
, Store at + 4°C. 
• BX2 ButTer (0.25 M Tris) 
., 15.12gTris. 
» Dissolve in dH10, pH to 6.8 with conc. HCI, final volume 500 mt. 
, Store at + 4°C. 
• Running ButTer 
, 3 g Tris. 
, 14.4 g Glycine. 
, 5 ml 20% SDS. 
, Dissolve in 1000 ml of dHzO. 
• Sample ButTer (20 J-lI) 
, 6.7 J-li of 3 X SDS (Biolabs). 
, 0.67 J-li of 30 X reducing agent DTT (Biolabs). 
, Appropiate volume of protein sample and dH20. 
, PH to 7.6 with conc. HCl 
, Add 10 ml of Tween 20 (Sigma) 
, Final volume 1000 mt. 
, Store at + 4°C. 
• Stacking Gel 
, 3.7 ml dH10. 
» 5 ml BX2 butTer. 
» I ml of 40% Acrylamide/Bis-acrylamide. 
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.,. 50 fJl of 20 % SDS. 
,. 100 fJl of 10% Ammonium Pcrsulphate. 
" 30 fJI TEMED. 
• Resolving Gel 
7% 10 % 
H~O 5.8 ml 4.5 ml 
AX2 10 ml 10 ml 
Acry:Bis 3.5 ml 5 ml 
10 % SDS 200 fJl 200 fJl 
I ()",'o (wi\') 
200 III 200 III 
Ammonium Persulphate 
Temed 50 III 50 III 
WESTERN BLOT SOLUTION 
• 5% (w/v) Blocking Buffer 
15 % 
2ml 
10 ml 
7.6 ml 
200 III 
200 III 
50 III 
,. 5 g of Dried Skimmed Milk (Marvel) in 100 ml of 1 X TBS/Tween 20. 
• Transfer Buffer 
KIT 
» 3 g Tris. 
» 14.4 g Glycine. 
» 200 ml Methanol. 
» 800 ml dH20. 
• SupcrSignal~ West Pico Chemilumincscent Substrate. Pierce. 
• PE-Conjugated monoclonal active caspase-3 antibody apoptosis kit. BD 
PharMingen. 
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• Anncxin V -FITC Apoptosis detection kit. Oncogene Research Products. 
• Caspase-Glo ™ 9 assay. 
• Bio-Rad DC Protcin Assay. 
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Calicivirus translation initiation requires 
an interaction between VPg and eIF4E 
Ian Goodfellowl+, Yasmin ChaudhrY, Ioanna Gioldasr, Andreas Gerondopoulosl, Alessandro NatonP, 
Louisette LalJrie3, lean-FranfOis LalibertP & Lisa Roberts2++ 
I School of Animal and Microbial Sciences, University of Reading, Whiteknights, Reading, UK, 2School of Biomedical and Molecular 
Sciences, University of Surrey, Guildford, Surrey, UK, and 3INRS-Institut Annand-Frappier, Laval, Quebec, Canada 
Unlike other positive-stranded RNA viruses that use either a 5'-cap 
structure or an internal ribosome entry site to direct translation of 
their messenger RNA,. calicivirus translation is dependent on the 
presence of a protein covalently linked to the 5' end of the viral 
genome (VPg>. We ha~ shown a direct interaction of the calici-
virus VPg with the cap-binding protein eIF4E. This interaction 
is required for calicivirus mRNA translation, as sequestration of 
elF4E by 4E-8P1 inhibits translation. Functional analysis has 
shown that VPg does not interfere with the interaction between 
elF4E and the cap structure or 4E-8P1, suggesting that VPg binds 
to elF4E at a diffftent site from both cap and 4E-8P1. This work 
lends support to the idea that calicivirus VPg acts as a novel 'cap 
substitute' during initiation of translation on virus mRNA. 
Keywords: calicivirus; eIF4E; translation; VPg 
EM so report" advance online publication 26 August 2005; 
doi:IO.I03S1lj.embor.7400510 
INTRODUCTION 
Protein synthesis can be considered as a three-stage process 
consisting of initiation, elongation and termination (reviewed by 
Hershey & Merrick, 2000). In eukaryotic cells, initiation requires 
the participation of several initiation factors (eIFs) that help to 
assemble 485 preinitiation complexes on messenger RNA before 
the assembly of the 80S initiation complex at the initiation codon. 
The first step in translation of 5'-capped host-cell mRNAs is the 
binding of the initiation factor elF4F (Gingras et ai, 1999). elF4F 
consists of three subunits; elF4E binds to the cap, whereas elF4A is 
an RNA helicase. The largest of the three proteins, eIF4G, acts as a 
'scaffold' and bridges the ribosome to the mRNA through e1F3. 
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Positive-stranded RNA viruses have evolved to use a wide 
variety of mechanisms for translation initiation (reviewed by 
Pe'ery & Mathews, 2000). Several viruses use a 5'-cap-dependent 
mechanism for initiation, whereas other viruses adopt a cap-
independent tactic, the best example being the Picornaviridae, 
which have an internal ribosome entry site (IRES) element 
(Bel sham & Jackson, 2000). It now seems that caliciviruses may 
use a novel strategy for translation initiation that probably involves 
the interaction of initiation factors with VPg, a viral protein 
covalently linked to the 5' end of the viral genome. 
The human caliciviruses (noroviruses and sapoviruses) are the 
main cause of non-bacterial gastroenteritis in adults worldwide. 
In animals, related viruses are responsible for a wider range of 
symptoms and may cause respiratory, haemorrhagic and vesicular 
diseases. Earlier work showed that the removal of VPg from 
feline calicivirus (FeV) mRNA noticeably decreased translation 
of the genomic RNA, suggesting a role for VPg in protein synthesis 
(Herbert et aI, 1997). More recently, work with Norwalk virus VPg 
has shown an interaction with elF3, as well as with other initiation 
factors (Daughenbaugh et ai, 2003), although a functional role for 
this interaction was not shown. 
To understand fully the role of VPg in translation, we have 
studied its interaction with translation initiation factors. Here, 
we show that Fev and Lordsdale virus (LDV; a human enteric 
calicivirus) VPg bind directly to elF4E and that this interaction 
is required for translation of calicivirus VPg-linked viral mRNA 
in vitro. This would thus constitute a novel mechanism by which 
certain animal RNA viruses use a proteinacious 'cap substitute' to 
initiate translation of their mRNAs. 
RESULTS 
Calicivirus VPg interacts with elF4E 
To understand the role of VPg in translation initiation, we assessed for 
direct interadion of VPg with the components of the elF4F complex. 
Recombinant His-tagged FCV VPg was purified from Escherichia 
coli and used in in vitro pull-down assays with Hela 510 extracts 
(Fig 1A). Western blot analysis showed that elF4E was pulled down 
when VPg was coupled to agarose beads (Fig 1 A). The remaining 
components of the elF4F complex, namely elF4G and elF4A, were 
not detected under the conditions used in this assay (Fig 1A). 
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Fig 1 I Calicivirus VPg intera with e1F4E- (Al His-tagged feline 
ca1iClvirus (FCV) VPg coupled 10 NT A-agarose beads was incubated with 
HeLa 10 extra Complex~ were isola led by low-speed centrifugation 
and proleins bound were analysed for the components of the elF4F 
complex by western bloL (8) Pg interaction with murine elF4E and 
elI'4G. as hown by enzyme-linked immunosorbenl assay-based binding 
y. Well were precoaled with 1.0llg of untagged VPg from both FCV 
and Lordsdale virus (LDV) and in ubated with increasing amounts of an 
Es,hmchill coli Iy le expre ing comparable levels of glutathione 
S-tran ferase (GST)-elF4E or GST - elF4G. Complexes were detected 
using anti-G T antibodi~. 00. optical density. 
To show that the observed interaction between FCV VPg and 
elF4E was dir and was not bridged b another protein present in 
th S10 tra , an enz me-linked immunosorbent assay (ELlSA)-
based bmding a ay (l onard et aI, 2(00) was carried out with 
IF4F components expressed in f . coli. Recombinant FCV and LDV 
(a human calicivirus) VPg were purified from E. coli (see the 
sup pi mentary mfOl'mation online) and were shown to bind directly 
to glutathi ne S-tran f r (GSn-tagged eIF4E, but not to elF4G 
(Fig 1 B), IF4 or pol A)-bmding protein (pABP; data not shown). 
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ORF1 ORF2 ORF3 
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Fig 21 Translation of calicivirus RNA prepared from replication 
complexes is dependent on VPg. Feline calicivirus (FeV) messenger RNA 
or in vitro-transcribed control mRNA was treated with proteinase K 
( + Pk) or mock trealed (-Pk) before translation in rabbit reticulocyte 
Iysates. A schematic of the FCV genome is shown (adapted from 
Sosnovtsev et al. 2002). 
markedly decreased protein synthesis, but translation of an 
in vitro-transcribed control RNA (of the form cap-CAT/EMCV 
IRESILUC) was unaffected by the proteinase K treatment (Fig 2). 
Previous data have shown that in vitro translation of FCV VPg-
linked RNA was not inhibited by cap analogue (Herbert et aI, 
1997). Equally, here, translation of FCV mRNA prepared from 
replication complexes was not inhibited by high concentrations of 
cap analogue-conditions that inhibited cap-dependent transla-
tion, but not IRES-dependent translation, from the CAT/IRES/LUC 
mRNA (Fig 3A). The interaction of VPg with elF4E, shown in 
the ELISA-based binding assay, was also unaffected by high 
concentrations of cap analogue (Fig 3B), which suggests that 
the binding sites for VPg and cap are distinct. 
VPg interacts with elF4E in infected cells 
After shOWing a direct interaction of calicivirus VPg with elF4E 
in vitro, we used m7-GTP Sepharose affinity chromatography to 
pull down elF4E and associated VPg from infected cells (Fig 4A). 
Analysis of complexes that are able to bind to cap-Sepharose 
showed that, in addition to the mature form of VPg (p13), the 
VPg precursors p43, p88 and p120 also bind to elF4E (Fig 4A). The 
putative calicivirus ATPase-RNA helicase (p39) was not purified by 
cap-Sepharose chromatography, confirming the specific interaction 
ofVPg in its mature and precursor forms with elF4E in infected cells 
and also indicating an in vivo interaction between elF4E and VPg. 
In addition, neither VPg nor elF4E was isolated when purifications 
were carried out using unmodified Sepharose 48 (Fig 4B). 
4E-BP1 inhibits calicivirus translation 
To show the importance of the initiation factor in calicivirus 
mR A translation, inactivation of elF4E was achieved using 
the elF4E inhibitor 4E-BP1 (Lawrence & Abraham, 1997). Prior 
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120 
Fi, 31 Calicivirw transJati n and VPg~IF4E interaction is insensitive to 
cap analogue. (A) Feline cali ivirw (FCV) messenger RNA or control 
di . Ironi mRNA translated in rabbit reticulocyte Iysates in the 
pre n t of incrta5UlJ con entrations of cap analogue. (8) The interaction 
of VPg with elF4E in the p~nct of high concentrations of m'·GTP was 
anaJysed using the enzyme·linked immunosorbent assay· based binding 
y. Unl eel Lordsdale virw (LOV) or FCV VPg (l1Ig) was bound to 
the plate and 10lig of glutatluone 5-transf'erase (GST)~IF4E-containing 
lysate wu p ssed o~r in the presence of increasing amounts of m7·GTP. 
Bound proteins ere detected with anti-GST antibody. 
in ub tion of RRL ith purified recombinant 4E-BPl resulted in 
a dose-d pend nt IOhibition of both cap-dependent and VPg-
d nd nt tran lation, with little or no effect on EMCV IRES-
mediated Iran lation (cap-ind pend nt; Fig SA). Quantification of 
th I I of tran lalion howed that Pg-dependent translation 
wa inhib.ted to imilar lev Is a that seen for cap-dependent 
tran lation (Fig 58), indicating that calicivirus translation is 
depend nt on IF4E. Th addition 0 e ogenous 4E-BPl as a 
competitor to th Ell A-based initiation factor capture assay had 
no on lh lOt r ction of VPg with elF4E but Significantly 
d r sro th I v I f IF4E captured b immobilized 4E-BPl 
(Fig Sq. Thi would ugg that Pg and 4E-BPl interact with 
distl it on eIF4E. Thi wa con Irmed b our ability to detect a 
VP IF4E E-8Pl compl ormed on immobilized VPg (Fig 50). 
01 ION 
and th 0 Oaugh nbaugh et al (2003), who 
interaction 0 orwalk virus VPg with 
e1F3, ugg t th t caliciviru VPg ma function as a cap substitute 
in th lOitiation 0 caliclvirus tran lation. Interestingly, elF4E 
and al 0 0 h r tran lat. n initiation factor were present in 
purified rwal Pg IF3 int racting complexes, although the 
dir tint raction be~.... n Pg and elF4E was not investigated 
(Daugh nbaugh I aI, 2003). H r ,w show a direct interaction 
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__ p120 p30-VPg-p76 
- pBS VPg-p76 
- p43 p30-VPg 
- p13 VPg 
cap-Sepharose Cell lysate 
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Anti.p39D - p39 
8 
1_ I Anti·VPg ;::_ ======~::::;_ (P43) 
Antj·e1F4E 
cap- Sepharose 
Sepharose 
Fig 41 VPg interacts with eIF4E in infected cells. Feline kidney cells were 
mock infected or infected with feline calicivirus and extracts were 
prepared 5 h after infection. Extracts were incubated with either 
cap-Sepharose (A), as described (Ptushkina et ai, 1999), or Sepharose 4B 
(8) and bound proteins were analysed by Western blot with antisera 
to VPg, p39 or eIF4E. 
between FCV and LDV VPg with elF4E using in vitro studies and 
isolation of FCV VPg from infected cells on cap-Sepharose. In this 
way, VPg may bind to elF4E and elF3 in the recruitment of an 
initiation complex to the viral mRNA. 
It seems that FCV p43 is preferentially isolated on cap-
Sepharose compared with the mature form of VPg (Fig 4). 
However, this simply reflects the relative ratios of VPg to p43 
seen in an infected cell, as p43 seems to be the main form of VPg 
found during infection. Quantification using densitometry con-
firms this (data not shown). The role of precursor-eIF4E inter-
actions in translation is unknown, but it is possible that the high 
concentrations of VPg-containing precursors in the replication 
complexes may function to effectively concentrate elF4E at the 
sites of replication and translation, in a similar manner to VPgPro 
from Turnip mosaic virus (TuMV; Leonard et aI, 2004). 
Given that a VPg-containing complex can be isolated from 
calicivirus-infected cells using cap-Sepharose, we suggest that the 
VPg·binding site on elF4E is distinct from the region known to 
bind to cap. From this, it could be predicted that expression of VPg 
during infection would not contribute to the shutting off of host-
cell protein synthesis observed in FCV infection (Willcocks et aI, 
2004). Overexpression of either FeV or LDV VPg in cells was 
found to affect neither cap-dependent nor EMCV IRES-dependent 
translation (data not shown). However, in previous work, the 
addition of recombinant Norwalk virus VPg protein to in vitro 
translation reactions was shown to inhibit both cap-dependent 
and IRES-dependent translation (Daughenbaugh et aI, 2003). 
Norwalk virus VPg inhibits both the EMCV and cricket paralysis 
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Protc.~ln-dlf( .. 'ltt:·d \iral tr ... 1n,l.1tlon InltlJtion 
I. GoodIeI/o" PI.11 
.... ~Ig ~ 41' HPI Lnhlbl!> .alle'vlrus translatIon but does not ati'ect 
\ Pg ,'11'41 interaction (A) III 1'l1ro translation reactions were carried 
ut Jft~r pr~ c ubatlon of rabbit reticulocyte lysate with • 16 or 32 ~g of 
~c mblOant H':·BPI USlOg either in 1,.lro-transcribed. capped dicistroni 
me "nger R A (t.. T/IRESILl'C) or teline calicivirus (F V) mRNA. 
RrJdllln were .lnaly,ed by 12.5% SOS-polyacrylamide gel 
r r trophorem ( ) and quantified by phosphorimaging (8). The level of 
tnn,) tilln L' expre"ed.l a per 'entage of the control reactwn. (C) Wells 
were prccoated wlth 10 ~g ot un tagged F V and Lordsdale virus (LOV) 
\ Pg t1r 41·111'1 and Incubated with In Escherrch.a coli lysate expres 109 
t.' r ell'4l, either 10 the presence or ab en e of 5,lg of 4E-8PI. 
c"mp)e,~, were detected u ing anu-elF41:. antisera and expressed as 
a percentage tlt 4E bound 10 the absence of exogenous 4E-8PI. 
(D) f nn'me-linked immunoorbent assay showing the formation of a 
\ 1'1\ eIl1l-4E-BPI complex, The as ay was set up as 10 te). except that 
mait",e-bmdlOg protein (.\lBP) was absorbed to the plate to control 
or nompeutic 4E·BP1 binding and bound 4EBP1 was dete ted using 
anti-III, tag antISera 0, optical density. 
III \ Itro (f Ig 5D~ Indic.1ting that the Pg- and 4E-BP1-binding sites 
on L'If.j[ .He dl,tlnct It is th 'refore li~ely that th inhibition of 
{.lllll\ Iru tran,latlon ob,el'\ed in the pr sence of 4E·BPI IS a 
rl',ul 01 the abdlt\ 01 4[·BPI to prevent the binding of elF4E to 
elf 4G H.lghigh.ll et.1/, 1995), Thi would suggest that a functional 
elf·H lOmple I~ reqUired for calicivirus translation. Our failure to 
1,01.11l' other components 01 the elF4F omplex using re ombinant 
\ Pg fig 1 15 probabl\ owing to the stabilization of the elF4F 
lompll' on \f'g-lln~ed RNA through the interaction of elF4G or 
elF4 \ \\ Ith the Viral R, A. Prel,minaf\ results confirm that elF4A 
l.ln bind to th ') nd of the Fe genome (data not hownl. 
\\ l' have prey lou,h sho\\ n that the elF4GI and elF4GII cleavage 
product" gC'nerated during F infection r m<lin a sociated with 
elf-it lFig 2 In \ ill 0 ~ et ai, 2004), Indi ating that th interaction 
01 Vl'g With elf4[ does not affect the eIF4E-4G inter<lction and 
turther strengthening the hypothesis that an interaction between 
elF4E .lI1d elF4G is requir d tor cali ivirus translation. 
The Intera tl n of the cali IVIrUS VPg protein with translation 
InitiatiOn tators IS not unlqu ,a the potyvlrus VPg proteins have 
abo been shO\\ n to Interact With elF4E (Wittmann et ai, 1997; 
leonard el .1/, 2000; chaad et ai, 2000). The importance of this 
tor intection has b en hown in mutant Arabidopsis thaliana 
pl.1I1h that do not e'pr s eIF(lso)4E (Ouprat et ai, 2002; Lellis 
t't ai, 2002), Although the plants had a normal phenotype, they 
\\ ere Immune to TuM . Pg has also been hown to have a role 
In O\l'rl.oming lilral re I tanl. In plant and the host reces Ive 
rl'",t.1I1l 'gen 'has been Identified a en oding elF4E (Ruffel et ai, 
2002 "t,ll<;e l't .1/,2003), R centl), a pr ur or of VPg (VPgPro) 
01 Tu'\\\. \\.1~ shown to interact wllh PABP (Leonard et ai, 2004); 
thl' m.l\ lead to \:lfal R circularization. Interaction With 
·If ,'0 -il ,1nci P{\BP ~uggests that VPgPro may serve as a fo al 
pOint 1m tran,IJtlon inltl.ltlon omple assembly. 
Hl'Il', I\l'dt" nbt' thl' i",t functional characterization of a viral 
protl'IIl,ll "OU\ .1p .. ubstltute initiation factor Intera tion for any 
m.1I11m.lll.1n R"J \ virus. The GiltClvlfU VPg-eIF 4E interaction 
'l 'Ill' to rl pre'l"nt J novel \\ ay In which animal RNA viruse 
rl'crUlt till' rlb()',ome tor tr,lnslatlon initiation. Further functional 
.In.11\ '" 01 l-.llttlliIfU<; tr.1n.lation i In progres to determine whether 
.111 th' component- 01 the elF4F compl '< are required for initiatl n. 
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Disruption of this interaction may provide a useful antiviral strategy 
for the control of this economically important group of viruses. 
METHODS 
HeLa S10 pull-downs. Nuclease-treated SlO extracts were pre-
pared from HeLa S3 cells as described (Barton et ai, 1995). The 
FCV F9 VPg coding gene was amplified by reverse transcription-
PCR (RT -PCR) from RNA isolated from infected CRFK cells and 
cloned into pET28a. Expression and purification were carried 
out according to the manufacturer's instructions (Novagen, 
Nottingham, UK). His-tagged FCV VPg was bound to nickel NTA-
agarose and incubated with S10; bound proteins were analysed 
by western blot using antisera to eIF4A, elF4E and eIF4G, which 
were gifts from S. Morley (University of Sussex, UK). 
ELISA-based initiation factor capture assay. To assess any direct 
binding of FCV VPg with the elF4F complex components and 
PABP, an ELISA-based binding assay was conducted, as described 
previously (Leonard et ai, 2000). Plasm ids encoding GST-fused 
forms of murine elF4GI and eIF4E, as well as elF4A and PABP, 
were generous gifts from N. Sonenberg (McGill University). 
Recombinant untagged forms of FCV and LDV VPg proteins were 
produced using the ubiquitin fusion system previously described 
(Gohara et ai, 1999) and purified using standard chromatographic 
methods (see the supplementary information online). For assays in 
which 4E-BP1 was included, recombinant 4E-BP1 (a gift from 
S. Morley) was preincubated with the elF4E-containing lysate 
before binding to immobilized VPg or 4E-BP1. Complexes were 
detected with either anti·His, to detect bound 4E-BP1, or anti-eIF4E. 
VPg-dependent translation assay. Replication complexes were 
prepared as described (Green et ai, 2002) and total RNA was 
prepared (GenElute, Sigma, Gillingham, UK). Translation reac-
tions were carried out using the Flexi reticulocyte system 
according to the manufacturer's instructions using 25 J.lglml of 
RNA (Promega, Southampton, UK). Capped control dicistronic 
mRNAs containing the EMCV IRES were synthesized in vitro from 
the plasmid pGEM-CATIEMCV/LUC (van der Velden et ai, 1995). 
To study the effects of prior treatment with either exogenous cap 
or 4E-BP1, reticulocyte lysate was preincubated with inhibitor 
for 15 min at 30°C. Recombinant purified 4E-BP1 was a generous 
gift from S. Morley. 
Isolation of elF4E complexes using m7-GTP Sepharose. CRFK 
cells were infected with FCV and elF4E·associated protein was 
purified using either m 7-GTP Sepharose, as described (Ptushkina 
et ai, 1999), or Sepharose 4B as a control. 
Supplementary information is available at fMBO reports online 
(http://www.emboreports.org). 
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The mitochondrial pathway of apoptosis is 
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Feline ca/icivirus (FeV) belongs to the family Caliciviridae and is an important pathogen of the 
upper respiratory tract of cats. Recent studies have shown that cells infected with Fev undergo 
apoptosis, as evidenced by caspase activation, chromatin condensation and cleavage of 
poly(ADP-ribose) polymerase. Here, the upstream events were investigated in order to define the 
molecular mechanism of apoptosis in FCV-infected cells. It was shown that FCV induced 
translocation of phosphatidylserine to the cell outer membrane and release of cytochrome c from 
mitochondria at about 6-8 h post-infection. These events were preceded by the loss of 
mitochondrial membrane potential and Bax translocation from the cytosol to mitochondria between 
4 and 6 h after infection. Release of cytochrome c from mitochondria triggered the activation 
Received 2 August 2005 
Accepted 12 October 2005 
of caspase-9 and the subsequent activation of the executioner caspase, caspase-3. These results 
suggest that the mitochondrial pathway of apoptosis is triggered during FeV infection. 
Apo~to is is an in~nsi~ cell-suicide programme used by 
multicellular orgamsms ill the regulation of cell numbers 
or as a defence .again t pathogens (Arends & Wyllie, 1991; 
Adam, 2003; Jlang & Wang, 2004). Apoptosis is charac-
terized by a series of well-defined morphological and 
biochemical changes, including cell shrinkage, nuclear chro-
matin condensation and proteolysis of key cellular proteins 
by members of a highly conserved family of cysteine pro-
teases called caspases. Activation of caspases occurs through 
proteolysi of the interdomain linker with the removal of 
the pro-domain and subsequent cleavage to yield the large 
and mall fragments that reassociate to form the catalytically 
active enzyme (reviewed by Boatright & Salvesen, 2003). 
There are two well-defined yet cross-talking mechanisms 
that can induce the activation of distinct initiator caspases: 
the death receptor (extrinsic) and the mitochondrial (intrin-
ic) pathways. vera! apoptogeoic stimuli such as UV 
irradiation and drugs promote the release of factors such as 
cytochrome c from mitochondria (Kroemer & Reed, 2000; 
Green & Kroemer, 2004; Jiang & Wang, 2004). Cytochrome 
c interacts with the apoptotic protea e-activating factor 1 
( paf- l ), which forms an essential part of the apoptosome 
(Jiang & Wang, 2004). Recruitment of pro-caspase-9 into 
the apopto orne leads to activation of caspase-9, which 
mediate the activation of down tream effector caspases 
uch pase-3 and -7. 
Members of the family Caliciviridae are responsible for a 
number of dj ease of man and animals (reviewed by Clarke 
& Lambden, 2(00). Feline calicivirus (FCV), a member of 
the genu Vesivirtl.s, cau e upper re piratory tract disease in 
cat . The genom i a ingle strand of po itive-sense RNA 
0008-1399 © 2006 SGM Printed In Great Bn/ain 
of about 7'5 kb (Carter et aI., 1992); it is polyadenylated 
and has a 15 kDa protein called VPg covalently linked to the 
5' end (Herbert et aI., 1997). The genome is organized 
into three open reading frames (ORFs): ORF1 encodes the 
non-structural proteins, ORF2 encodes the capsid protein 
and ORF3 encodes a small basic protein that is a minor 
component of virions (Sosnovtsev & Green, 2000). ORF2 
and ORF3 are expressed from a sub genomic mRNA 
(Herbert et aI., 1996). 
It has been shown previously that FCV induces apoptosis 
in cultured cells (Al-Molawi et al., 2003; Sosnovtsev et aI., 
2003). Activation of the executioner caspases, caspase-3 and 
-7 (Al-Molawi et al., 2003), and of the initiation caspases, 
caspase-8 and -9 (Sosnovtsev et al., 2003) and caspase-2 (Al-
Molawi et aI., 2003), has been shown to occur during 
infection. In addition, cleavage of the 62 kDa viral capsid 
protein into a 40 kDa protein has been observed con-
comitant with the apoptotic changes (AI-Molawi et al., 
2003). Although it has been shown that synthesis of virus 
proteins is required (Sosnovtsev et aI., 2003), the molecular 
mechanism and especially the nature of the events leading 
to apoptosis are not well understood. We have sought to 
understand the molecular mechanism ofFCV-induced apop-
tosis in more detail by analysing the early apoptotic events. 
In order to analyse the time of activation of caspase-3, 
Crandell-Rees feline kidney (CRFK) cells were infected with 
FCV F9 at an m.o.i. of 100 p.f.u . per cell, or mock infected 
as described previously (AI-Molawi et a1., 2003). Cells were 
harvested at various times following infection and caspase-3 
processing was measured by flow cytometric detection of the 
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neo-epitope generated as a result of the cleavage of pro-
caspase-3 to the p17/p20 fragments by immunostaining with 
a phycoerythrin-conjugated anti-active caspase-3 antibody 
as recommended by the manufacturer (BO Pharmingen) 
(Macanas-Pirard et aI., 2005).ln parallel, cells were analysed 
for signs of apoptosis, as asse ed by phosphatidylserine 
(PS) exposure on their surface. CRFK cells were infected as 
de cribed above, trypsinized, centrifuged and incubated 
with Annexin Y-FITC as recommended by the supplier 
(Oncogene Re earch Products) and propidium iodide 
(PI, 0·6 I1g ml- 1; Calbiochern/Oncogene). A minimum of 
10000 events was acquired in list mode using a Beckman 
Coulter Epics XL, while gating the forward and side scatters 
to exclude cell debris, and analysed in FLl (Annexin V-
FITe) and FL3 (PI) channels. Induction of apoptosis was 
d~tected at 8 h post-infection (p.i.) (Fig. la) and correlated 
Wlth the appearance of activated caspase-3 (Fig. 1b). Both 
PS exposure and caspase-3 activation were sensitive to the 
pan-caspase inhibitor Z-YAD-fmk (100 11M; Bachem). 
In order to define the events upstream of caspase-3 acti-
vation, we analysed FCY-infected cells for any changes in 
mitochondrial membrane potential (t..l/lm). The loss of .1.I/Im 
is an early event in cells undergoing apoptosis (Oecaudin 
et al., 1997; Bossy-Wetzel et al., 1998) and has been observed 
in other virus infections (Tropea et aI., 1995; Eleouet et aI., 
1998; Summerfield et aI., 1998; Jacotot et aI., 2000). The 
mechanism is not well understood, but it is a clear indication 
of the involvement of mitochondria in apoptosis. t..l/lm was 
measured by flow cytometry (data not shown) and confocal 
laser microscopy. For the latter, CRFK cells were grown on 
coverslips and infected as before. At each time point pj., the 
medium was removed and replaced with Oulbecco's PBS 
upplemented with o-glucose. The cells were incubated 
with tetramethyirhodamine ethyl ester (TMRE; 100 nM) in 
the dark for 40 min at 37 °C and examined by confocal laser 
microscopy using an LSM 510 Meta (Zeiss). The correct 
subcellular localization of TMRE was confirmed by co-
localization with MitoTracker Green FM (50 nM; both 
reagents from Molecular Probes). This dye selectively stains 
mitochondria and becomes fluorescent once it accumulates 
in the rnitochondriallipid environment, but, unlike TMRE, 
the emission does not depend on t..l/lm (Fig. 2). The depen-
dence of TMRE mitochondrial staining on t..l/lm was con-
firmed further by showing that CRFK cells pre-treated with 
10 11M of the mitochondrial uncoupler carbonyl cyanide 
3-chlorophenylhydrazone failed to sequester TMRE, but 
showed unaltered MitoTracker Green staining (data not 
shown). In mock-infected celis, the presence of a high t..t/lm 
was evidenced by an intense and punctate staining with 
TMRE (Fig. 2, top row). At 6 h after infection with FCY 
(Fig. 2, bottom row), a near complete loss ofTMRE staining 
was recorded, demonstrating a substantial decrease in t..t/lm. 
Previous reports have shown that Bax translocation and 
cytochrome c release coincide with a major collapse of t..t/lm 
that probably involves the rapid opening of the mitochon-
drial permeability transition pore (Green & Kroemer, 2004; 
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Fig. ~. Induction of apoptosis and caspase-3 activation during 
FCV Infection. CRFK cells were infected (lnf) with FCV for the 
times indicated and analysed for PS exposure using Annexin V 
binding (a) and caspase-3 activation (b) by flow cytometry as 
described in the text. Where indicated, the cells were pre-
treated with the pan-caspase inhibitor Z-VAD-fmk (100 ~M) for 
1 h prior to infection. Appropriate controls were generated by 
mock infection of the cells (Cont 8 h). Results shown are 
representative of four independent experiments. 
Jiang & Wang, 2004; Sharpe et aI., 2004). We therefore 
analysed the location of Bax and cytochrome c during FCY 
infection of CRFK cells. Cells were infected as above and at 
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TMRE MitoTracker Green Merge 
Control 
Infection 4 h 
Infection 6 h 
Fig. 2. FCV In ect lon Induces a decrease In IiIm. CRFK cells grown on poly-L-Iysine-coated glass coversl ips were infected 
with FCV and stained with TMRE (100 nM; dependent on I'1 Vm) and MitoTracker Green (mitochondrial dye, independent of 
\ ",,.,) or 40 min pnor to the ,nd,cated time pOints, when the cells were transferred to a Zeiss POC chamber mounted on an 
LS 510 eta con ocal laser microscope. Cells were visualized and the S-blt signal from control cells (mock infected for 6 h) 
wa ca brat d to fall with in the dynamiC range of the Instrument. 
the IIldl~,lkd time pomt were \ Jshed, re~uspended in 
mtr,lu.:lluIM medium buffer 20 m~1 , a ' I, 100 mM KCI, 
1 1ll~1 ~l g( I ,I m~1 H;IA 23 Ill ~t HEPE , pI! 7' 1) supple-
Ill~nted "Ith I p:-.t lydosponn (to prevent mito hon-
lIn,11 pallle,lbtlit . traosillon pore opening during ample 
pro (ssing) and pameablllled on Ice fo r 10 min by th l' 
,ldlli tlon of 600 pg digl tol1ln 1111 I (Macanas Pirard et al., 
200S). I Iere, digi tonin WJS u ed Imtead ofaponin (MJcana -
!'Ir,!rtf C{ cl/., 200:- ) as It pro\ ided a su perior concentration 
r,lIlg( of plaslllJ membr,lIle perme,lbih7J IIOn J nd dam age 
to the ou ter mitod1Ondriai l11e mbrane (G. E. . Kass, 
unpubh hnf ob ~f\a t iom . (ells were cen tnfuged (2000 g 
for -: 11111l ) to scpar,lIe l.\ tosohc pro tems from ml'mbr,lIl l' 
( milO hondna) a,so i,l ted protems. Equa l amount of 
pro tCIll lrom calh Ir,ldion were as ayed by D PAGE 
,llId Il1ll11Ullllhlll ll lllg ( :-' 1.I~,l n ,1 Plr.trd t:{ al., 2005). Pro tei n 
"l're ddntld u\lng ,lIl tlbodll:' r,lI,cd ,Igalll st cytoc hro mc c 
(done 71 1 2( 12, dllu tcd I : 1000; BD Ph,trlllIngcn ), Bax 
(l' 20, dllu tnl I : ·00, ,lIl t,1 ('rul BlO tc hnology), <: to -
duol11c I 0 Ida d( O\. subuni t 1\-, donc _O F C 12, diluted 
I : 1000; ~l olclul.H Prohes ) or Ii S1.70 (di luted I: 1000; 
http:// r.sgmJourna S org 
' tressgen Biotechnologies). At 4 h p.i. , the localization of 
cytochroml' c was still mitochondrial [(Fig. 3a, P (particu-
late) J. Thc appearan e of cytochrome c in the cytosolic 
fractio n (Fig. 3a, S) was clearly de tected by 6 h and was 
almost complete at 8 h, therefore preceding the procc sing 
of caspa e-3 and P cxposurc. The release of cytochrome c 
also correlated wi th the transloca tion of the p ro-apopto tic 
Bcl-2 protein fami ly member, Bax, from the cytosol to the 
mitochondria at 6 h p.i. (Fig. 3b). The de tect ion of COX 
was u cd as a con trol for the cytosolic frac tion to 
demon trate the lack of contami nation by m itochondria , 
whereas I Isc70 was used as a loading control for the 
cytosolic fraction . At 8 h p.i., we detected a decrease in the 
amount ofIIsc70 in the cytosol (Fig. 3b); however, this was 
probably due to the general permeabili zation of the plasm a 
membrane late in infection. 
Oncc cytochroml' c has transloca ted into the cytosol, it 
in tera ts with Apaf I to form the apopto ome (Jiang 
& Wang, 2004). Rec rui tment of pro-caspase-9 into the 
apopto omc leads to a tiva tion of caspasc-9, which mediates 
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FIg. 3. Caspase-9 actIVation following Sax translocation and 
cytochrome c re ease from mitochondria. (a, b) Western blot 
analysIs of mltochondnal (P) or cytosolic (5) content of cyto-
chrome c and Sax. Infected cells (In!) were harvested and their 
plasma membranes permeabilized by digitonin. Following 
separatIOn of the cytosolic fraction from the membrane-bound 
fractIOn, samples were analysed for cytochrome c (a) and Sax 
(b) as descnbed in the text. Loading controls were achieved by 
reprob.ng the blots for COX IV and Hsc70. (c, d) Infected cells 
were also assayed for the processing of pro-caspase-9 by 
Western blot analySIs (c; loading controls were achieved by 
reprobmg the blots for Hsc70) and caspase-9 activation by an 
enzymic assay (d). The results shown are representative of 
three Ind pend nt expe ments. 
the activation of down tream caspases such as caspase-3. 
Therefore, w analysed the timing of pro-caspase-9 
pro es ing during F infection. Cell were infected as 
de ribed a e and cell lysate were ubjected to DS-
PAGE and immunoblotting with anti-caspa e-9 anti era (a 
gift from Profe or Yuri Laz bnik, Cold pring Harbor 
Laboratory, U ; Rodriguez Lazeboik, 1999). Activation 
of p -9, a mea ured by the di appearance of the 
47 kDa pro-form, w clearly een by 6 p.i. (Fig. 3c), which 
coin ided with the rel of cytochrome c, but preceded 
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caspase-3 activation (Fig. 1). Activation of caspase-9 was 
also measured using an enzymic assay (Caspase-Glo 9; 
Promega). Briefly, cells were collected 8 h after infection 
with FCV and incubated with Caspase-Glo 9 reagent as 
recommended by the manufacturer. Relative light units 
(RLU) were read using a luminometer (LumiCount; 
Packard Bioscience) . This method demonstrated a large 
increase in caspase-9 activity at 8 h p.i., in line with the 
increase in activity seen in CRFK cells treated with 
staurosporine (STS, 1 11M for 8 h) (Fig. 3d). 
During infection, CRFK cells present the hallmarks of 
apoptosis-chromatin condensation, poly(ADP-ribose} 
polymerase cleavage, DNA fragmentation and caspase acti-
vation. In the present study, we extended these observations 
and studied events upstream of caspase-3 activation to 
define the molecular mechanism of FCV -induced apopto-
sis. Consistent with previous reports, we showed that the 
executioner caspase, caspase-3, was activated at 8 h after 
infection with FCV (Al-Molawi et al., 2003; Sosnovtsev et al., 
2003). This correlated with the onset of apoptosis at B h 
p.i., as demonstrated by PS exposure on the cell surface. The 
pan-caspase inhibitor Z-VAD-fmk prevented caspase-3 
activation and inhibited apoptosis. This demonstrated 
that, in FCV infection, the execution of apoptosis is depen-
dent on caspases. In order to understand the molecular 
events leading to caspase-3 activation in FCV infection, we 
analysed early apoptotic events preceding caspase-3 activa-
tion. We saw a loss in Al/lm from 6 h p.i. and this coincided 
with the translocation of Bax to, and the release of 
cytochrome c from, mitochondria. The release of cyto-
chrome c was paralleled by caspase-9 processing and only 
at B h when it was completed did it correspond to the time 
of activation of caspase-3. It bas been reported that 
cytochrome c can be released from mitochondria during 
the extrinsic pathway as a result of the cleavage of Bid by 
caspase-B (McDonnell etal., 2003). However, this is unlikely 
to explain events in our system, since the caspase-B inhibitor 
acetyl-lle-Glu-Thr-Asp-aldehyde (100 11M) failed to inhibit 
or delay FCV-induced apoptosis (data not shown). These 
results strongly suggest that the mitochondrial pathway of 
apoptosis is triggered in FCV infection. 
The events upstream of Bax translocation to mitochondria 
in FCV-infected cells are currently under investigation. 
However, many other RNA viruses can trigger the mito-
chondrial pathway of apoptosis in infected cells. For 
example, poliovirus (PV) has been shown to induce apop-
tosis through this pathway, inducing cytochrome c release 
and activation of caspase-9 (Belov et al., 2003). Further-
more, expression of PV 3C protease in cells can trigger 
apoptosis (Barco et al., 2000). FCV protease shares features 
with the picornavirus superfamily 3C proteases and the 
potential role of this protein in FCV-triggered apoptosis 
is being investigated. Similarly, the 2C protein of avian 
encephalomyelitis virus has been shown to trigger apop-
tosis through the mitochondrial pathway (Liu et al., 2004). 
The FCV p39 protein contains the NTP-binding domain 
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conserved in picornavirus 2C proteins and it is attractive 
to speculate that it may act in a similar manner to the 
picornavirus 2C protein. However, it is possible that more 
than one FCV protein may be responsible for triggering 
apoptosis. While it is clear that FCV-infected cells undergo 
apoptosis, the biological consequences of this process in 
terms of virus replication are not known. It has been 
demonstrated that inhibition of apoptosis during astrovirus 
infection drastically decreases the amount of virus released 
from cells (Guix et aL, 2004), while inhibition of apop-
tosis in vesicular stomatitis virus infection has no effect 
on replication (Hobbs et aL, 2(03). Understanding the 
~ol«:uJar mechanisms of apoptosis triggered in calicivirus 
tnfecho~ may also be important in understanding the 
progressIon of disease in the animal. In addition, using 
FCV as a model may shed light on the mechanism of cell 
destruction in human calicivirus infections. It has been 
reported that calicivirus infections in intestinal transplant 
patients give rise to similar apoptotic features to those seen 
in allograft rejection (Kaufman et aL, 2003; Morotti et aL, 
2004) and therefore infection can be mistaken for rejection. 
Thus, it may be possible to define the specific apoptotic 
changes triggered during infection to help distinguish 
between infection and rejection. 
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